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„Der unermeßlich reichen, stets sich erneuernden Natur gegenüber wird der Mensch, 
soweit er auch in der wissenschaftlichen Erkenntnis fortgeschritten sein mag, 
immer das sich wundernde Kind bleiben  
und muss sich stets auf neue Überraschungen gefasst machen.“  
(Max Planck) 
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ABSTRACT 
This thesis describes the synthetic work on the natural product (−)-ent-oldhamine A 
(CHAPTER I), the establishment of a compound library with molecules featuring fivefold 
symmetry for a symmetry-based approach towards new ion channel blockers (CHAPTER II) 
and studies towards the self-assembly of highly symmetric polyhedra (CHAPTER III). 
The first and main chapter focuses on the synthesis design and the synthetic studies towards 
the norterpenoid alkaloid (−)-ent-oldhamine A. Due to its intriguing structure incorporating a 
highly unusual cyclopentadienyl anion that forms an internal salt with a tertiary ammonium 
ion and with the intention to perform full evaluation of its biological activities, this molecule 
was a logical target for total synthesis. The establishment of two key building blocks, first, of 
a highly functionalized pyrrolizidine featuring four of the five stereogenic centers of the 
natural product and, second, a bicyclic lactone is described. The synthesis of the pyrrolizidine 
portion was carried out asymmetrically in a series of elegant and highly robust reaction steps, 
which allowed a performance on multigram scales. For the synthesis of the bicyclic lactone 
building block, several methodologies were investigated and finally, a palladium-catalyzed 
[3+2] cycloaddition gave rise to the desired carbon framework in a straightforward fashion. 
Searching for new opportunities to control ion channels and thus neuronal activities, a new 
approach towards the design of potential drugs was explored that is described in the second 
chapter. It was intended to employ fivefold symmetric molecules as channel antagonists to 
match the inherent fivefold symmetry of pentameric ion channels and thus enable pentavalent 
binding. Hence, a series of compounds with fivefold symmetry was synthesized and subjected 
to biological screening to determine their potential in neuronal control. Indeed, some of these 
molecules were found to be very biologically active and pentameric ion channels are in fact 
their targets. 
Studies on the self-assembly of highly symmetric icosahedral structures are described in the 
third chapter. It was planned that fivefold symmetric small molecules having adequate 
coordinating groups would act as ligands on threefold symmetric transition metal complexes 
and thus assemble to highly symmetric polyhedra with dodecahedral structures. In the course 
of extensive experimental studies, new compounds could be characterized and several new 
crystal structures of interesting transition metal complexes were elucidated. 
 
VI 
INHALT 
Diese Dissertation beschreibt synthetische Studien am Naturstoff (−)-ent-Oldhamine A 
(CHAPTER I), die Erstellung einer Verbindungsbibliothek von fünffachsymmetrischen 
Verbindungen für einen symmetriebasierten Zugang zu Ionenkanalblockern (CHAPTER II) 
und Studien zum self-assembly hochsymmetrischer Polyeder (CHAPTER III).  
Das erste Kapitel konzentriert sich auf das Synthesedesign sowie auf synthetische Arbeiten 
am Norterpenoidalkaloid (−)-ent-Oldhamine A. Aufgrund seiner faszinierenden Struktur, die 
ein äußerst ungewöhnliches Zyklopentadienylanion aufweist, welches ein internes Salz mit 
einem tertiären Ammoniumion bildet, als auch der Absicht die vollständige biologische 
Aktivität dieses Moleküls zu evaluieren stellt dieser Naturstoff ein deduziertes Ziel für eine 
Totalsynthese dar. Konkret wird die Entwicklung von zwei Schlüsselbausteinen beschrieben. 
Zum Einen ist dies ein hochfunktionalisiertes Pyrrolizidin, das bereits vier der fünf 
stereogenen Zentren des besagten Naturstoffs aufweist und zum Anderen ein bizyklisches 
Lakton. Die Synthese des Pyrrolizidinbausteins wurde asymmetrisch in einer Reihe von 
eleganten und robusten Reaktionsschritten durchgeführt, die eine Umsetzung im 
Multigrammmaßstab erlaubten. Im Hinblick auf die Synthese des Laktonbausteins wurden 
verschiedene Synthesestrategien eruiert, wobei schließlich eine palladiumkatalysierte [3+2] 
Zykloaddition elegant zur Bildung des erwünschten Kohlenstoffgerüstes führte. 
Auf der Suche nach neuen Wegen zur Kontrolle von Ionenkanälen und damit neuronaler 
Aktivität wurde ein neuer Denkansatz zur Entwicklung potentieller Wirkstoffe untersucht, der 
im zweiten Kapitel beschrieben ist. Hierzu wurde die Anwendung fünffachsymmetrischer 
Moleküle angedacht, die der inhärenten Symmetrie pentamerer Ionenkanäle entsprechen und 
damit pentavalent an diese binden können. Dementsprechend wurde eine Reihe von 
Molekülen mit Fünffachsymmetrie synthetisiert und einem biologischem Screening 
unterworfen. Es stellte sich heraus, dass einige dieser Moleküle eine außerordentlich potente 
biologische Aktivität zeigen und dass tatsächlich pentamere Ionenkanäle deren Ziele sind. 
Studien zum self-assembly hochsymmetrischer, ikosaedrischer Strukturen sind im dritten 
Kapitel beschrieben. Fünffachsymmetrische kleine Moleküle mit geeigneten funktionellen 
Gruppen sollten als Liganden an dreifachsymmetrischen Übergangsmetallkomplexen agieren 
und sich durch Selbstorganisation zu hochsymmetrischen Strukturen mit dodekaedrischer 
Geometrie zusammenfügen. Im Zuge dieser Studien konnten einige interessante neue 
Verbindungen und Kristallstrukturen charakterisiert werden.  
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SUMMARY 
CHAPTER I: TOWARDS THE TOTAL SYNTHESIS OF OLDHAMINE A 
Daphniphyllum alkaloids are a structurally diverse group of natural products found in 
Daphniphyllum, a genus of dioecious evergreen trees and shrubs native to the Southeast of 
Asia. Presently, more than two hundred Daphniphyllum alkaloids have been isolated from this 
genus.[9] Some of them have been shown to exhibit considerable biological activities and 
alkaloidal extracts of their parent plants had applications in traditional folk medicine for the 
treatment of a variety of diseases.[4]-[7]  
One representative of this class of natural products is (+)-oldhamine A (I.226), a norterpenoid 
alkaloid featuring a highly unusual cyclopentadienyl anion in its fused-hexacyclic carbon 
skeleton (Figure A).[63]  
       
Figure A: (+)-Oldhamine A (I.226): a) Chemical structure; b) crystal structure. 
 
The unique structure of I.226 and the intent to perform a full biological and pharmaceutical 
characterization necessitated a launch of a total synthesis of this intriguing natural product. 
Possible synthetic precursors are depicted in Scheme A. 
 
Scheme A: (−)-ent-Oldhamine A (I.240) and its possible precursors in the total synthesis program. 
a) b) 
VIII 
In terms of the retrosynthetic analysis, which for economic reasons targeted the unnatural 
enantiomer (−)-ent-oldhamine A (I.240), it was planned to construct the quaternary 
stereogenic center in I.240 by a stereoselective addition of methyl cuprate to the fulvene 
system in I.241. The resulting anion could easily attack the vicinal methyl ester, thereby 
giving the natural product in an elegant and convenient fashion. Fulvene I.241 can be 
dissected by conjugate addition, subsequent enolate addition and a McMurry reaction to the 
bicyclic precursors I.322 and I.245. Lactone I.322 can be traced back to δ-valerolactone 
(I.302), while pyrrolizidine I.245 was planned to be made from L-glutamic acid (I.251). The 
synthesis in the “forward direction” is shown in Schemes B and C. 
Scheme B: Synthetic route towards pyrrolizidine I.245. 
 
Transferring this strategy, the synthesis started with I.251, which was converted into I.277 
over ten steps. Formation of two new stereogenic centers was directed by the stereochemical 
information of natural L-glutamic acid (I.251). A conjugate addition of the sterically hindered 
secondary amine I.277 to ethyl propiolate and subsequent reduction furnished tertiary 
amine I.247. Finally, a Dieckmann cyclization gave rise to pyrrolizidine I.245, which features 
four of the five stereogenic centers present in the natural product.  
 
 
Scheme C: Synthetic route towards lactone I.322. 
 
Concerning lactone I.322, the synthesis started from δ-valerolactone (I.302), which was 
unsaturated in two steps (→ I.256) and then coupled in a [3+2] cycloaddition with acetate 
I.255 using a methodology, which has been developed by Trost and coworkers.[72] Resulting 
intermediate I.298 was dihydroxylated and protected to give key building block I.322. 
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Figure D: Chemical structure and shape on the basis of selected crystal structures of fivefold symmetric small 
molecules prepared for the symmetry approach. 
 
Pleasingly, it was found that some of these molecules are highly biologically active and 
indeed pentameric ion channels are their targets. More specifically, it was sodium 
pentacyanocyclopentadienide II.10, which was found to be a potent open channel blocker of 
the GABAA receptor (IC50 = 1.3 µM). In cooperation with Prof. Dr. Erwin Sigel and Novartis 
AG, the detailed mode of action is currently being studied and its potential application as an 
insecticide is investigated. 
 
CHAPTER III: SELF-ASSEMBLY OF HIGHLY SYMMETRIC MOLECULES 
Fivefold symmetric molecules appear to be suitable building blocks for highly symmetric 
organometallic complexes.[144]-[149] Based on model studies, it was speculated that the 
pentacyanocyclopentadienide anion could act as a ligand on facially substituted threefold 
symmetric transition metal complexes and thus, due to the distances and angles „encoded“ in 
these building blocks, self-assemble into highly symmetric polyhedra (Figure E). 
       
Figure E: Self-assembly of a molecular dodecahedron: a) Schematic illustration of a single vertex; b) model of a 
dodecahedral arrangement of [Cr(CO)3]20[C10N5]1212-. 
a) b) 
 XI 
In order to „neutralize“ the 12 negative charges that would accumulate in a dodecahedron 
formed of a neutral transition metal complex and the anionic ligand, tight ion pair salts of 
pentacyanocyclopentadienide with fivefold symmetric counter ion were synthesized 
(Scheme D).  
                    
Scheme D: Decamethylferrocenium pentacyanocyclopentadienide (III.3): a) Synthesis; b) crystal structure. 
 
This counter ion was found in the decamethylferrocenium cation, which could be introduced 
by a simple salt metathesis with III.3. X-ray analysis of a single crystal confirmed the 
structure of III.17 and showed an orthogonal arrangement of discrete ion pairs. 
A number of facially substituted threefold symmetric transition metal complexes was 
prepared and reacted with pentacyanocyclopentadienide salts. Upon extensive experimental 
efforts, several new compounds and crystal structures could be characterized. When, for 
example, [Cr(MeCN)3(CO)3] (III.4) was treated with III.17, formation of an interesting 
metallocene complex with an intriguing structure was observed (Scheme E). 
      
Scheme E: Metallocene (C5Me5)2Cr0.33Fe0.67C10N5 (III.18): a) Synthesis; b) crystal structure. 
 
Discrete ion pairs arrange towards each other in a shifted but linear fashion, thus generating 
linear metallocenium pentacyanocyclopentadienide rods. This fascinating structure represents 
a new and highly unusual fivefold symmetric metallocenium salt. 
a) b) 
a) b) 
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CHAPTER I: TOWARDS THE TOTAL SYNTHESIS OF 
OLDHAMINE A 
1.1 Project Background and Aims 
1.1.1  Daphniphyllum Alkaloids 
Nature has always been a great source of inspiration for chemists. She manages to solve 
complex problems in efficient and elegant ways, making the accomplishment look simple. 
One impressive example is how small molecules with low molecular weight are used in many 
different ways to perform highly specific tasks.  
Thus, it is not surprising that studying natural products has been demonstrated to be the most 
important source of discovery of pharmaceutical drugs.[1] Their development has heavily 
contributed to the elongation of life expectancy to an average of 80 years in 2012 in 
industrialized countries and is thus of great significance for mankind.[2]  
A rich source of a large number of natural products with diverse structures is the genus 
Daphniphyllum, which comprise the dioecious evergreen trees and shrubs of the family 
Daphniphyllaceae. These vegetals are native to the east and Southeast of Asia and 
predominantly to Japan.[3] Crude extracts from these trees have been used in traditional folk 
medicine for many purposes such as the treatment of asthma.[4] Some natural products 
isolated from these plants were also shown to have considerable cytotoxic effects,[5] 
antioxidation properties,[6] and some also enhance neurotropic factor biosynthesis.[7] 
However, the overall biological functions and pharmacology of the Daphniphyllum alkaloids 
are poorly studied to date due to their limited natural supply. 
Since the isolation of the first alkaloid from Daphniphyllum was reported in 1909,[8] these 
natural products have attracted considerable attention by research groups worldwide resulting 
in the identification of more than 230 Daphniphyllum alkaloids to date. Hence, a series of 
manifold complex polycyclic structures has been elucidated, which have been classified 
according to their carbon skeletons.[9] Up to now, 22 different structural types have been 
characterized. This number is likely to further increase given that new compounds from this 
genus are continuously discovered. In 2012 alone, three new structures were disclosed.[10] In 
order to illustrate the diversity of these compounds, a complete collection of carbon skeletons 
present in Daphniphyllum alkaloids is shown in Figure I.1. The structures are ordered and 
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classified by their carbon backbone.[9] However, members of each skeletal class can heavily 
differ by their oxidation states and degree of functionalization.  
 
Daphniphylline-type Secodaphniphylline-type 
 
Leaves of 
Daphniphyllum 
oldhamii, 2008.[11] 
Potent effects against 
platelet aggregation. 
 
Roots of Daphniphyllum 
oldhamii, 2007.[6] 
Antioxidant activities 
against hydrogen 
peroxide-induced 
impairment in PC12 cells. 
Yuzurimine-type Daphnilactone A-type 
 
Whole plant of 
Daphniphyllum 
angustifolum HUTCH, 
2011.[12] 
Weak inhibition of 
tumor growth against 
HL-60, MCF-7 and 
A549 cell lines. 
 
Leaves of Daphniphyllum 
teijsmannii, 2011.[13] 
Unusual 2,8-dioxabicyclo 
[3.2.1] octane moiety. 
Daphnilactone B-type Yuzurine-type 
 
Leaves of 
Daphniphyllum 
humile, 2006.[14] 
Features a seven-
membered lactone 
moiety. 
 
Fruits of Daphniphyllum 
longeracemosum, 
2010.[15] 
Spiro Daphniphyllum 
alkaloid. 
Bukittinggine-type Daphnezomine A-type 
 
Twigs of 
Daphniphyllum 
calycinum, 2008.[16] 
Features a 
[5-6-6-5-5-7] 
hexacyclic core. 
 
Leaves of Daphniphyllum 
humile, 1999.[17] 
Contains an aza-
adamantane core. 
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Daphnezomine F-type Daphnezomine L-type 
 
Fruits of 
Daphniphyllum 
longeracemosum, 
2011.[18] 
Contains 
1-azabicyclo[5.2.2] 
undecane ring 
system.  
Twigs of Daphniphyllum 
calycinum, 2008.[16] 
Unusual 2,3,4,5-
tetrahydropyridine 
moiety. 
Daphnicyclidin-type Daphmanidin A-type 
 
Whole plant of 
Daphniphyllum 
angustifolum HUTCH, 
2011.[19] 
Diamino 
Daphniphyllum 
alkaloid. 
 
Leaves of 
Daphniphyllum 
teijsmannii, 2011.[13] 
Shows moderate 
cytotoxicity against 
murine lymphoma L1210 
cells. 
Daphmanidin C-type Daphniglaucin A-type 
 
Leaves of 
Daphniphyllum 
teijsmannii, 2005.[20] 
Together with 
daphmanidin C the 
sole member of this 
group to date. 
 
Whole plant of 
Daphniphyllum 
angustifolum HUTCH, 
2011.[12] 
Effects against platelet 
aggregation. 
Daphniglaucin C-type Calyciphylline A-type 
 
Fruits of 
Daphniphyllum 
macropodum, 
2007.[21] 
Features a [5-6-7-5] 
tetracyclic core. 
 
Leaves of 
Daphniphyllum 
glaucenses, 2004.[22] 
Highly fused hexacyclic 
core. 
Calyciphylline B-type Calyciphylline C-type 
 
Leaves of 
Daphniphyllum 
oldhamii, 2004.[23] 
Features nine 
stereogenic centers. 
 
Fruits of Daphniphyllum 
macropodum, 2007.[24] 
Features an unusual 
azetidine ring. 
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Calyciphylline D-type Paxdaphnine A-type 
 
Leaves of 
Daphniphyllum 
calycinum, 2007.[25] 
Features a [6-5-5-5] 
tetracyclic core. 
 
Fruits of Daphniphyllum 
longeracemosum, 
2008.[26] 
Heptacyclic ring system. 
Calyciphylline G Angustimine 
 
Stem of 
Daphniphyllum 
calycinum, 2007.[27] 
Contains a 2-H 
pyrrolium ring. 
 
Whole plant of 
Daphniphyllum 
angustifolum HUTCH, 
2011.[19] 
Sole representative of this 
group. 
 
Figure I.1: A selection of Daphniphyllum alkaloids, illustrating all their different skeletal types together with source 
and year of the first isolation. 
 
This diversification among all the Daphniphyllum alkaloids is remarkable since they are 
proposed to biosynthetically arise from a common precursor: By performing feeding 
experiments, it was shown that the Daphniphyllum alkaloids are all derived from squalene 
(I.23, Scheme I.1).[28] Since the number of carbon atoms in the framework can vary due to 
biosynthetic modifications, the Daphniphyllum alkaloids can not generally be classified by 
means of a compound class. However, being commonly derived from I.23, they are often 
referred to as norterpenoid alkaloids,[9] although it would be more descriptive to call them 
triterpenoid and nortriterpenoid alkaloids.  
A detailed mechanism for the formation of the secodaphnan framework from squalene was 
originally proposed by Heathcock and coworkers (Scheme I.1).[29] They were able to support 
their concept by a biomimetic total synthesis of (±)-proto-daphniphylline, utilizing the 
proposed pentacyclization pathway (vide infra, Section 1.1.2, Scheme I.7).[30] Even though 
participation of I.23 in the biosynthesis of the Daphniphyllum alkaloids was already 
suggested before,[28, 31] it was the success of this work which attracted large interest for the 
elucidation of detailed biosynthetic mechanisms and pathways towards other skeletal types of 
the Daphniphyllum alkaloids.[9],[32] 
1.1 Projekt Background and Aims 
 
5 
 
Scheme I.1: Proposed biosynthetic pathway to secodaphniphylline-type alkaloids from squalene (I.23) without 
showing enzymatic activities.  
 
In the first step, squalene (I.23) could oxidatively be transformed into dialdehyde I.24 with 
loss of one double bond to form a desymmetrized species containing an enone and an 
aldehyde. This was proposed to occur via imine formation with an amine provided by either 
an enzyme[32a] or pyridoxamine, followed by prototopic rearrangement.[33] The corresponding 
enolate I.25 could then undergo an intramolecular conjugate addition, followed by cyclization 
of I.26 to afford hemiketal I.27. Formal condensation with one equivalent of ammonia 
(presumably provided by pyridoxamine) could give rise to 2-azadiene I.28, which would then 
be set up to form tetrahydropyridine I.29 via an intramolecular Diels-Alder reaction. This 
intermediate could undergo an Alder-Ene reaction to provide pentacycle I.30, which, upon 
reduction, would furnish the framework of the secodaphniphylline-type alkaloids (I.31).[9]  
Their structural complexity and beauty has attracted the attention of synthetic chemists and a 
number of approaches to several of the Daphniphyllum alkaloids have been reported so far. 
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The construction of their polycyclic frameworks is the key task in their strategies. Many of 
these syntheses stand out for their use of elegant domino reactions, building key frameworks 
in a single step. A complete description of these follows in the next section.  
 
1.1.2  Synthetic Approaches towards the Daphniphyllum Alkaloids 
 
1.1.2.1 Turner´s approach towards (±)-methyl homosecodaphniphyllate 
The first attempt to construct the complex core of homosecodaphniphylline-type alkaloids 
was performed in 1983 by the group of Turner, who aimed for a Diels-Alder approach using 
acceptor-substituted dienophiles in an effort towards (±)-methyl homosecodaphniphyllate 
(I.36, Scheme I.2).[34] 
 
Scheme I.2: First synthetic approach towards Daphniphyllum alkaloids - construction of the tricyclic core of 
(±)-methyl homosecodaphniphyllate (I.36). 
 
Starting from diene I.32 and enone I.33, a regioselective suprafacial endo-addition under 
thermal conditions gave tricycle I.34 in a moderate 20 % yield. I.34 could then be converted 
in three steps into tetracycle I.35, which already features the core skeleton of (±)-methyl 
homosecodaphniphyllate (I.36). 
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1.1.2.2 Yamamura´s approach towards (±)-codaphniphylline 
The group of Yamamura reported in 1986 a synthesis of the northern part of 
(±)-codaphniphylline (I.44, Scheme I.3),[35] a daphniphylline-type alkaloid which they had 
previously isolated and characterized.[36] Their synthesis was of great use to confirm the 
proposed structure. 
 
Scheme I.3: A synthetic approach towards the northern part of (±)-codaphniphylline (I.44) to confirm the structure 
of I.44. 
 
Geraniol (I.37) was converted in four steps into acetate I.38, which was then subjected to 
mercury-promoted cyclization, reductive demercuration and subsequent oxidation to yield 
ketone I.39. This intermediate was processed in four steps into thioacetal I.40, which upon 
oxidation and spontaneous lactone formation was chemoselectively reduced and acetylated to 
furnish bicycle I.41. Compound I.41 was converted over four steps into alkene I.42, which 
was subjected to ozonolysis followed by reductive workup to result in spontaneous formation 
of desired ketal I.43, which features the northern part of (±)-codaphniphylline (I.44).  
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1.1.2.3 Heathcock´s first generation synthesis of (±)-methyl homodaphniphyllate 
The total synthesis of (±)-methyl homodaphniphyllate (I.51, Scheme I.4) in 1986 represents 
the first completed total synthesis of a Daphniphyllum alkaloid. It was executed by the group 
of Heathcock, who dominated this field in the following years by presenting a series of 
elegant total syntheses of several Daphniphyllum alkaloids with different skeletal types. The 
first generation synthesis of I.51 was carried out in 14 linear steps and provided the natural 
product in an overall yield of 2 %.[37] 
 
Scheme I.4: Total synthesis of (±)-methyl homodaphniphyllate (I.51). 
 
Amide formation of ketone I.45 with acetal I.46 followed by acid-catalyzed iminium ion 
formation and intramolecular nucleophilic trapping by means of a Mannich-type reaction gave 
rise to tetracycle I.47. This molecule was then converted in six steps into enone I.48. An E/Z 
unselective aldol condensation with acetaldehyde followed by acid-mediated hydrolysis of the 
ketal triggered an intramolecular conjugate addition to furnish I.49, which exhibits the cyclic 
core of the natural product. Conjugate addition of methyl cuprate and trapping the resulting 
enolate with diethyl phosphochloridate gave an enol phosphate, which was transformed into a 
double enol phosphate using LDA and diethyl phosphochloridate. The resulting intermediate 
was then reduced with lithium in tert-butanol and ethyl amine to give the deoxygenated and 
O-deprotected alkene I.50. The following reduction was achieved using highly optimized 
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conditions employing Pearlman´s catalyst with high pressure of hydrogen and at high 
temperature, under which a 1:1 mixture of diastereomers with respect to the isopropyl group 
was obtained. This mixture of diastereomers was subjected to Jones oxidation and Fischer 
esterification and could then be separated to give (±)-methyl homosecodaphniphyllate (I.51). 
 
1.1.2.4 Heathcock´s second generation synthesis of (±)-methyl homodaphniphyllate 
In 1989, Heathcock et al. reported the second generation synthesis of (±)-methyl 
homodaphniphyllate (I.51, Scheme I.5), employing a bio-inspired sequence, which featured a 
condensation/Diels-Alder/Alder-Ene cascade reaction previously developed in their own 
laboratories (vide supra, Section 1.1.1, Scheme I.1).[38],[39] By implementing this elegant 
domino reaction sequence, the number of linear steps was reduced to 12 and the overall yield 
was significantly improved to 13 %.[40],[41] 
 
Scheme I.5: Second generation synthesis of (±)-methyl homodaphniphyllate (I.51). 
 
The synthesis started with ester I.52, which was converted in three steps into dibromide I.53. 
This intermediate then participated in a Reformatsky reaction to give tricyclic lactone I.54. 
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Upon LAH reduction, diol I.55 was obtained, which was subsequently oxidized using Swern 
conditions. Reacting the corresponding dialdehyde in situ with a stream of gaseous ammonia 
resulted in the formation of a 2-azadiene, which upon treatment with acid underwent an 
intramolecular Diels-Alder/Alder-Ene cascade reaction to yield amine I.56. Reduction of the 
methylene group was then performed using hydrogen in the presence of Adam´s catalyst and 
the resulting intermediate was treated with DIBAL-H. This triggered a ring opening via a 
retro aza-Prins reaction and the reduction of the resulting iminium ion to provide alcohol I.57. 
Double addition of phenyl isocyanate followed by acid-mediated cyclization led to formation 
of carbamate I.58, which could be transformed to (±)-methyl homodaphniphyllate in three 
steps. Trapping the secondary amine with phenyl isocyanate was necessary to prevent 
protonation of the amine in the subsequent ring closing step. 
 
1.1.2.5 Heathcock´s first generation synthesis of (±)-methyl homosecodaphniphyllate 
The total synthesis of (±)-methyl homosecodaphniphyllate (I.36) was reported by the 
Heathcock group in 1988 (Scheme I.6). This synthesis was carried out in only nine linear 
steps, making use of the bio-inspired condensation/Diels-Alder/Alder-Ene cascade reaction 
(vide supra, section 1.1.1, Scheme I.1) to obtain the natural product in an overall yield of 
48 %. This biomimetic approach opened a short, elegant and convenient pathway towards the 
secodaphniphylline-type alkaloids.[39] 
 
Scheme I.6: First generation synthesis of (±)-methyl homosecodaphniphyllate (I.36). 
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Amide I.59 was turned into the corresponding lithium enolate, which underwent a conjugate 
addition into ester I.60 before being trapped with homogeranyl iodide (I.61). The resulting 
intermediate I.62 was then converted in three steps into diol I.63. Swern oxidation followed 
by reaction of the resulting dialdehyde with ammonia gave a 2-azadiene, which underwent an 
acid-catalyzed Diels-Alder/Alder-Ene cascade reaction to give pentacycle I.64. Having the 
desired carbon framework in hands, (±)-methyl homosecodaphniphyllate (I.36) could be 
obtained after three further steps. 
 
1.1.2.6 Heathcock´s second generation synthesis of (±)-methyl homosecodaphniphyllate 
A second generation synthesis of (±)-methyl homosecodaphniphyllate (I.36, Scheme I.7) was 
described by Heathcock et al. in 1990. This synthesis includes a biomimetic transformation of 
a squalene-derived bisaldehyde I.24 into (±)-proto-daphniphylline (I.30) via the proposed 
biosynthetic pathway for the formation of the secodaphniphylline-type alkaloids (i.a. Michael 
addition/condensation/Diels-Alder/Alder-Ene cascade, vide supra, Section 1.1.1, Scheme I.1). 
Even though obtaining the natural product in nine linear steps in an overall yield of 18 % 
appears less efficient than the first generation synthesis, employing the proposed biological 
intermediate, bisaldehyde I.24 and constructing all rings in one single step using simple 
reaction conditions is of great significance. This makes for one of the most elegant total 
syntheses reported so far.[30, 32a] 
CHAPTER I: Towards the Total Synthesis of Oldhamine A 
12 
 
Scheme I.7: Biomimetic total syntheses of (±)-proto-daphniphylline (I.30) and (±)-methyl 
homosecodaphniphyllate (I.36). 
 
Tert-butyl (trimethylsilyl)acetate (I.65) was alkylated with homogeranyl iodide (I.61) to give 
ester I.66. Peterson-type olefination with aldehyde I.67 followed by double reduction and 
double Swern oxidation yielded bisaldehyde I.24. After treatment of I.24 with KOH to trigger 
a Michael addition, the reaction mixture was exposed to gaseous ammonia to form a 
2-azadiene, which, upon heating in acetic acid, underwent an intramolecular 
Diels-Alder/Alder-Ene cascade reaction to furnish (±)-proto-daphniphylline (I.30). 
Compound I.30 could then be converted into (±)-methyl homosecodaphniphyllate (I.36) in 
four steps. 
 
1.1.2.7 Heathcock´s total synthesis of (±)-daphnilactone A 
In 1989, Heathcock and coworkers succeeded in synthesizing (±)-daphnilactone A (I.68, 
Scheme I.8). The synthesis proceeded over eleven linear steps and produced the natural 
product in 9 % overall yield. Alcohol I.57, which was accessible via the condensation/Diels-
Alder/Alder-Ene cascade reaction, was a common intermediate in both the total synthesis of 
(±)-methyl homodaphniphyllate (I.51, Scheme I.5) and the total synthesis of I.68.[38],[41] 
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Scheme I.8: Total synthesis of (±)-daphnilactone A (I.68). 
 
Alcohol I.57 was first subjected to Jones oxidation. The resulting carboxylic acid then 
participated in an oxa-Prins-Mannich-type reaction employing a formalin solution in an 
aqueous phosphate buffer. This reaction sequence furnished (±)-daphnilactone A (I.68) in 
50 % yield. 
 
1.1.2.8 Heathcock´s asymmetric total syntheses of (−)-methyl homosecodaphniphyllate 
and (−)-secodaphniphylline 
Another important achievement realized by the Heathcock group was the first asymmetric 
total synthesis of a Daphniphyllum alkaloid. In 1990, they introduced an asymmetric third 
generation synthesis of (−)-methyl homosecodaphniphyllate (I.79, Scheme I.9) and the total 
synthesis of (−)-secodaphniphylline (I.80, Scheme I.9). The northern part was constructed by 
means of a stereoselective carbonyl reduction using a chiral reducing agent. The synthesis of 
the southern part was accomplished using the previously established strategy employed for 
the racemic total synthesis of (±)-methyl homosecodaphniphyllate (I.36, vide supra, 
Scheme I.6), but starting from an L-alanine-derived chiral amide I.75. Thus, the total 
synthesis of I.80 proceeds over 9 linear steps and affords the natural product in 10 % overall 
yield.[42] 
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Scheme I.9: Asymmetric total syntheses of (−)-methyl homosecodaphniphyllate (I.79) and 
(−)-secodaphniphylline (I.80). 
 
After converting carboxylic acid I.69 into ketone I.70, an asymmetric reduction using a chiral 
aluminum complex with Darvon alcohol (I.71) afforded the enantiomerically enriched alkyne 
I.72. Alkyne zipper reaction followed by alkoxymercuration and ketal hydrolysis resulted in 
spontaneous cyclization to desired ketal I.73, which was converted in five steps into acid 
chloride I.74.  
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Chiral amide I.75 was subjected to a previously described Michael addition/alkylation 
sequence (vide supra, Scheme I.9) combining I.60 and I.61 to give intermediate I.76. Upon 
conversion into diol I.77 and oxidation to the dialdehyde, the Michael 
addition/condensation/Diels-Alder/Alder-Ene reaction sequence (vide supra, Section 1.1.1, 
Scheme I.1) gave rise to enantiomerically pure benzyl ether I.78. This intermediate was 
converted into (−)-methyl homosecodaphniphyllate (I.79) in three steps. Mixed Claisen 
condensation with acid chloride I.74 followed by Krapcho decarboxylation finally afforded 
(−)-secodaphniphylline (I.80). 
 
1.1.2.9 Heathcock´s total synthesis of (±)-bukittinggine 
The total synthesis of (±)-bukittinggine (I.90, Scheme I.10), which is the eponymous 
representative of its skeletal type within the Daphniphyllum alkaloids, was reported by the 
Heathcock group in 1992. The established condensation/Diels-Alder/Alder-Ene cascade 
reaction (vide supra, Section 1.1.1, Scheme I.1) was again key transformation in the 
synthesis. A palladium-catalyzed cyclization led to formation of the hexacyclic framework of 
I.90, thus providing the natural product in 14 % overall yield over 11 steps.[43] 
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Scheme I.10: Total synthesis of (±)-bukittinggine (I.90). 
 
Starting from benzyl ether I.81, ester I.82 was obtained in two steps and was then converted 
into alkene I.84 via a cuprate conjugate addition employing I.83. Iodide I.85 was obtained in 
5 steps from I.84. This building block was then employed as electrophile in the previously 
developed Michael addition/alkylation sequence (vide supra, Scheme I.9). Upon treatment of 
amide I.59 with LDA followed by addition of ester I.60 and I.85, benzyl ether I.86 was 
obtained. It was converted into diol I.87 in three steps. Serial treatment of I.87 under Swern 
conditions, gaseous ammonia and warm acetic acid resulted in the desired cascade reaction to 
form pentacycle I.88. The key C-N-bond was formed via intramolecular aminopalladation to 
give hexacycle I.89, which could be converted in five steps into (±)-bukittinggine (I.90). 
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1.1.2.10 Heathcock´s asymmetric total synthesis of (+)-codaphniphylline 
In 1995, Heathcock and coworkers developed an asymmetric total synthesis of 
(+)-codaphniphylline (I.99, Scheme I.11). The synthesis started from previously reported 
enantiomerically enriched compound I.92, which was accessible by Noyori asymmetric 
reduction and featured the well-established condensation/Diels-Alder/Alder-Ene cascade 
reaction (vide supra, Section 1.1.1, Scheme I.1) to form the polycyclic secodaphniphylline 
carbon skeleton. This core structure could then be converted into the daphniphylline skeleton 
of I.99 using a previously developed strategy (vide supra, Scheme I.5). Overall, this 
asymmetric synthesis proceeded over 17 steps and furnished the natural product in 9 % 
yield.[44] 
 
 
Scheme I.11: Total synthesis of (+)-codaphniphylline (I.99). 
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A Noyori asymmetric reduction of ketoester I.91 provided starting alcohol I.92 in good yield 
and enantiomeric purity. Alkylation of this compound with homogeranyl iodide (I.61) gave 
ester I.93, which was converted in four steps into halide I.94. A Reformatsky reaction 
utilizing inactivated zinc dust in the presence of zinc chloride resulted in formation of lactone 
I.95, which was then reduced to the corresponding diol I.96. Swern oxidation gave a 
dialdehyde, which was reacted in situ with methylamine to undergo the previously developed 
Diels-Alder/Alder-Ene cascade reaction (vide supra, Section 1.1.1, Scheme I.1). This 
sequence provided a tertiary cation which underwent an intramolecular hydride transfer to 
give an iminium ion. This species was hydrolyzed upon aqueous workup to provide directly 
the saturated pentacycle I.97. From this intermediate, iodide I.98 was obtained in six further 
steps. Chiral alcohol I.73, a building block which had been prepared during the asymmetric 
synthesis of (−)-secodaphniphylline (I.80, vide supra, Scheme I.9) was converted in five steps 
into aldehyde I.100. Lithiation of I.98 and subsequent treatment with aldehyde I.100 gave a 
mixture of alcohols, which was directly subjected to Jones oxidation to furnish 
(+)-codaphniphylline (I.99). 
 
1.1.2.11 Denmark´s approach towards (±)-daphnilactone B 
In the course of their study on tandem double-intramolecular [4+2]/[3+2] cycloadditions of 
nitroalkenes,[45] the group of Denmark successfully built in 2009 the south-western part of the 
daphnilactone B-type alkaloids. The key transformation involved a tetracyclic nitroso acetal 
I.110, which resembles the core structure of (±)-daphnilactone B (I.114, Scheme I.12) and 
encouraged to devise a strategy for the total synthesis.[46]  
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Scheme I.12: Tandem double-intramolecular [4+2]/[3+2] cycloaddition approach towards daphnilactone B-type 
alkaloids. 
 
Enantiomerically enriched epoxide I.102 was available from the racemate I.101 using 
Jacobsen´s hydrolytic kinetic resolution protocol,[47] and was converted into I.103 in three 
steps. A carbocupration using I.104 followed by a palladium-catalyzed cross coupling with 
iodide I.105 afforded alcohol I.106. Compound I.107, which was obtained in 12 steps from 
I.106 was then treated with SnCl4. This gave rise to an intramolecular exo-hetero Diels-Alder 
reaction between the electron rich trisubstituted olefin and the heterodiene contained in the 
nitroolefin moiety. Subsequent intramolecular [3+2] cycloaddition between the resulting 
nitronate and the electron poor double bond formed nitroso acetal I.108 together with 
diastereoisomer I.109. Isomer I.108 was separated and subjected to ozonolysis in the presence 
of sodium methoxide followed by reductive workup to obtain methyl ester I.110. 
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Raney-nickel mediated hydrogenation and subsequent TBS protection gave lactone I.111. 
After formation of an amine-borane complex, cyclization could be achieved using 
triethylamine in the presence of platinum on charcoal to yield lactam I.112. Reduced 
pentacycle I.113 could then be obtained in two further steps. This completed the western 
carbon framework of (±)-daphnilactone B (I.114). 
 
1.1.2.12 Bonjoch´s approach towards (±)-calyciphylline A 
The group of Bonjoch reported in 2005 their work on methyloctahydroindoles on a way to 
calyciphylline A-type alkaloids such as (±)-calyciphylline A (I.122, Scheme I.13). The key 
step was a palladium-catalyzed intramolecular coupling of an amino-tethered vinyl bromide 
with the α-position of a ketone.[48] 
 
Scheme I.13: Construction of the south-western part of (±)-calyciphylline A (I.122). 
 
Ketone I.115 was alkylated in a six-step sequence to form alkene I.116, which was subjected 
to a tandem ozonolysis/double reductive amination sequence to provide amine I.117. This 
intermediate was converted in three steps into bromide I.118 and was then engaged in a 
palladium-catalyzed cyclization to give tricycle I.119. In order to achieve reduction of the 
alkene with the correct diastereoselectivity, a Luche reduction employing sodium borohydride 
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was performed. The resulting amine-borane complex could be reduced in a diastereoselective 
manner using hydrogen in the presence of a chiral rhodium catalyst. Saturated tricycle I.120 
was converted in two steps into ketone I.121, which features the carbon skeleton of the south-
western part of (±)-calyciphylline A (I.122). 
 
1.1.2.13 Tanabe´s approach towards the construction of the ring system of 
(±)-daphnezomine C 
In 2007, Tanabe and coworkers reported their studies on ring closing metathesis for the 
formation of the 11-membered ring system of the secodaphniphylline-type alkaloid 
(±)-daphnezomine C (I.132, Scheme I.14).[49] 
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Scheme I.14: Studies on a RCM approach towards (±)-daphnezomine C (I.132). 
 
Dimethylmalonate (I.123) was the common starting material for both the mixed anhydride 
I.124 and the TBS ether I.125. Addition of the lithium enolate of I.125 to I.124 led to 
formation of ester I.126. Upon O-deprotection and oxidation, aldehyde I.127 was obtained, 
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which was heated in the presence of ammonium acetate and acetic acid to give a mixture of 
dihydropyridine I.128 and undesired Diels-Alder product I.129. In order to convert I.128 to 
macrocyclic compound I.130, I.129 was subjected to several ring closing metathesis 
conditions. However, no conditions could be found to achieve this transformation. The initial 
plan was to subsequently undergo a Diels-Alder reaction to form tetracycle I.131, which 
would have already featured the southern section of I.132. Thus, the group concluded that 
molecules of the type I.128 were too rigid and therefore inappropriate for a RCM approach 
towards (±)-daphnezomine C (I.132). 
 
1.1.2.14 Overman´s approach towards (+)-daphnipaxinin 
An asymmetric approach towards the skeleton of the daphnicyclidin-type alkaloids was 
described in 2009 by Overman et al. The key transformation was an aza-Cope-Mannich 
reaction, which was utilized to construct the [7-5] bicyclic ring system, also setting the correct 
stereochemistry at the important quaternary stereogenic center at the ring junction. The third 
cycle was formed via a ring closing metathesis, thus completing the south-western part of 
(+)-daphnipaxinin (I.145, Scheme I.15).[50] 
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Scheme I.15: Synthesis of the south-western part of (+)-daphnipaxinin (I.145). 
 
An organocatalytic asymmetric Diels-Alder reaction of diene I.134 with dienophile I.133 
gave a chiral aldehyde,[51] which was methylated using nickel-catalysis to give alcohol 
I.135.[52] This compound was converted in ten steps into ketone I.136, which was subjected to 
stereoselective addition of lithiated I.137 to give alkene I.138. Treatment with silver nitrate 
led to in situ generation of an iminium ion, which underwent a sequence of aza-Cope 
rearrangement followed by Mannich reaction to form bicycle I.139. Addition of 
vinylmagnesium bromide (I.140) provided allylic alcohol I.141, which underwent ring 
closing metathesis in the presence of Grubbs second generation catalyst I.142. The resulting 
tricyclic amine I.143 was converted in four steps into ammonium salt I.144, which already 
features the south-western rings of (+)-daphnipaxinin (I.145). 
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1.1.2.15 Iwabuchi´s approach towards (−)-ent-daphnicyclidin A 
Another approach towards the daphnicyclidin alkaloids was reported by Iwabuchi and 
coworkers in 2009 when they presented their strategy to construct the tricyclic southern core 
of (−)-ent-daphnicyclidin A (I.160, Scheme I.16). The synthesis features a highly 
stereoselective conjugate addition of nitromethane, an Ireland-Claisen rearrangement and a 
tandem acyliminium Mannich-type reaction.[53] 
 
Scheme I.16: Synthesis of the southern part of (−)-ent-daphnicyclidin A (I.160). 
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After conversion of cycloheptanone (I.146) into 8-phenyl-(−)-menthyl ester I.147, a 
diastereoselective alkylation using the lithium salt of nitromethane followed by the trapping 
of the resulting enolate with TIPSOTf gave nitrocompound I.148. This intermediate was then 
converted into amine I.149 in two further steps. Acetal I.150, which was available from 
D-mannitol, was the precursor of ester I.151. Compound I.151 was turned into the 
corresponding TBS-enol ether, and, upon treatment with acid, it underwent an Ireland-Claisen 
rearrangement to give acid I.152. Ketal I.153 was obtained after four further steps and was 
then coupled with I.154 to give amide I.155. This intermediate was sequentially treated with 
TsCl in the presence of a base and TBAF to achieve a one-pot elimination and deprotection. 
Following hydrogenation gave ketone I.156, which was carried on as a mixture of 
diastereomers with respect to the newly generated stereogenic center. In situ generation of 
HCl resulted in acetal cleavage and subsequent formation of an acyliminium ion, which 
directly underwent a Mannich-type reaction to give I.157 and I.158. The minor isomer I.157 
was allylated to yield tricyclic amine I.159, which was planned to be used as building block to 
complete the total synthesis of (−)-ent-daphnicyclidin A (I.160). 
 
1.1.2.16 Carreira´s asymmetric total synthesis of (+)-daphmanidin E 
In 2011, the group of Carreira reported an asymmetric total synthesis of the 
daphmanidin A-type alkaloid (+)-daphmanidin E (I.174, Scheme I.17). Key transformations 
were a series of two subsequent Claisen rearrangements to install a quaternary stereogenic 
center in a hindered position and a cobalt-catalyzed alkyl-Heck cyclization. Overall, the 
synthesis proceeded over 27 linear steps and provided the natural product in 0.3 % yield.[54]  
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Scheme I.17: Total synthesis of (+)-daphmanidin E (I.174). 
 
Enantiomerically enriched bicyclo[2.2.2]octadienone I.161 was accessible from diethyl 
succinate and could be resolved by either enzymatic resolution of the racemate or by 
chromatographic separation of the corresponding diastereomeric hydrazones. I.161 was 
converted in five steps into acetal I.162, which was O-alkylated with cyclic alkene I.163 to 
form enol ether I.164. Upon heating, this compound underwent a Claisen rearrangement to 
provide ketone I.165. A similar sequence of O-allylation/Claisen rearrangement using I.166 
was repeated to give alkene I.167, thus selectively establishing the desired quaternary 
stereocenter. Nitroolefin I.168, which was generated from I.167 in seven steps, was 
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diastereoselectively methylated using dimethylzinc in the presence of copper(I) and chiral 
ligand I.169 to give nitroalkane I.170. Compound I.170 was converted in three steps into 
iodide I.171, which underwent alkyl-Heck-type cyclization in the presence of cobalt catalyst 
I.172 and blue light in excellent yield. The resulting tetracyclic ketone I.173 could be 
converted into (+)-daphmanidin E (I.174) in six steps. 
 
1.1.2.17 Coldham´s approach towards (−)-daphcalycine  
The yuzurimine-type alkaloid (−)-daphcalycine (I.180) was the target of an approach 
described by Coldham and coworkers in 2011 (Scheme I.18). In the context of their studies on 
intramolecular 1,3-dipolar cycloadditions, the group was able to construct the main core of 
this natural product.[55] 
 
Scheme I.18: Approach towards the synthesis of (−)-daphcalycine (I.180). 
 
Known nitrile I.175 was converted in six steps into aldehyde I.176, which was reacted with 
hydroxylamine to give oxime I.177. A tandem intramolecular N-alkylation/intramolecular 
1,3-dipolar cycloaddition then furnished isoxazolidine I.178. Reductive cleavage of the 
N-O-bond, followed by formation of the N-O-acetal gave tetracycle I.179, which features the 
carbon framework of the western part of (−)-daphcalycine (I.180). 
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1.1.2.18 Coldham´s approach towards (±)-daphnilactone B  
In 2011, Coldham and coworkers also described an approach towards the 
daphnilactone B-type alkaloids by synthesizing the carbon skeleton of their eponymous 
representative (±)-daphnilactone B (I.114). The key transformation was again a tandem 
N-alkylation/1,3-dipolar cycloaddition reaction cascade (Scheme I.19).[56] 
 
Scheme I.19: Approach towards the synthesis of (±)-daphnilactone B (I.114). 
 
Aldehyde I.181 was converted in seven steps into bromide I.182. Reacting I.182 with 
hydroxylamine gave an oxime, which immediately underwent an N-alkylation cyclization 
reaction followed by intramolecular 1,3-dipolar cycloaddition to form isoxazolidine I.183. 
Cleavage of the N-O-bond using H2 in the presence of Raney nickel followed by treatment 
with base resulted in the formation of lactam I.184. Parikh-Döring oxidation followed by a 
Wittig reaction yielded alkene I.185, which was reduced with hydrogen in the presence of 
nickel boride to selectively obtain tricycle I.186, representing the scaffold of 
(±)-daphnilactone B (I.114). 
 
1.1.2.19 Wang´s approach towards (−)-daphnilongeranin B 
In the course of their studies on the construction of the tricyclic core of calyciphylline A-type 
alkaloids using a Grob fragmentation,[57] the group of Wang reported in 2012 the synthesis of 
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the tetracyclic core of  (−)-daphnilongeranin B (I.199, Scheme I.20).[58] The nitrogen atom 
was incorporated utilizing an Overman rearrangement. The key strategy employed to establish 
the [5-6-7] tricyclic core was a [2+2] photochemical cycloaddition followed by a Grob 
fragmentation. 
 
Scheme I.20: Approach towards the synthesis of (−)-daphnilongeranin B (I.199). 
 
Diol I.188, which was available as a single enantiomer from S-(+)-carvone (I.187),[59] was 
converted in two steps into PMP-ether I.189. Formation of a trichloroacetimidate and 
subsequent Overman rearrangement provided carbamate I.190, which could be transformed 
into enone I.191 in 4 steps. Irradiation with UV-light triggered a [2+2] cycloaddition to give 
I.192 together with side product I.193. The latter was speculated to be formed via a retro-
aldol-type pathway to release ring strain. Diastereoselective reduction and mesylation of I.192 
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gave I.194, which was treated with potassium carbonate in methanol to initiate a Grob 
fragmentation. Resulting tricycle I.195 was converted in two steps into mesylate I.196 and 
was then treated with TMSI followed by triethylamine to give tetracyclic amine I.197. 
Compound I.197 could be reduced diastereoselectively, resulting in the formation of ketone 
I.198, which represents the south-western part of (−)-daphnilongeranin B (I.199). 
 
1.1.2.20 Lévesque´s approach towards (±)-daphnilactone B 
In 2011, the group of Lévesque reported another approach towards the hexacyclic core of 
(±)-daphnilactone B (I.114). Key sequence was a Vilsmeier-Haack cyclization followed by an 
intramolecular azomethine ylide cycloaddition cascade, constructing three rings in one single 
step (Scheme I.21).[60] 
 
Scheme I.21: Approach for the synthesis of (±)-daphnilactone B (I.114). 
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Succinic acid monoethyl ester I.200 was converted in two steps into lactone I.201, which was 
alkylated using KHMDS and triflate I.202 to produce benzyl ether I.203. Upon reduction to 
the corresponding lactol, an unselective Kluge-Wittig reaction using I.204 gave methyl enol 
ether I.205 as a mixture of E/Z-isomers. Upon conversion to allyl enol ether I.206, this 
intermediate underwent a thermal Claisen rearrangement to give aldehyde I.207, which was 
subjected to RCM using Grubbs second generation catalyst. The resulting cycloheptene I.208 
could be transformed over four steps into enone I.209, which underwent a Vilsmeier-Haack 
cyclization upon treatment with triflic anhydride. The resulting iminium ion was treated with 
DIPEA to generate an azomethine ylide, which was intramolecularely trapped by the electron 
poor double bond by means of a [3+2] cycloaddition. The thus generated tetracycle I.210 
represents the south-western part of (±)-daphnilactone B (I.114). 
 
1.1.2.21 Dixon´s approach towards (±)-daphniyunnine B 
The group of Dixon reported in 2011 a strategy to synthesize the core of 
calyciphylline A-type alkaloids. Employing a ring closing metathesis to create the [5-6-7] 
tricyclic ring system and a Claisen rearrangement to install the quaternary stereogenic center 
gave rise to the southern core of (±)-daphniyunnine B (I.219, Scheme I.22).[61] 
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Scheme I.22: Approach towards the synthesis of (±)-daphniyunnine B (I.219). 
 
Ketone I.211 was converted into enone I.212 in three steps. An intramolecular conjugate 
addition of the in situ generated potassium enolate and subsequent trapping with allyl tosylate 
I.213 provided allyl enol ether I.214. Heating this compound resulted in a thermal Claisen 
rearrangement to give bisalkene I.215, which was subjected to RCM using Grubbs first 
generation catalyst I.216 to yield tricycle I.217. After performing a Krapcho decarboxylation 
and O-allylation, subsequent heating provoked another Claisen rearrangement which provided 
tricyclic amine I.218. This intermediate features the [5-6-7] tricyclic core and the quaternary 
stereogenic center of (±)-daphniyunnine B (I.219). 
 
1.1.2.22 Dixon´s approach towards (±)-daphniyunnine D  
In 2012, Dixon and coworkers described their approach to construct the north-eastern part of 
calyciphylline A-type alkaloids. The key step in this synthesis was an intramolecular Pauson-
Khand reaction to obtain the tricyclic scaffold featured in (±)-daphniyunnine D (I.225, 
Scheme I.23).[62] 
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Scheme I.23: Approach towards the synthesis of (±)-daphniyunnine D (I.225). 
 
Cycloheptanone (I.146) was converted in five steps into alkyne I.220. Formation of the 
cobalt-alkyne complex followed by treatment with NMO to trigger a Pauson-Khand reaction 
provided a diastereomeric mixture of enones I.221 and I.222. This mixture was stirred with 
base to perform a double-bond migration, which gave ester I.223 as single a diastereomer. 
Stereoselective radical allylic oxidation followed by reductive workup finally provided 
tricycle I.224 with the substitution pattern of (±)-daphniyunnine D (I.225). 
Another fascinating molecule of this natural product family is the daphnicyclidin-type 
alkaloid (+)-oldhamine A (I.226, vide infra, Figure I.2), the isolation and structure of which 
will be discussed in the next section. 
 
1.1.3  Isolation and Structure of (+)-Oldhamine A   
 
(+)-Oldhamine A (I.226, Figure I.2) is a striking example of a daphnicyclidin-type 
Daphniphyllum alkaloid with an intriguing structure. This remarkable natural product has 
been isolated from the tree Daphniphyllum oldhamii and its structure was elucidated in 2008 
by Hao and coworkers. The determination of the structure was supported by X-ray analysis of 
a single crystal.[63]  
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Figure I.2: (+)-Oldhamine A (I.226): a) Source of isolation, Daphniphyllum oldhamii;[64] b) chemical structure; 
c) crystal structure of I.226∙H2O∙MeOH (CCDC-code: 671960).[63] 
 
(+)-Oldhamine A (I.226) is a zwitterionic nortriterpenoid alkaloid which is composed of six 
fused rings (A-F) including five stereogenic centers, one of which is quaternary. A unique 
feature of I.226 is the presence of a cyclopentadienyl anion forming an internal salt with a 
tertiary ammonium ion. A cyclopentadienyl anion which is not part of a polyaromatic system 
is an extremely rare structural motif in nature and has been found in only one other instance, 
that is to say in the Daphniphyllum alkaloid (−)-macropodumine B.[65] The complex scaffold 
of I.226 can be divided in the south-western rings B and C, representing a pyrrolizidine part 
that bears all the stereogenic centers and northern rings E and F, forming a bicyclic lactone 
portion.  
By titrating I.226 in an NMR tube with TFA or Na2CO3, respectively, it was shown that I.226 
is in equilibrium with its tautomer I.227, however strongly favoring the zwitterionic structure 
(Scheme I.24). 
 
Scheme I.24: (+)-Oldhamine A (I.226) and its tautomer I.227. 
 
A speculated biosynthetic pathway for the formation of I.226 in nature is shown in 
Scheme I.25.  
a) b) c) 
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Scheme I.25: Biosynthesis of (+)-oldhamine A (I.226) as speculated by Hao.[63] 
 
As described in detail in the previous section, squalene (I.23) was proposed to form 
secodaphniphyllate-type structures like I.31 (vide supra, Section 1.1.1, Scheme I.1).[29],[33] 
I.31 is assumed to be a precursor of I.228, representing the daphnezomine A/B-type 
skeleton.[32c] Further biosynthetic modifications were speculated to lead to yuzurimine-type 
alkaloids like I.229 and I.230.[17] These were said to originate from the daphnicyclidin-type 
alkaloids. I.230 was proposed to be converted into I.231, which could rearrange to give I.232. 
Oxidative cleavage would lead to daphnicyclidin H (I.233), which could cyclize to give 
daphnicyclidin A (I.234).[66] Hao and coworkers speculated that a sequence of oxidation and a 
subsequent unusual Hofmann rearrangement would lead to the formation of (+)-oldhamine A 
CHAPTER I: Towards the Total Synthesis of Oldhamine A 
36 
(I.226).[63] These proposed biosynthetic pathways are highly speculative and detailed studies 
are still to be carried out. 
Although some preliminary studies on the pharmacology of I.226 have been completed,[63] the 
biological activity of I.226 is yet to be determined. Thus, the reason why I.226 is made by 
species of the genus Daphniphyllum and the role this natural product plays in nature still 
remains unknown. 
Intrigued by its aesthetical appeal and in order to get access to sufficient amounts to fully 
evaluate its biological activity, a synthetic approach towards the synthesis of I.226 was 
initiated in this work, the retrosynthetic analysis of which is described in the next section. 
 
1.1.4  Retrosynthetic Analysis of (–)-ent-Oldhamine A 
 
The retrosynthetic strategy aimed at an asymmetric and short yet flexible route to also allow 
for the efficient preparation of natural product analogues. This could potentially be achieved 
by constructing the B-C pyrrolizidine ring system and the E-F lactone ring system separately, 
and then assembling them using a short and robust reaction sequence. Starting from amino 
acids would allow the natural product to be synthesized separately in both enantiomeric 
series. This work, however, focused on the synthesis of unnatural (−)-ent-oldhamine A (I.240) 
as a model system, as it can be traced back to cheaper natural L-amino acids as starting 
materials. 
A key element of the strategy was to devise a plan for the installation of the quaternary 
stereogenic center. It was initially intended to implement a cascade reaction triggered by the 
addition of an organometallic species like, for example, a cuprate into a fulvene 
(Scheme I.26). This cascade reaction process would allow for a swift and elegant access to the 
natural product. 
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Scheme I.26: Planned tandem conjugate addition condensation sequence as key step to synthesize 
(−)-ent-oldhamine A (I.240). 
 
More specifically, it can be speculated that methyl cuprate (I.242) would attack fulvene I.237 
at the C5-position to form cyclopentadienyl anion I.238, which could then intercept the 
vicinal methyl ester in an intramolecular fashion to form the A-ring of I.240. Hexacycle I.239 
might spontaneously aromatize to form its tautomer (−)-ent-oldhamine A (I.240). The 
addition of organometallic species into fulvenes at the desired position has recently been 
investigated.[67] Even though several alternative reaction pathways such as 1,4-additions or 
even attacks on the ketone might compete with the proposed key reaction, careful 
optimization could lead to the required conditions to achieve the attack selectively at the 
desired position. The fulvene is activated by the lactone carbonyl group at C-21, for which 
reason the desired reaction represents a vinylogous conjugate addition onto the corresponding 
Michael system. This reaction would lead to a stabilized aromatic system and would as well 
result in a significant release of strain. The retrosynthetic analysis based on the key 
cyclization process is shown in Scheme I.27.  
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Scheme I.27: Retrosynthetic analysis of (−)-ent-oldhamine A (I.240). 
 
Cleaving I.240 according to the projected key step leads to fulvene I.241 and methyl cuprate 
I.242. Further dissection by means of a McMurry cyclization gives diketone I.243.[68] 
Alternatively, the same bond can easily be formed via a Knoevenagel condensation between 
the pyrrolizidine ketone and the cyclopentadiene in the bicyclic lactone. I.243 can be traced 
back to bicyclic lactone I.244, pyrrolizidine I.245 and acrolein I.246 by conjugate addition 
and Krapcho decarboxylation followed by enolate addition and appropriate protection. 
Stereogenic centers formed in the latter reactions are of no consequence for the formation of 
the natural product. 
The envisaged synthesis of building blocks I.245 and I.244 should not only be short and 
straightforward, but also high yielding with the potential to produce gram quantities of the 
key precursors. Therefore, several strategies for the synthesis of I.245 and I.244 have been 
considered (Scheme I.28). 
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Scheme I.28: Strategies to synthesize pyrrolizidine I.245. 
 
First, pyrrolizidine I.245 was traced back to enone I.248 by means of an intramolecular 
conjugate addition. Even though this 5-endo-trig cyclization is unfavoured according to the 
Baldwin rules, literature precedence was found for the corresponding cyclization reaction of 
analogous proline derivatives.[69] On the other hand, I.245 can be dissected by means of a 
Dieckmann cyclization, leading to tertiary amine I.247. Both intermediates I.248 and I.247 
were planned to be made from benzyl ether I.249, which can be traced back to I.250 by 
means of a 1,2-addition to the corresponding N-acyl iminium ion. The introduction of the 
stereogenic center in I.250 via an SN2 reaction is considered as an important challenge. A 
literature procedure for the synthesis of I.250 from L-pyroglutamic acid (I.251) is known. 
However, it provides the desired product in poor yield.[70] Thus, in order to efficiently and 
reliably produce large amounts of I.250, either improved conditions to acquire I.250 from 
I.251 have to be found or an alternative procedure to functionalize the C4-position has to be 
developed, e.g. starting from L-glutamic acid (I.252). For the synthesis of I.244, three 
different strategies were considered, which are depicted in Scheme I.29. 
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Scheme I.29: Different possible strategies to synthesize lactone I.244. 
 
A first method to dissect lactone I.244 by means of a Pauson-Khand reaction leads back to 
ester I.254. This reaction is well precedented, as exemplified by the construction of the 
skeletal core of Daphniphyllum alkaloids by Dixon,[62] and was thus considered to provide 
swift access to the desired carbon framework. Besides, a literature procedure to deliver 
bicyclic lactones from cyclopropylidenes such as I.253 using copper(II)salts was intended to 
be investigated as well.[71] Finally, I.244 can be traced back to acetate I.255 and enone I.256 
via a palladium-catalyzed [3+2] dipolar cycloaddition. This reaction process has been 
introduced by Trost and coworkers[72] and has proven useful in two past total syntheses.[73]  
All depicted reaction sequences to synthesize I.245 and I.244 have been investigated and the 
results of these studies are described in the next section. 
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1.2 Results and Discussion 
1.2.1 Studies on C4- and C5-functionalized L-glutamic Acid Derivatives 
 
At first, a convenient route towards the asymmetric synthesis of I.249 was to be elaborated 
starting from inexpensive amino acids. The main challenge of this approach was to effect 
stereoselective C-C bond formations at the C4- and the C5-position. For this purpose, 
L-pyroglutamic acid was initially chosen as a starting material (I.251, Scheme I.30).   
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Scheme I.30: Literature procedure for C4-functionalization of L-pyroglutamic acid derivative I.257. 
 
L-pyroglutamic acid (I.251) was esterified and N-protected following established 
procedures.[74],[75] In order to form the desired C-C bond at C4, N-acyl carbamate I.257 was 
treated with LiHMDS followed by benzyloxymethyl chloride.[70] However, desired product 
I.250 was only obtained in a moderate 27 % yield due to the formation of the C4-diastereomer 
I.261 (18 %) as well as other side products such as double-alkylation species. No conditions 
could be found to enhance the ratio of I.250 to I.261. Improved workup and chromatographic 
purification protocols finally allowed to perform the reaction on a 50 g scale to afford 
sufficient quantities of the desired product. However, the low yield and the requirement to 
separate diastereomers by extensive column chromatography demanded for an alternative 
pathway.  
More specifically, it was found that the desired C4-functionalization can be cleanly achieved 
by employing L-glutamic acid (I.252) -derived linear starting materials (Scheme I.31). The 
general method for this transformation was already established[76] and was found to be of 
great use in the synthesis of I.250. 
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Scheme I.31: Improved synthesis of I.250 by C4-functionalization of L-glutamic acid derivative I.258. 
 
After conversion of L-glutamic acid (I.252) into N-protected diester I.258 following a known 
literature procedure,[77] treatment with two equivalents of LiHMDS followed by alkylation 
with BOMCl cleanly afforded benzyl ether I.259. Since formation of the diastereomer at the 
C4-position was not observed, this reaction process was much more convenient than the 
corresponding functionalization of L-pyroglutamate derivative I.257 (Scheme I.30). It could 
thus be easily performed on a 20 g scale. I.259 was then N-deprotected with TFA and heated 
in toluene for two days to trigger cyclization. Upon reprotecting the secondary amine, I.260 
could be isolated in 51 % yield together with 45 % of protected starting material I.259, raising 
the yield to 85 % based on recovered I.259. In order to convert I.260 into I.250, methyl ester 
I.260 was saponified and converted into ethyl ester I.250 using Steglich conditions. This 
protecting group swap was necessary to achieve subsequent functionalizations in high yields 
and to confirm the desired stereochemistry at C4 by comparison with the literature 
precedent.[70] At this point, it is worth mentioning that the same C4 alkylation employing the 
corresponding diethyl ester I.264 provides the desired product only in a poor 4 % yield, as 
shown in Scheme I.32. Overall, the five-step procedure starting from L-glutamic acid (I.252) 
provides I.250 in a total yield of 62 %, whereas the three-step procedure starting from 
L-pyroglutamic acid (I.251) gives I.250 in only 25 % yield. 
The discrepancy in selectivity for the C4-alkylation of I.257 in contrast to I.258 is 
remarkable. The low selectivity in the functionalization of I.257 was attributed to the 
flexibility of the five-membered ring system. In contrast, linear L-glutamic acid derivative 
I.258 can adopt a closed transition state, thus allowing for a highly enhanced selectivity of the 
nucleophilic attack.  A plausible transition state was proposed by Hanessian and coworkers 
and is shown in Figure I.3.[76] 
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Figure I.3: Proposed transition states for the formation of I.250.[76] 
 
The double anion formed in situ presumably adopts a closed transition state tethered by the 
corresponding counter ion. More specifically, a lithium ion was proposed to be coordinated 
by the carbamoyl anion of the Boc protecting group and either the methoxy oxygen of the 
ester moiety (transition state I.262a) or the ester enolate oxygen (transition state I.262b). In 
both cases, the electrophile would preferentially be attacked in an equatorial fashion, resulting 
in formation of I.250.[76] 
As mentioned before, it was intended to improve the step economy and avoid the final ester 
protecting group swap by employing the same reaction sequence with diester I.265. However, 
I.264 failed to deliver advantageous quantities of the functionalized product I.265 
(Scheme I.32). 
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Scheme I.32: Attempted C4-functionalization of diethyl ester I.264. 
 
The sequence started with esterification of L-glutamic acid (I.252)[78] (→ I.263) and 
subsequent N-protection to afford diethyl ester I.264.[79] Subjecting I.264 to the same reaction 
conditions as for the synthesis of I.259 resulted in formation of a complex mixture, from 
which I.265 could be isolated in 4 % yield upon extensive chromatographic purification. 
NMR analysis of the crude reaction mixture showed formation of the undesired diastereomer 
at the C4-position as well as overalkylated species.[80] It can be speculated that with the 
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change from the methyl ester to the more bulky ethyl ester, no closed transition state can be 
adopted and thus no stereoselective functionalization can be carried out. Thus, the five-step 
procedure as described in Scheme I.31 was the method of choice to synthesize I.250. 
At this point, attention was focused on the introduction of the methyl group at the 
C5-position. A literature precedent suggested that this could be achieved by employing an 
organocuprate reagent to undergo a 1,2-addition to an in situ formed iminium ion 
(Scheme I.33).[70] 
 
Scheme I.33: Stereoselective C5-functionalization of I.250 to synthesize I.249. 
 
After superhydride-mediated reduction of the N-acyl lactam, treatment with p-TsOH in the 
presence of methanol resulted in the formation of hemiaminal ether I.266 as a 4:1 mixture of 
diastereomers, which was directly used in the next step without further purification. Addition 
of methyl cuprate to the in situ generated N-acyl iminium ion (I.267, Figure I.4) and treatment 
of the resulting product with Boc2O in the presence of aqueous sodium bicarbonate furnished 
carbamate I.249 in an overall 40 % yield. Treatment with Boc2O became necessary in order to 
reprotect the amino function, which was partially deprotected under the previous reaction 
conditions.  
 
Figure I.4: Illustration of the cuprate addition to N-acyl iminium ion I.267 generated from I.266. 
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The conversion of I.266 into I.249 proved to be highly selective. The benzyloxy side chain in 
I.266 shields the si-face of the N-acyl iminium ion and therefore directs the cuprate attack to 
occur on the opposite side. NMR analysis of the crude reaction mixture showed no signals of 
the C4-epimer. 
Having installed the key stereogenic centers at C4 and C5, a strategy to construct the bicyclic 
pyrrolizidine part of (−)-ent-oldhamine A (I.240) was explored, the development of which is 
described in the next two sections. 
 
1.2.2  Intramolecular Conjugate Addition Approach towards the Synthesis 
of the Pyrrolizidine Portion of (–)-ent-Oldhamine A 
 
After the successful synthesis of I.249, its subsequent functionalization and, more 
specifically, pathways for the formation of the bicyclic pyrrolizidine ring system were then 
explored. In the first approach to construct the pyrrolizidine core of (−)-ent-oldhamine 
(I.240), it was planned to employ a known protocol to cyclize the pyrrolidines in an 
intramolecular fashion. In the course of their studies on the total synthesis of 
(−)-ent-absouline and (+)-laburnamine the group of Potier presented a simple construction of 
pyrrolizidine ring systems via a 5-endo-trig cyclization, albeit without C4 and C5 
modifications.[69] Based on the literature precedent, a similar approach to construct I.268 was 
investigated (Scheme I.34), although this reaction process is unfavored according to the 
Baldwin rules.  
 
Scheme I.34: Pyrrolizidine-formation via a 5-endo-trig cyclization. 
 
Hence, enone I.248 had to be prepared. It was planned to be achieved by simple modification 
of the ester side chain of I.249. 
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First, a redox-economical one-step procedure was investigated in order to synthesize allyl 
alcohol I.269 via an in situ formed aluminum complex at the aldehyde oxidation state. 
However, the ester moiety in I.249 proved to be relatively unreactive and standard 
transformations required unusually harsh conditions. Thus, a variety of reaction conditions 
were screened to elaborate the most convenient method (Table I.1).  
 
Entry Reagent Solvent Temperature Time Yield 
1 DIBAL-H, CH2−CH−MgCl THF −5 °C to reflux 18 h (I.269) -[a]  
2 HNMe(OMe)∙HCl, i-PrMgCl THF 0 °C to reflux 18 h (I.270) -[b]  
3 HNMe(OMe)∙HCl, Me3Al THF 0 °C to reflux 18 h (I.270) -[c]  
4 LiOH THF, H2O reflux 18 h (I.271) 36 %[d]  
5 LiOOH THF, H2O reflux 18 h (I.271) 39 %[d]  
6 Me3SnOH THF reflux 18 h (I.271) -[b]  
7 DIBAL-H THF 50 °C 18 h (I.272) 35 %[e]  
8 NaAlH2(OCH2CH2OCH3)2 THF 50 °C 18 h (I.272) 33 %[e]  
9 LiAlH4 THF r.t. then 45 °C 18 h, then 3 h (I.272) 20 %[e]  
10 LiBH4 THF r.t. 18 h (I.272) 48 %  
 [a] double addition, formation of I.273; [b] no reaction observed, reisolation of starting material; [c] formation of a 
complex mixture of polar materials; [d] formation of the C2-epimer; [e] overreduction, formation of I.274. 
Table I.1: Selected conditions for the transformation of I.249. 
 
It was found that reacting I.249 with DIBAL-H followed by treatment with vinylmagnesium 
chloride to synthesize I.269 in one step resulted in the double addition of the Grignard reagent 
to give I.273 (Table I.1, Entry 1), indicating an unsuccessful initial reduction of the ester 
moiety. If I.249 was subjected to a mixture of N,O-dimethylhydroxyamide hydrochloride salt 
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and isopropylmagnesium chloride to form Weinreb amide I.270, no reaction was observed 
and starting material was recovered (Table I.1, Entry 2). Using a mixture of the same reagent 
and trimethylaluminium resulted in the formation of a complex mixture of polar materials 
(Table I.1, Entry 3). Saponification using aqueous lithium hydroxide in refluxing THF 
provided the corresponding acid I.271, however, as a mixture of diastereomers at the C2-
carbon (Table I.1, Entry 4). This epimerization was also observed when a mixture of lithium 
hydroxide and hydrogen peroxide was employed (Table I.1, Entry 5). The use of even milder 
conditions, specifically trimethyltin hydroxide, did not provide any desired product and the 
starting material could be recovered (Table I.1, Entry 6). Reduction of the ester to I.272 using 
DIBAL-H occurred in THF only at elevated temperatures, however, accompanied with the 
formation of the N-methyl derivative I.274 as a result of overreduction of the Boc-protecting 
group (Table I.1, Entry 7). Similar results were observed when Red-Al® (Table I.1, Entry 8) 
and LAH (Table I.1, Entry 9) were employed. Interestingly, the reduction could be carried out 
at room temperature when lithium borohydride was used, providing the alcohol I.272 as 
single product albeit in a moderate 48 % yield (Table I.1, Entry 10). 
The relatively low reactivity of I.249 could potentially be related to the large protecting 
groups (representing ca. 50% of the molecular weight of I.249), which could shield the 
pyrrolidine core and thus lower the reactivity of the vicinal ester. 
The lithium borohydride reduction was chosen as the method to prepare gram quantities of 
I.272 and subsequently, a strategy for the required carbon chain elongation was elaborated 
(Scheme I.35). 
 
Scheme I.35: Synthesis of allylic alcohol I.269. 
 
Upon reduction of I.249 according to the previously established procedure, alcohol I.272 was 
obtained and was subjected to Swern oxidation conditions. The resulting aldehyde I.275 was 
CHAPTER I: Towards the Total Synthesis of Oldhamine A 
48 
directly reacted with vinylmagnesium bromide (I.276) in the presence of lithium chloride to 
give allylic alcohol I.269 as a 2:3 mixture of diastereomers.  
The subsequently planned oxidation to corresponding enone I.248 proved to be a challenging 
task due to the instability of the product under various reaction conditions. Hoping to find 
conditions under which the sensitive product could be isolated, several oxidation methods 
were applied. A selection of these attempts is summarized in Table I.2.  
 
Entry Oxidant Additive Solvent Temperature Time Yield 
1 DMP, NaHCO3 - CH2Cl2 r.t. 3 h -[a] 
2 (COCl)2, DMSO, then i-Pr2EtN - CH2Cl2 −78 °C 0.5 h -[a] 
3 Pr4NRuO4, NMO - CH2Cl2 r.t. 18 h -[a] 
4 MnO2 - CH2Cl2 reflux 2 h -[b] 
5 DMP, NaHCO3 BHT CH2Cl2 r.t. 3 h -[a] 
6 (COCl)2, DMSO, then i-Pr2EtN BHT CH2Cl2 −78 °C 0.5 h -[a] 
7 Pr4NRuO4, NMO BHT CH2Cl2 r.t. 18 h -[a] 
8 MnO2 BHT CH2Cl2 reflux 2 h -[b] 
 [a] formation of a complex product mixture; [b] formation of insoluble material. 
Table I.2: Selected conditions for the attempted allylic oxidation of I.269. 
 
Treatment of the diastereomeric mixture of alcohols I.269 with DMP in the presence of 
sodium bicarbonate resulted in the formation of a complex reaction mixture (Table I.2, 
Entry 1). The same result was observed when I.269 was subjected to Swern conditions 
(Table I.2, Entry 2) or to Ley oxidation (Table I.2, Entry 3). Employing manganese dioxide to 
perform the desired allylic oxidation resulted in the formation of insoluble material and no 
organic product could be isolated from the reaction mixture. In order to improve these results, 
the same reactions were performed under exclusion of light and in the presence of a radical 
inhibitor such as BHT (Table I.2, Entries 5-8). Moreover, the diastereomeric mixture of 
alcohols I.269 was separated by HPLC and the individual alcohols were separately subjected 
to the same reaction conditions. Again, complex reaction mixtures were obtained and 
formation of I.248 could never be observed.  
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The instability of I.248 represented a major obstruction in the development of a reliable and 
scalable route to pyrrolizidine I.268. Thus, the intramolecular conjugate addition strategy was 
abandoned and a different, more convenient pathway for the construction of the pyrrolizidine 
core was elaborated. These results are described in the next section. 
 
1.2.3  Dieckmann Cyclization Approach to Construct the Pyrrolizidine Ring 
System of (−)-ent-Oldhamine A 
 
In order to establish a new strategy that would allow swift access to the desired pyrrolizidine 
framework, I.245 was now retrosynthetically disconnected at the α-position of the carbonyl 
group (Scheme I.36).  
 
Scheme I.36: Pyrrolizidine-formation via Dieckmann cyclization. 
 
Thus, I.245 can be traced back to aminoester I.247 by means of a Dieckmann cyclization, 
which could be prepared from I.249 via a straightforward functionalization of the nitrogen 
atom. More specifically, I.249 had to be deprotected and subsequently N-alkylated. The 
required N-deprotection was found to be easily achieved under standard conditions 
(Scheme I.37).  
  
a) 
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Scheme I.37: a) Standard N-deprotection; b) direct incorporation of the N-deprotection into the established 
procedure. 
 
Secondary amine I.277 was obtained upon treating carbamate I.249 with TFA in the presence 
of thioanisole (Scheme I.37a). I.277 could also be obtained more readily by incorporating the 
deprotection in the established procedure (Scheme I.37b). I.250 was reduced and methylated 
using the same conditions as for the synthesis of I.249 (vide supra, Section 1.2.1, 
Scheme I.33). Then, N-acyl iminium ion I.257 was generated and intercepted by methyl 
cuprate. Subsequent treatment of the resulting product mixture with TFA in the presence of 
thioanisole completed the N-deprotection and afforded amine I.277 in an overall 40 % yield. 
As for the subsequent N-alkylation, it was first envisaged to obtain saturated tertiary amine 
I.247 in one step via a Michael addition of I.277 to ethyl acrylate (I.278). This venture proved 
to be challenging as the secondary amine underwent the desired reaction only under relatively 
harsh conditions (Table I.3). Addition of Lewis acids, which are known to catalyze conjugate 
additions of amines to acrylates did not lead to an improvement in yield, but to extended 
polymerization.[81],[82] This observation was attributed to sterical hindrance at the 
aminofunction of I.277. 
 
 
 
b) 
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Entry Solvent Additive Temperature Time Yield 
1 -[a] - reflux 72 h 39 %[b] 
2 -[a] TiCl4 r.t. 24 h -[b,c] 
3 MeCN Bi(OTf)3 r.t. 6 d -[b,c] 
4 CH2Cl2 FeCl3 reflux 24 h -[b,c] 
5 -[a] SMe2Br2 r.t. 24 h 37 % 
[a] The reaction was performed neat in an excess of I.278; [b] formation of polymeric material was observed; 
[c] traces of product mass could be observed by LCMS. 
Table I.3: Selection of reaction conditions for the Michael addition of I.277 to I.278. 
 
In the first instance, amine I.277 was heated to reflux for 72 h in neat ethyl acrylate (I.278) to 
afford a complex product mixture of polymerized material from which the desired product 
could be isolated in 39 % yield (Table I.3, Entry 1). When stirring a mixture of I.277 and 
I.278 in the presence of titanium tetrachloride, a complex mixture was obtained, in which 
only traces of the desired product could be detected (Table I.3, Entry 2). Similar results were 
obtained when bismuth triflate was present in an acetonitrile solution of I.277 and I.278 
(Table I.3, Entry 3), or when refluxing a mixture of I.277, I.278 and iron trichloride in 
dichloromethane (Table I.3, Entry 4). Employing SMe2Br2 as additive under solvent-free 
conditions provided the product in a moderate yield of 37 % (Table I.3, Entry 5). 
Since the low reactivity of I.277 was speculated to be due to the sterically hindered nature of 
the secondary amine, a smaller and more reactive electrophile was utilized. Thus, ethyl 
propiolate (I.279), which was previously shown to react with highly hindered amines such as 
TMP, was employed.[83] Indeed, I.279 smoothly underwent the desired conjugate addition 
with amine I.277 (Scheme I.38). From this intermediate desired pyrrolizidine I.245 could be 
prepared in only two steps. 
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Scheme I.38: Synthesis of pyrrolizidine I.245. 
 
Michael addition of I.277 onto ethyl propiolate (I.279) afforded enamine I.269. Subsequent 
reduction of the corresponding iminium ion, which was generated in glacial acid, provided 
amine I.247. Even though a two-step process was required to access saturated amine I.247, 
this procedure proved to be more convenient than the previously investigated usage of ethyl 
acrylate (I.278) and therefore became the method of choice to synthesize I.247. Having gram 
quantities of I.247 in hands, the stage was set for the cyclization to form pyrrolizidine I.245. 
After screening several bases,[84] KHMDS was found to be most efficient to effect the 
following Dieckmann cyclization and to provide pyrrolizidine I.245 in good yield. 
The elaborated synthesis of the properly functionalized pyrrolizidine proved to be reliable and 
can be carried out on a multigram scale. Building block I.245 represents the B-C-ring system 
of (−)-ent-oldhamine A (I.240) and already features four of the five stereogenic centers of the 
natural product.  
The synthesis of the E-F-ring system of (−)-ent-oldhamine A (I.240) was investigated 
subsequently and is described in the next sections.  
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1.2.4  Studies on the Construction of the Bicyclic Lactone Portion of 
(−)-ent-Oldhamine A by a Pauson-Khand Reaction 
 
For the construction of the bicyclic lactone framework of the E- and F-rings of 
(−)-ent-oldhamine A (I.240), a one-step procedure utilizing a Pauson-Khand reaction was first 
considered. The success of this method would allow a swift access to lactone I.244 from a 
simple starting material, namely ester I.254 (Scheme I.39). 
 
Scheme I.39: Formation of bicyclic lactone I.244 by means of a Pauson-Khand reaction. 
 
Synthesis of ester I.254 proved to be straightforward and also the subsequent formation of a 
cobalt-alkyne complex required for the Pauson-Khand reaction was achieved using standard 
conditions (Scheme I.40).  
 
Scheme I.40: Synthesis of cobalt-alkyne complex I.282 as a precursor for the Pauson-Khand reaction. 
 
A Fischer esterification of propiolic acid (I.280) and alcohol I.281 provided ester I.254 in 
moderate yield. Formation of cobalt-alkyne complex I.282 was then achieved by treatment of 
propiolate I.254 with dicobalt octacarbonyle.  
As a second precursor for the Pauson-Khand reaction, TMS-propiolate I.284 was prepared 
(Scheme I.41).  
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Scheme I.41: Synthesis of alternative PKR-precursor I.285. 
 
3-(Trimethylsilyl)propionic acid (I.283) was esterified using I.281 in the presence of EDCI 
and 4-pyrrolidinopyridine, which had to be conducted at low temperatures to avoid side 
reactions. Conversion into I.285 was achieved employing the same conditions as in the 
synthesis of I.282 (Scheme I.40).  
Subsequently, I.282 and I.285 were subjected to a number of conditions which had previously 
been developed for Pauson-Khand reactions, a selection of which is summarized in 
Table I.4.[85] In general, the reaction mixtures were stirred until complete consumption of the 
starting material and the crude mixture was analyzed by TLC, GCMS, LCMS and NMR. 
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Entry Additive Solvent Temperature Atmosphere Yield (I.244) Yield (I.286) 
1 -  DME reflux CO -[a] -[a] 
2 - DME/CF3CH2OH 1:1 reflux Ar -[a] -[a] 
3 - DME/CF3CH2OH 1:1 reflux CO -[a] -[a] 
4 - CF3CH2OH reflux Ar -[a] -[a] 
5 - CF3CH2OH reflux CO -[a] -[a] 
6 cy-NH2 DME reflux Ar -[a] -[a] 
7 cy-NH2 DME reflux CO -[a] -[a] 
8 cy-NH2 DME/CF3CH2OH 1:1 reflux Ar -[a] -[a] 
9 cy-NH2 DME/CF3CH2OH 1:1 reflux CO -[a] -[a] 
10 NMO  CH2Cl2 0 °C to r.t. Ar -[a] -[a] 
11 NMO CH2Cl2 0 °C to r.t. air -[a] -[a] 
12 NMO CH2Cl2 0 °C to r.t. CO -[a] -[a] 
13 NMO DME 0 °C to r.t. Ar -[a] -[a] 
14 NMO∙H2O  CH2Cl2 0 °C to r.t. Ar -[a] -[a] 
15 NMO∙H2O CH2Cl2 0 °C to r.t. air -[a] -[a] 
16 NMO∙H2O CH2Cl2 0 °C to r.t. CO -[a] -[a] 
17 NMO∙H2O DME 0 °C to r.t. Ar -[a] -[a] 
18 TMANO  CH2Cl2 0 °C to r.t. Ar -[a] -[a] 
19 TMANO CH2Cl2 0 °C to r.t. Ar -[a] -[a] 
20 TMANO CH2Cl2 0 °C to r.t. CO -[a] -[a] 
21 TMANO DME 0 °C to r.t. Ar -[a] -[a] 
[a] formation of a complex mixture of polar materials. 
Table I.4: Selected conditions for the transformation of I.282 and I.285. 
 
At first, I.282 and I.285 were subjected to thermal PKR-conditions.[85f] When I.282 and I.285, 
respectively, were heated to reflux in DME under a CO atmosphere, a complex mixture of 
polar materials was slowly formed (Table I.4, Entry 1). The same result was obtained when 
I.282 or I.285, respectively, were heated to reflux in a 1:1 mixture of DME and CF3CH2OH 
under either an argon atmosphere (Table I.4, Entry 2) or a CO atmosphere (Table I.4, 
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Entry 3). The same outcome was also observed in pure CF3CH2OH under either an argon 
atmosphere (Table I.4, Entry 4) or a CO atmosphere (Table I.4, Entry 5).  
After these first trials, the same reaction was performed using cyclohexylamine as additive. 
These conditions have been shown to drastically accelerate the rate of PKR in some 
instances.[85c, 85d] Again, formation of a complex mixture of polar materials was observed if 
I.282 and I.285, respectively, were heated in the presence of cyclohexylamine in DME under 
an argon (Table I.4, Entry 6) or a CO atmosphere (Table I.4, Entry 7). Changing to a 
DME/CF3CH2OH solvent system did not improve the results regardless to the atmosphere 
under which the reaction was run (Table I.4, Entry 8 and 9). 
Addition of oxidants to transform a carbonyl ligand into CO2 and therefore facilitate its loss 
was also investigated.[85a, 85b] When I.282 and I.285, respectively, were stirred in CH2Cl2 in 
the presence of NMO under an argon (Table I.4, Entry 10), an air (Table I.4, Entry 11) or a 
CO atmosphere (Table I.4, Entry 12), a complex mixture of polar materials was formed. The 
same results were obtained if NMO monohydrate (Table I.4, Entries 14-16) or TMAO (Table 
I.4, Entries 18-20) were used instead. Stirring I.282 and I.285, respectively, in DME under an 
argon atmosphere did not improve the results for either NMO (Table I.4, Entry 13), NMO 
monohydrate (Table I.4, Entry 17) or TMAO (Table I.4, Entry 21).  
A possible explanation for the low reactivity of I.282 and I.285 is the high stability of cobalt 
complexes with propiolic acid derivatives, as already observed by Pauson.[86] Side reactions 
are presumably faster than the desired reaction, thus leading to the formation of a complex 
mixture of reaction products. 
Although there are many more conditions that could have been applied in the Pauson-Khand 
reaction, like the use of different metals and additives, an alternative method for the 
construction of the desired carbon framework had been found in the meantime (vide infra, 
Section 1.2.6). Therefore, no more reaction conditions were screened in the scope of this 
work.  
A different approach featuring a copper-catalyzed cyclization reaction is described in the next 
section. 
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1.2.5  Studies on the Construction of the Bicyclic Lactone Portion of 
(−)-ent-Oldhamine A via a Copper-Catalyzed Cyclization Reaction 
 
In this approach, I.244 was planned to be synthesized via a literature-known procedure to 
construct the bicyclic lactone framework (Scheme I.42).  
 
Scheme I.42: Dissection of I.244 by means of a Kornblum oxidation and an established copper(II)-mediated 
cyclization.[71] 
 
Bicyclic lactone I.244 can be traced back to literature-known iodide I.287 by means of a 
Kornblum oxidation. A synthesis of this intermediate from I.253 was presented by Huang and 
coworkers in the course of their study on the use of copper(II) halides to mediate cyclization 
reactions of cyclopropylidene esters.[71] The synthesis of cyclopropylidene ester I.253 was 
straightforward and could be achieved following literature procedures (Scheme I.43). 
 
Scheme I.43: Synthesis of cyclopropylidene I.253. 
 
Commercially available ylen I.288 was allylated using I.166 in refluxing chloroform followed 
by treatment with aq. NaOH to deliver allyl phosphorane I.289.[87] A Wittig reaction 
employing I.290 in the presence of a catalytic amount of benzoic acid then furnished 
cyclopropylidene ester I.253.[88] 
With I.253 in hands, the reported copper(II)-mediated cyclization process was investigated.[71] 
Unfortunately, when employing the reaction conditions described in literature, the desired 
product could never be observed. Instead, triiodide I.291 was isolated (Scheme I.44). 
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Scheme I.44: Attempted synthesis of iodide I.287. 
 
When cyclopropylidene ester I.253 was treated with catalytic amounts of copper(I) iodide and 
an excess of iodine and heated in a 3:1 mixture of acetonitrile and water, instead of the 
desired product I.287, triiodide I.291 was obtained in 51 % yield. This was the only product 
that could be characterized and despite extensive efforts to analyze side products of this 
reaction process, formation of desired bicycle I.287 was not observed. The structure of I.291 
could be confirmed by means of single crystal X-ray analysis (Figure I.5). 
 
Figure I.5: Crystal structure of triiodide I.291. 
 
The formation of I.291 was speculated to occur via iodolactonization and subsequent opening 
of the cyclopropane (Scheme I.45). 
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Scheme I.45: Speculated reaction mechanism for the formation of iodide I.291. 
 
Upon initial formation of iodonium ion I.292, the molecule could undergo a iodolactonization 
to form intermediate I.293, which can be assumed to be hydrolyzed under the reaction 
conditions. The resulting iodolactone I.294 can be speculated to react with a second 
equivalent of iodine to form the spiro iodonium ion I.295, which could undergo ring opening 
to form triiodide I.291. An alternative mechanism for the iodolysis of the three-membered 
ring could proceed via a copper-mediated conjugate addition  of previously formed iodide 
(→ I.296) to give enolate I.297 and subsequent attack on iodine. 
Since the desired bicyclic lactone was not obtained with the copper catalysis approach, 
another route for the formation of I.244 had to be explored, the details of which are described 
in the next section. 
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1.2.6 Studies on the Construction of the Bicyclic Lactone Portion of 
(−)-ent-Oldhamine A via a [3+2] Cycloaddition 
 
The third approach for the construction of the E-F-ring system utilized a palladium-catalyzed 
[3+2] cycloaddition reaction (Scheme I.46), which was discovered by Trost and coworkers.[72] 
 
Scheme I.46: Dissection of I.244 via [3+2] cycloaddition. 
 
Lactone I.244 could be the result of an oxidation sequence from I.298. By means of the 
envisaged palladium-catalyzed [3+2] cycloaddition reaction, I.298 can be traced back to 
acetate I.255 and lactone I.256, both of which are readily available starting materials. Acetate 
I.255 was prepared first following an established procedure (Scheme I.47).[89] 
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C C
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60 .C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xx
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Scheme I.47: Synthesis of acetate I.255. 
 
Dichloride I.299 was monosilylated using trichlorosilane in the presence of triethylamine and 
catalytic amounts of copper(I) to provide silylchloride I.300. After conversion to the 
corresponding trimethyl silane I.301, the mixture was heated in the presence of potassium 
acetate to furnish acetate I.255. 
With large amounts of acetate I.255 in hands, the synthesis of I.298 was initiated. The 
reaction sequence started with a literature-known unsaturation of δ-valerolactone using a 
Saegusa oxidation.[90],[91] The subsequent [3+2] cycloaddition proved to be suitable for the 
synthesis of I.298 and could be carried out on large scale (Scheme I.48). 
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Scheme I.48: Synthesis of bicyclic lactone I.298. 
 
δ-Valerolactone (I.302) was converted into silyl enol ether I.303 by treatment with LDA and 
TMS chloride. Subsequent treatment with catalytic amounts of palladium acetate in the 
presence of methyl allyl carbonate (I.304) smoothly provided unsaturated lactone I.256. 
Bicyclic lactone I.298 could then be obtained by heating a mixture of I.255 and I.256 in the 
presence of palladium acetate and triisopropyl phosphite. In some instances, formation of 
small amounts of bisalkene I.305 was observed as a byproduct. However, since I.305 could 
easily be separated by column chromatography, this was of no consequence for the successful 
synthesis of gram-quantities of I.298. 
In the course of the studies on this reaction, it was found that small amounts of water were 
essential to produce I.298 in high yields. Yields dropped significantly when no water or too 
much water was present in the reaction mixture (Table I.5).  
 
Entry Conditions Solvent Temperature Time water-additive yield 
1 Pd(OAc)2 (2.5 mol %), P(Oi-Pr)3 toluene reflux 15 h - -[a] 
2 Pd(OAc)2 (2.5 mol %), P(Oi-Pr)3 toluene reflux 15 h 1.00 eq 39 % 
3 Pd(OAc)2 (2.5 mol %), P(Oi-Pr)3 toluene reflux 15 h 0.100 eq 61 % 
4 Pd(OAc)2 (2.5 mol %), P(Oi-Pr)3 toluene reflux 15 h traces[b] 85 % 
[a] reisolation of starting material, traces of product observed by LCMS; [b] utilization of analytical grade solvent, 
which has been exposed to air moisture prior to use. 
Table I.5: Selection of reaction conditions employed in the optimization of the [3+2} cycloaddition. 
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If water-free conditions were applied, only traces of product could be observed in the 
resulting reaction mixture and starting material was recovered (Table I.5, Entry 1). If, 
however, the same reaction was carried out in the presence of one equivalent of water, a yield 
of 39 % was obtained (Table I.5, Entry 2), When a defined amount of 0.100 eq of water was 
added, the reaction provided a 62 % yield of I.298 (Table I.5, Entry 3). The best yield was 
obtained when trace amounts of water were present in the reaction mixture. It was thus found 
that employing analytical grade toluene that had been exposed to air moisture prior to the 
reaction was ideal and led to a 85 % yield of I.298 (Table I.5, Entry 4). The reaction process 
has already been studied in detail and a proposed mechanism is depicted in Scheme I.49.[92] 
 
Scheme I.49: Proposed reaction mechanism for the formation of I.298. 
 
First, palladium acetate in the presence of triisopropyl phosphite and catalytic amounts of 
water forms a palladium(0) complex, which oxidatively inserts into acetate I.255 to form 
palladium π-allyl complex I.306. This compound can be attacked by the previously formed 
acetate to give I.307, which can then undergo a conjugate addition onto enone I.256. The 
thereby generated enolate I.308 intramolecularely attacks the π-allyl palladium complex, thus 
providing organopalladium compound I.309. Upon β-hydride elimination and reductive 
elimination of acetic acid, the catalyst is generated and I.298 is liberated.  
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The formation of byproduct I.305 is indeed intriguing and can be rationalized via a 
mechanism such as described in Scheme I.50. 
 
Scheme I.50: Proposed mechanism for the formation of side product I.305. 
 
It can be speculated that intermediate I.307, which is formed analogously to the previously 
described mechanism via I.306, first undergoes an SN2’ reaction with acetate I.255 instead of 
the usual conjugate addition to enone I.256. The resulting intermediate I.310 then presumably 
follows the known reaction mechanism where allylic anion I.311 is formed as a result of the 
attack of the acetate anion. Then, zwitterion I.311 could undergo a conjugate addition onto 
enone I.256 to form intermediate I.312. Intramolecular trapping of the resulting enolate would 
result in formation of organo-palladium compound I.313, which upon β-hydride elimination 
would provide I.305. 
Having the bicyclic lactone I.298, which represents a key building block in the synthesis of 
both enantiomers of oldhamine A (I.226 and I.240), in hands, preliminary studies on its 
subsequent oxidation were carried out. 
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The first strategy to convert I.298 into I.244 involved the formation of the lactone alpha-beta 
unsaturation, followed by oxidative cleavage of the exo-methylene group. This order of 
ketone formation and unsaturation was considered to be crucial to avoid problems concerning 
the regioselectivity of the olefin formation step. Thus, unsaturated bicyclic lactone was 
synthesized first, which could be achieved by means of a Grieco elimination (Scheme I.51). 
 
Scheme I.51: Synthesis of unsaturated lactone I.315. 
 
Lactone I.298 was converted into selenide I.314 using LiHMDS and phenyl selenyl bromide 
in the presence of HMPA. Upon treatment with aqueous hydrogen peroxide, I.314 underwent 
Grieco elimination to form unsaturated lactone I.315. 
The subsequently planned oxidative cleavage of the exo-methylene group proved to be 
difficult. Various well-known one-step procedures failed to provide desired ketone I.316 
(Table I.6). 
 
Entry Conditions Solvent Temperature Time yield 
1 O3, then Me2S CH2Cl2 −78 °C, then r.t. 5 min, then 18 h -[a] 
2 OsO4, NaIO4 CH2Cl2 r.t. 16 h -[a] 
3 m-CPBA, then HIO4 CH2Cl2 r.t. then reflux 16 h, then 16 h -[b] 
 [a] Formation of a complex mixture of polar compounds; [b] isolation of epoxide I.317 in 49 % yield. 
Table I.6: Conditions for the attempted oxidative cleavage of I.315. 
 
When I.315 was treated with ozone followed by a reductive workup, formation of a complex 
mixture of polar compounds was observed (Table I.6, Entry 1). A similar result was obtained 
when performing a Lemieux-Johnson oxidation with osmium tetroxide and sodium periodate 
(Table I.6, Entry 2). If I.315 was treated with meta-chloroperbenzoic acid and then with 
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periodic acid, no oxidative cleavage could be accomplished and epoxide I.317 was isolated 
(Table I.6, Entry 3). 
Since all typical one-step procedures failed to deliver I.316, alternative procedures to oxidize 
the exo-methylene double bond were tested. First, I.315 was subjected to a Prileschajew 
reaction to obtain epoxide I.317 (Scheme I.52).  
 
Scheme I.52: Synthesis of epoxide I.317. 
 
Epoxide I.317, which was obtained from I.315 after treatment with m-CPBA, was then 
subjected to several standard conditions for epoxide opening. However, despite extensive 
efforts, a selection of which is shown in Table I.7, no conditions for the synthesis of glycol 
I.318 could be found. 
 
Entry Reagent Solvent Temperature Time yield 
1 H2SO4, H2O THF r.t. to reflux 18 h -[a] 
2 HClO4, H2O THF r.t. 16 h -[b] 
3 KOH DMSO, H2O 50 °C 16 h -[b] 
4 BF3∙OEt2, then H2O THF r.t. to reflux 16 h -[a] 
[a] Reisolation of starting material; [b] formation of a complex mixture of polar compounds. 
Table I.7: Selection of conditions for the attempted epoxide opening. 
 
When I.317 was subjected to oleum in wet THF and heated to reflux for 18 h, no reaction was 
observed and starting material was reisolated (Table I.7, Entry 1). Upon treatment with an aq. 
60 % solution of perchloric acid, a complex mixture of polar compounds was formed 
(Table I.7, Entry 2). A similar result was obtained, when a DMSO solution of I.317 was 
treated with aqueous potassium hydroxide and heated to 50 °C for 16 h (Table I.7, Entry 3). 
Subsequently, Lewis acid-mediated ring opening was investigated. However, I.317 proved to 
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be unreactive under these conditions and starting material was recovered. If, for example, 
I.317 was heated in the presence of boron trifluoride diethyl etherate in THF, no reaction was 
observed (Table I.7, Entry 4). 
Attempts to directly access diol I.318 via Upjohn dihydroxylation on I.315 resulted in the 
formation of an undesired product (Scheme I.53). 
 
Scheme I.53: Osmium tetroxide-mediated dihydroxylation of I.315. 
 
Upon treatment with osmium tetroxide in the presence of NMO and water, I.315 underwent 
an unusual dihydroxylation and I.319 was formed. Instead of the electron rich and more 
accessible double bond, the enone in I.315 was found to react preferentially. In order to 
further investigate this dihydroxylation approach and to potentially find a pathway to avoid 
the observed regioselectivity issues, the diol moiety was already introduced in I.298 
(Scheme I.54).  
 
Scheme I.54: Synthesis of dioxolane I.322. 
 
Upon osmium tetroxide-mediated dihydroxylation, diol I.320 was obtained, which was 
directly protected using I.321 to provide dioxolane I.322.[93] The further functionalization of 
I.322 remains to be studied in more details. 
The achievements towards the total synthesis of (−)-ent-oldhamine A (I.240) are summarized 
in the next section. 
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1.2.7 Summary, Conclusions and Outlook  
 
In summary, a reliable large-scale preparation of the two key building blocks towards the total 
synthesis of (−)-ent-oldhamine A (I.240) was established in this work. The literature-known 
synthesis of key precursor I.250 has successfully been optimized and can now be carried out 
routinely on a 50 g scale. Also, an alternative pathway for the synthesis of I.250 has been 
elaborated, which delivers this key precursor in a much more convenient fashion with 69 % 
yield over six steps from literature-known L-glutamic acid derivative I.258. 
Two methods to prepare highly functionalized pyrrolizidine I.245 have been investigated. 
While a conjugate addition approach failed to deliver the desired product, a reliable and 
scalable process to access I.245 was established utilizing a Dieckmann cyclization.  
Intermediate I.277 could be prepared in a short and convenient fashion on a multigram scale, 
which can be carried out with only one chromatographic purification step in a 40 % yield 
from I.250. Pyrrolizidine I.245 was accessible in three further steps and was successfully 
prepared on a two gram scale. Thus, the construction of the southern B-C-ring system bearing 
four of the five stereogenic centers of I.240 has been completed (Scheme I.55). 
 
Scheme I.55: Summarized overview on the developed synthesis of I.245 from literature-known compound I.258. 
 
After investigation of three methodologies, the palladium-mediated [3+2] cycloaddition 
turned out to be a powerful method to construct the southern E-F-ring system of I.240. The 
key reaction was optimized and was successfully carried out on a multigram scale. Overall, 
the elaborated synthesis opens a short and convenient pathway for the construction of the 
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bicyclic lactone portion in I.240, which can be carried out in a single step from literature-
known starting materials I.255 and I.256 and provides I.298 in a 85 % yield. 
Furthermore, first experiments to further functionalize I.298 have been carried out. 
Pleasingly, it was found that I.298 can easily be converted into I.315 employing a Grieco 
elimination. Additionally it was found that I.298 can be oxidized by means of an Upjohn 
oxidation furnishing dioxolane I.322 (Scheme I.56).  
 
Scheme I.56: Successful synthesis of bicyclic lactones from literature-known compounds I.255 and I.256. 
 
Future work will have to focus on functionalization of the β-ketoester moiety in I.245 to 
incorporate the C3-carbon chain into the molecule. This could, for example, be achieved by an 
O-allylation/Claisen rearrangement sequence via I.323 and I.324, followed by Krapcho 
decarboxylation. At this stage, an opportunity is provided to adjust the stereochemistry at the 
allyl side-chain by a deprotonation-protonation sequence under kinetic conditions to obtain 
I.325. A hydroboration and double-oxidation sequence should provide aldehyde I.326 
(Scheme I.57). 
 
Scheme I.57: Envisioned synthetic route to install the C3-carbon chain at I.245. 
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Bicyclic lactone I.322 will be converted into unsaturated derivative I.327 followed by a 
deprotection, oxidative cleavage and double bond migration sequence to provide I.244 
(Scheme I.58). 
 
Scheme I.58: Envisioned sequence for the synthesis of I.244. 
 
Possible strategies to convert I.245 and I.244 into the natural product have been lined out in 
the retrosynthetic analysis (vide supra, Section 1.1.4), the execution of which will require 
further experimental studies. One possible pathway for the endgame is shown in Scheme I.59.  
 
Scheme I.59: Possible strategy to complete the total synthesis of I.240. 
 
Compounds I.244 and I.245 could be coupled by means of an aldol-type reaction followed by 
appropriate protection to give I.328. One possible pathway to close the seven-membered ring 
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would be a McMurry coupling to provide I.329. Upon global deprotection and sequential 
oxidation of both alcohols and the cyclopentene to the corresponding fulvene I.237, the stage 
is set for the key step (vide supra, Section 1.1.4), which would directly provide I.240 in a 
single step from I.237. 
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1.3 Experimental Section 
 
General experimental details: 
Unless specified otherwise, all reactions were performed with magnetic stirring under an 
atmosphere of argon and in oven-dried glassware. Isolated products were dried on a high 
vacuum line at a pressure of 10–2 mbar using an ATB-Loher oil pump by Flender. Diethyl 
ether and THF were distilled prior to use from sodium and benzophenone. Triethylamine, 
diisopropylamine and diisopropylethylamine were distilled over calcium hydride. Toluene, 
benzene dichloromethane (CH2Cl2), chloroform (CHCl3), ethanol (EtOH), methanol (MeOH), 
acetonitrile (MeCN) and acetone (Me2CO) were purchased from Acros Organics as 'extra dry' 
reagents under inert gas atmosphere and over molecular sieves. All other reagents were 
purchased from commercial sources and used without further purification. Petroleum ether is 
referred to as hexanes and relates to fractions of isohexanes, which boil between 40 °C and 
60 °C. Reactions were monitored by TLC using E. Merck 0.25 mm silica gel 60 F254 glass 
plates. TLC plates were visualized by exposure to UV light (254 nm) and subsequent 
treatment with an aqueous solution of CAM, an aqueous solution of potassium permanganate, 
an acidic solution of vanillin, a solution of ninhydrin or a mixture of silica and finely 
grounded iodine followed by heating the plate with a heat gun. If appropriate, reactions were 
additionally monitored by Proton nuclear magnetic resonance (1H-NMR) using a Varian 200 
spectrometer or LCMS using an Agilent Technologies 1260 infinity machine equipped with an 
Agilent ZORBAX Eclipse Plus C18 reversed phase analytical 4.6 mm x 150 mm column. 
Flash column chromatography was performed as described by Still et al. employing silica gel 
(60 Å, 40-63 µm, Merck) at a pressure of approx. 1.3-1.5 bar generated by a gentle nitrogen 
flow.[94]  Reversed phase (RP) column chromatography was performed on Waters silica gel 
(Preparative C18, 125 Å, 55-105 µm) with the same techniques as described above. 
Analytical RP TLC was performed using pre-coated glass plates (silica gel C18 RP-
18W/UV254) from Macherey-Nagel. Yields refer to isolated and spectroscopically pure 
compounds. 
 
 
 
CHAPTER I: Towards the Total Synthesis of Oldhamine A 
72 
Instrumentalization: 
Infrared (IR) spectra were recorded on a Perkin Elmer Spectrum BX II (FTIR System), 
equipped with an attenuated total reflection (ATR) measuring unit. IR data is reported in 
frequency of absorption (cm−1).  
Proton nuclear magnetic resonance (1H-NMR) spectra were recorded on a Varian 300, Varian 
400, Inova 400 or Varian 600 spectrometer. Chemical shifts ( scale) are expressed in parts 
per million (ppm) and are calibrated using residual protic solvent as an internal reference 
(CDCl3:  = 7.26 ppm, (D3C)2CO:  = 2.05 ppm, (CD3)2SO:  = 2.50 ppm, CD2Cl2: 
 = 5.32 ppm).[95] Unless noted otherwise, data was recorded at 27 °C. Data for 1H-NMR 
spectra are reported as follows: chemical shift ( ppm) (multiplicity, coupling constants (Hz), 
integration). Couplings are expressed as: s = singlet, d = doublet, t = triplet, q = quartet, 
m = multiplet, br = broad, app = apparent or combinations thereof. Carbon nuclear magnetic 
resonance (13C-NMR) spectra were recorded on the same spectrometers at 75, 100 and 
150 MHz, respectively. Carbon chemical shifts ( scale) are also expressed in parts per 
million (ppm) and are referenced to the central carbon resonances of the solvents (CDCl3:  = 
77.16 ppm, (D3C)2CO:  = 29.84 ppm, (CD3)2SO:  = 39.52 ppm, CD2Cl2:  = 53.84 
ppm,).[95] 
Mass spectroscopy (MS) experiments were performed on a Thermo Finnigan MAT 95 
(electron ionization, EI) or on a Thermo Finnigan LTQ FT (electrospray ionization, ESI) 
instrument. 
Optical rotation was measured in a Polarimeter P8100-T of the company KRÜSS. [α] 

 values 
are quoted in units of deg 10−1 cm2 g−1; concentration c takes units of g/100 mL. 
Melting points were measured on an EZ-Melt automated melting point apparatus made by 
Stanford Research Systems and are uncorrected. 
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(S)-dimethyl 2-(tert-butoxycarbonylamino) pentanedioate (I.338)[74] and (S)-1-tert-butyl 
2-ethyl 5-oxopyrrolidine-1,2-dicarboxylate (I.257):[75]  
 
To a suspension of (S)-pyroglutamic acid (I.251, 50.0 g, 387 mmol, 1.00 eq) in dry ethanol 
(700 mL, 12.1 mol, 31.1 eq) was added SOCl2 (28.1 mL, 387 mmol, 1.00 eq) dropwise over 
the course of 30 min at 0 °C. The resulting mixture was stirred for 10 min at 0 °C and was 
then allowed to warm to room temperature to be stirred for 1 h at this temperature. Then, 
water (200 mL) and solid NaHCO3 (120 g) were added in small portions. The resulting solid 
was filtered off and the filtrate was concentrated until the bulk of EtOH was removed. The 
remaining aqueous solution was extracted with CH2Cl2 (3 x 500 mL). The combined extracts 
were washed with brine (200 mL), dried over MgSO4, filtered and concentrated to a white 
solid, which was used without further purification. An analytical sample was purified by 
recrystallization from ethanol to give I.338 as a colorless crystalline solid. 
TLC (EtOAc:Hex 2:1): Rf  = 0.17. 
mp: 48 °C. 
[α] 

 = –44.8 (c = 1.0, MeOH). 
1H NMR (300 MHz, CDCl3): δ = 6.38 (s, br, 1H), 4.27-4.16 (m, 3H), 2.52-2.32 (m, 3H), 
2.28-2.17 (m, 1H), 1.28 (t, J  = 7.1 Hz, 3H). 
13C NMR (75 MHz, CDCl3): δ = 177.8, 171.9, 61.7, 55.4, 25.2, 24.8, 14.1. 
IR (neat): ṽ
 max = 1693, 1199, 1156.  
HRMS (EI+):  m/z calcd. for C7H11NO3+:   157.0739 [M]+;  
found:      157.0735 [M]+. 
 
To a solution of the crude material obtained as described above (58.0 g, 449 mmol, 1.00 eq) in 
CH2Cl2 (1.00 L) was added DMAP (5.49 g, 44.9 mmol, 0.100 eq), BOC2O (196 g, 898 mmol, 
2.00 eq) and Et3N (187 mL, 1.35 mol, 3.00 eq). After gas evolution had ceased (3 h), the 
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mixture was stirred for 15 h at room temperature. Then, a 10 % aq. citric acid solution 
(300 mL) was added and the mixture was stirred until gas evolution had ceased (1 h). The 
organic layer was separated, washed with a 10 % aq. citric acid solution (2 x 300 mL) and 
brine (500 mL), dried over MgSO4 and concentrated. Purification by silica flash column 
chromatography (EtOAc:Hex 1:2 → 1:1) afforded crude I.257 as a yellow solid. This material 
was recrystallized from ethanol (40.0 mL) and washed with hexanes (100 mL) to afford I.257 
as colorless crystals (110 g, 95 % over two steps). 
TLC (EtOAc:Hex 2:1): Rf  = 0.46 . 
mp: 53 °C. 
[α] 

: –40.1 (c = 1.0, MeOH). 
1H NMR (300 MHz, CDCl3): δ = 4.59 (dd, J = 9.2, 3.0 Hz, 1H), 4.23 (q, J = 7.1 Hz, 2H), 
2.72-2.55 (m, 1H), 2.55-2.41 (m, 1H), 2.39-2.34 (m, 1H), 2.08-1.96 (m, 1H), 1.49 (s, 9H), 
1.29 (t, J = 7.1 Hz, 3H). 
13C NMR (75 MHz, CDCl3): 173.2, 171.3, 149.3, 83.5, 61.6, 58.9, 31.1, 27.9 (3C), 21.5, 14.2. 
IR (neat): ṽ
 max = 1772, 1247, 1025.  
HRMS (ESI+):  m/z calcd. for C12H20NO5+:   258.1341 [M+H]+;  
found:      258.1358 [M+H]+. 
 
(2S,4R)-1-tert-butyl 2-ethyl 4-(benzyloxymethyl)-5-oxopyrrolidine-1,2-dicarboxylate 
(I.250) from I.257 and (2S,4S)-1-tert-butyl 2-ethyl 4-(benzyloxymethyl)-5-oxopyrrolidine-
1,2-dicarboxylate (I.261):[70] 
 
To a solution of HMDS (56.3 mL, 256 mmol, 1.30 eq) in THF (88.0 mL) was added a 
solution of n-BuLi (2.50 M in hexanes, 95.6 mL, 241 mmol, 1.20 eq) dropwise at 0 °C. After 
complete addition, the mixture was allowed to warm to room temperature and stirred for 
another 30 min at this temperature. 
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The resulting LiHMDS solution was cooled to −78 °C and to this solution was added 
dropwise a solution of I.257 (51.7 g, 201 mmol, 1.00 eq) in THF (200 mL) over the course of 
20 min. Then, HMPA (45.4 mL, 261 mmol, 1.30 eq) was added over the course of 5 min and 
the mixture was stirred for 1 h at −78 °C. The resulting mixture was cannulated to a cooled 
solution of benzyloxymethyl chloride (55.7 mL, 402 mmol, 2.00 eq) in THF (100 mL) at 
−78 °C over the course of 25 min and stirred for 1 h at this temperature. The reaction was 
quenched with a 1:1 mixture of water and a sat. aq. NH4Cl solution (35.0 mL) and after 
warming to room temperature, the bulk of the solvent was removed in vacuo. The residue was 
diluted with diethyl ether (1000 mL) and successively washed with a sat. aq. NaHCO3 
solution (800 mL) and brine (800 mL). The organic layer was separated, dried over MgSO4, 
filtered and concentrated in vacuo. The resulting residue was purified by column 
chromatography (silica, EtOAc:Hex 1:10 → 1:2) to give I.250 as a colorless oil (20.8 g, 
27 %) and I.261 as a colorless oil (13.6 g, 18 %).  
I.250 was isolated by concentrating later fractions of the chromatographic purification step. 
TLC (EtOAc:Hex 1:2): Rf = 0.34. 
[α]

: −47.6 (c = 1.0, MeOH). 
1H NMR (300 MHz, CHCl3): δ = 7.40-7.26 (m, 5H), 4.65-4.42 (m, 3H), 4.23-4.10 (m, 2H), 
3.76 (dd, J = 9.4, 4.2 Hz, 1H), 3.66 (dd, J = 9.4, 7.3 Hz, 1H), 2.99-2.79 (m, 1H), 2.67-2.43 
(m, 1H), 2.16-1.96 (m, 1H), 1.49 (s, 9H), 1.24 (t, J = 7.1 Hz, 3H). 
13C NMR (75 MHz, CHCl3): δ = 173.0, 171.3, 149.3, 137.8, 128.6, 128.4 (2C), 127.7 (2C), 
83.6, 73.3, 69.1, 61.5, 57.6, 43.6, 27.9 (3C), 25.0, 14.1. 
IR (neat): ṽ
 max = 2981, 1791, 1748, 1719, 1369, 1318, 1153. 
HRMS (ESI+):  m/z calcd. for C20H27NNaO6+:  400,1736 [M+Na]+; 
found:      400.1731 [M+Na]+. 
 
I.261 was isolated by concentrating earlier fractions of the chromatographic purification step. 
TLC (EtOAc:Hex 1:2): Rf = 0.38. 
[α]

: −34.9 (c = 1.0, MeOH). 
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1H NMR (600 MHz, CHCl3): δ = 7.36-7.25 (m, 5H), 4.58-4.44 (m, 3H), 4.25-4.15 (m, 2H), 
3.71 (ddd, J =  13.1, 9.5, 4.6 Hz, 2H), 2.87 (dddd, J = 10.5, 9.1, 5.5, 3.7 Hz, 1H), 2.35 (ddd, 
J = 13.3, 10.5, 9.9, 1H), 2.20-2.12 (m, 1H), 1.48 (s, 9H), 1.26 (t, J = 7.1 Hz, 3H). 
13C NMR (150 MHz, CHCl3): δ = 173.0, 171.4, 149.3, 137.8, 128.4, 127.7 (2C), 127.6 (2C), 
83.5, 73.4, 68.4, 61.6, 57.4, 42.8, 27.9 (3C), 25.6, 14.2. 
IR (film): ṽ
 max = 2980, 1791, 1748, 1719, 1369, 1154. 
HRMS (ESI+):  m/z calcd. for C20H27NNaO6+:  400.1736 [M+Na]+; 
found:      400.1729 [M+Na]+. 
 
(S)-dimethyl 2-(tert-butoxycarbonylamino)pentanedioate (I.258):[77] 
 
To a solution of L-glutamic acid (14.7 g, 100 mmol, 1.00 eq) in methanol (250 mL) was 
added TMSCl (51.1 mL, 400 mmol, 4.00 eq) at 0 °C. After complete addition, the mixture 
was allowed to warm to room temperature and stirred overnight at this temperature.  
To the resulting solution containing I.339 was added NEt3 (90.0 mL, 650 mmol, 6.50 eq) and 
Boc2O (23.5 g, 110 mmol, 1.10 eq) to be stirred at room temperature until no more gas 
evolution was observed (4 h). The solvent was removed under reduced pressure, the resulting 
crude product was redissolved in diethyl ether (400 mL) and cooled to 0 °C. The thereby 
formed solid was filtered off, washed with diethyl ether (200 mL) and discarded. The 
combined filtrates were concentrated and purified by column chromatography (silica, 
EtOAc:Hex 4:1 → 2:1) to give I.258 as a colorless oil (24.6 g, 90 %). 
TLC (EtOAc:Hex 1:2): Rf = 0.29. 
[α]

: −25.5 (c = 1.0, MeOH). 
1H NMR (300 MHz, CHCl3): δ = 5.14 (s, br, 1H), 4.39-4.22 (m, 1H), 3.73 (s, 3H), 3.66 (s, 
3H), 2.47-2.33 (m, 2H), 2.23-2.08 (m, 1H), 2.02-1.89 (m, 1H), 1.42 (s, 9H). 
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13C NMR (75 MHz, CHCl3): δ = 173.1, 172.6, 155.3, 80.0, 52.8, 52.4, 51.7, 30.0, 28.3 (3C), 
27.7. 
IR (neat): ṽ
 max = 2956, 1737, 1712, 1514, 1366, 1159. 
HRMS (ESI+):  m/z calcd. for C12H21NO6+:   275.1369 [M]+; 
found:      275.1375 [M]+. 
 
(2R,4S)-dimethyl 2-(benzyloxymethyl)-4-(tert-butoxycarbonylamino)pentanedioate 
(I.259): 
 
To a solution of HMDS (36.4 mL, 171 mmol, 2.31 eq) in THF (30.4 mL) was added a 
solution of n-BuLi (2.50 M in hexanes, 62.2 mL, 156 mmol, 2.10 eq) dropwise at 0 °C. After 
complete addition, the mixture was allowed to warm to room temperature and stirred for 
another 30 min at this temperature. 
The resulting LiHMDS solution was cooled to −78 °C and to this solution was added 
dropwise a solution of I.258 (20.4 g, 74.1 mmol, 1.00 eq) in THF (200 mL) over the course of 
20 min. After being stirred for 30 min at this temperature, a solution of BOMCl (20.5 mL, 
148 mmol, 2.00 eq) in THF (200 mL) was added dropwise over the course of 20 min to be 
stirred for additional 3 h at –78 °C. The reaction mixture was quenched with an aq. 1.00 M 
HCl solution (100 mL) and the bulk of solvent was removed in vacuo. The residue was 
redissolved in diethyl ether (500 mL) and washed with a sat. aq. NaHCO3 solution (500 mL) 
and brine (300 mL), dried over MgSO4, filtered and concentrated. The crude product was 
purified by column chromatography (silica, EtOAc:Hex 1:10 → 1:2) to give I.259 as a 
colorless oil (26.1 g, 89 %). 
TLC (EtOAc:Hex 1:3): Rf = 0.38. 
[α]

: −39.6 (c = 1.0, MeOH). 
CHAPTER I: Towards the Total Synthesis of Oldhamine A 
78 
1H NMR (300 MHz, CDCl3, mixture of rotation isomers): δ = 7.39-7.23 (m, 5H), 5.13 (s, br, 
0.5H) 4.72-4.67 (s, 2H) 4.55-4.50 (m 1H) 4.35 (s, br, 0.5H) 3.76-3.63 (m, 6.5H) 2.88-2.75 (m, 
0.5H) 2.52-2.29 (m, 1H), 2.24-1.92 (m, 3H), 1.46 (s, 4.5H), 1.45 (s, 4.5H). 
13C NMR (75 MHz, CDCl3, mixture of rotation isomers): δ = 174.1, 173.2, 172.7, 172.6, 
155.4, 155.4, 141.0, 137.9, 128.5 (2C), 128.2 (2C), 127.9, 127.8, 127.7 (2C), 127.6 (2C), 
127.5, 127.0, 80.1, 80.0, 73.1, 70.1, 65.3, 52.4, 52.3, 52.1, 52.0, 51.8, 42.6, 31.1, 30.1, 28.3, 
28.2 (3C), 27.8 (3C).  
IR (neat): ṽ
 max = 3370, 2978, 1731, 1712, 1512, 1366, 1160. 
HRMS (ESI+):  m/z calcd. for C20H29NNaO7+:  418.1842 [M+Na]+; 
found:      418.1835 [M+Na]+. 
 
(2R,4R)-1-tert-butyl 2-methyl 4-(benzyloxymethyl)-5-oxopyrrolidine-1,2-dicarboxylate 
(I.260): 
 
A mixture of  I.259 (17.9 g, 45.4 mmol, 1.00 eq), CH2Cl2 (50.0 mL) and trifluoroacetic acid 
(46.0 mL) was stirred for 1 h at room temperature. After removal of the solvent in vacuo, the 
residue was diluted with a sat. aq. Na2CO3 solution (30.0 mL) and a sat. aq. NaHCO3 solution 
(270 mL) and subsequently extracted with diethyl ether (5 x 350 mL). The combined extracts 
were washed with brine (500 mL), dried over MgSO4 and concentrated.  
The resulting residue containing I.340 was dissolved in toluene (150 mL) and heated to reflux 
for 48 h. The mixture was allowed to cool to room temperature and concentrated to give a 
brown oil. 
To a solution of this residual oil containing I.341 and I.340 in CH2Cl2 (60.0 mL) was added 
DMAP (6.65 g, 54.4 mmol, 1.20 eq), Boc2O (10.9 g, 49.9 mmol, 1.10 eq) and triethylamine 
(6.94 mL, 49.9 mmol, 1.10 eq) to be stirred for 16 h at room temperature. The reaction 
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mixture was diluted with diethyl ether (350 mL), washed with an aq. 1.00 M HCl solution 
(350 mL), a sat. aq. NaHCO3 solution (350 mL) and brine (250 mL), dried over MgSO4 and 
concentrated. The crude product was purified by column chromatography (EtOAc:Hex 
1:5 → 1:2) to give I.260 as a colorless oil (8.46 g, 51 %) along with recovered starting 
material I.259 (7.71 g, 45 %).  
TLC (EtOAc:Hex 1:3): Rf = 0.25. 
[α]

: −42.2 (c = 1.0, MeOH). 
1H NMR (400 MHz, CDCl3): δ = 7.44-7.09 (m, 5H), 4.56-4.48 (td, J = 9.1, 6.2 Hz, 1H), 
4.48-4.41 (d, J = 3.44 Hz, 2H), 3.79-3.56 (m, 5H) 2.90-2.77 (m, 1H), 2.54-2.44 (dt, J = 13.6, 
9.5 Hz, 1H) 2.10, 1.99 (dt, J = 13.4, 6.7 Hz, 1H), 1.46 (s, 9H). 
13C NMR (75 MHz, CDCl3): δ = 173.0 171.7, 149.2, 137.8, 128.4 (2C), 127.7 (2C), 127.6, 
83.6, 73.3, 69.0, 57.5, 52.3, 43.6, 27.8 (3C), 25.0.  
IR (neat): ṽ
 max = 1727, 1181. 
HRMS (ESI+):  m/z calcd. for C19H25NNaO6+: 386.1580 [M+Na]+; 
found:      386.1575 [M+Na]+. 
 
(2S,4R)-1-tert-butyl 2-ethyl 4-(benzyloxymethyl)-5-oxopyrrolidine-1,2-dicarboxylate 
(I.250) from I.260: 
 
To a solution of I.260 (150 mg, 413 µmol, 1.00 eq) in ethanol (2.50 mL) was added a 1.50 M 
aq. lithium hydroxide solution (0.550 mL, 0.826 µmol, 2.00 eq). The mixture was stirred for 
4  h at room temperature and was then concentrated in vacuo. The residue was diluted with an 
aq. 1.00 M HCl solution (25.0 mL) and extracted with CH2Cl2 (3 x 25.0 mL). The combined 
extracts were dried over MgSO4, filtered and concentrated.  
The resulting residue containing I.342 was redissolved in CH2Cl2 (2.50 mL) and to the 
solution was added DCC (93.7 mg, 454 µmol, 1.10 eq), DMAP (55.5 mg, 454 µmol, 1.10 eq) 
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and ethanol (0.200 mL, 3.39 mmol, 8.20 eq) to be stirred for 16 h at room temperature. Then, 
the mixture was filtered and the filter cake was washed with diethyl ether (3 x 5.00 mL). The 
combined filtrates were washed with brine (15.0 mL), dried over MgSO4, filtered and 
concentrated. Purification by column chromatography (silica, EtOAc:Hex 1:5 → 1:1) gave 
I.250 as a colorless oil (141 mg, 91 %). 
TLC (EtOAc:Hex 1:2): Rf = 0.34. 
[α]

: −47.6 (c = 1.0, MeOH). 
1H NMR (300 MHz, CHCl3): δ = 7.40-7.26 (m, 5H), 4.65-4.42 (m, 3H), 4.23-4.10 (m, 2H), 
3.76 (dd, J = 9.4, 4.2 Hz, 1H), 3.66 (dd, J = 9.4, 7.3 Hz, 1H), 2.99-2.79 (m, 1H), 2.67-2.43 
(m, 1H), 2.16-1.96 (m, 1H), 1.49 (s, 9H), 1.24 (t, J = 7.1 Hz, 3H). 
13C NMR (75 MHz, CHCl3): δ = 173.0, 171.3, 149.3, 137.8, 128.4 (2C), 127.7 (2C), 83.6, 
73.3, 69.1, 61.5, 57.6, 43.6, 27.9 (3C), 25.0, 14.1. 
IR (neat): ṽ
 max = 2981, 1791, 1748, 1719, 1369, 1318, 1153. 
HRMS (ESI+):  m/z calcd. for C20H27NNaO6+:  400.1736 [M+Na]+; 
found:      400.1731 [M+Na]+. 
 
(S)-diethyl 2-aminopentanedioate (I.263):[78] 
 
To a suspension of L-glutamic acid (I.252, 40.0 g, 272 mmol, 1.00 eq) in ethanol (400 mL, 
6.80 mol, 25.0 eq) was added dropwise thionyl chloride (43.4 mL, 600 mmol, 2.20 eq) at 
0 °C. After being stirred for 1 h at 0 °C, the mixture was allowed to warm to room 
temperature and stirred for 16 h at this temperature. Then, the bulk of solvent was removed in 
vacuo and to the remaining solution was added water (50.0 mL) and Na2CO3 (60.0 g, 
571 mmol, 2.10 eq) in small portions. The resulting mixture was diluted with a sat. aq. 
NaHCO3 solution (750 mL) and extracted with dichloromethane (5 x 750 mL). The combined 
extracts were dried over MgSO4 and concentrated to yield I.263 as a colorless oil (49.0 g, 
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89 %). The resulting crude product was pure enough to be used in the next step without 
further purification. 
TLC (EtOAc:Hex 3:1): Rf = 0.29. 
[α]

: +10.2 (c = 1.0, CHCl3). 
1H NMR (600 MHz, CDCl3): δ = 4.06 (q, J = 7.1 Hz, 2H), 4.02 (q, J = 7.1 Hz, 2H), 3.41 (dd, 
J = 8.3, 5.3 Hz, 1H), 2.41 (t, J = 7.5 Hz, 2H) 2.10-1.97 (m, 1H), 1.75-1.69 (m, 1H), 1.36 (s, 
br, 2H), 1.27-1.18 (m, 6H). 
13C NMR (75 MHz, CDCl3): δ = 175.5, 173.0, 60.8, 60.3, 53.7, 30.6, 30.0, 14.1 (2C).  
IR (neat): ṽ
 max = 1727, 1181. 
HRMS (ESI+):  m/z calcd. for C9H17NO4+:   203.1158 [M]+; 
found:      203.1148 [M]+. 
 
(S)-diethyl 2-(tert-butoxycarbonylamino)pentanedioate (I.264):[79] 
 
To a mixture of I.263 (53.6 g, 264 mmol, 1.00 eq), Boc2O (63.3 g, 290 mmol, 1.10 eq) and 
CH2Cl2 (1000 mL) was added Et3N (110 mL, 791 mmol, 3.00 eq) and then DMAP (3.22 g, 
26.4 mmol, 0.100 eq). The flask was equipped with a bubbler and the mixture was stirred for 
16 h at room temperature. Then, a 10 % aq. citric acid solution (800 mL) was slowly added 
and the mixture was stirred until gas evolution had ceased (1 h). The organic layer was 
separated, washed with brine (900 mL), dried over MgSO4 and concentrated. Purification by 
column chromatography (silica, EtOAc:Hex 4:1 → 2:1) gave I.264 as a colorless solid 
(72.0 g, 90 %). 
TLC (EtOAc:Hex 3:1): Rf = 0.32. 
[α]

: +11.0 (c = 1.0, CHCl3). 
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1H NMR (300 MHz, CDCl3): δ = 5.10 (s, br, 1H), 4.41-4.26 (m, 1H), 4.17 (q, J = 7.1 Hz, 
2H), 4.11 (q, J = 7.1 Hz, 2H), 2.44-2.29 (m, 2H), 2.20-2.09 (m, 1H), 2.03-1.89 (m, 1H), 1.42 
(s, 9H), 1.28-1.21 (m, 6H). 
13C NMR (75 MHz, CDCl3): δ = 172.7, 172.2, 155.3, 79.8, 61.4, 60.6, 52.9, 30.3, 28.5, 
28.2 (3C), 14.1, 14.0.  
IR (film): ṽ
 max = 1726, 1249, 1159. 
HRMS (ESI+):  m/z calcd. for C14H25NO6+:   303.1682 [M]+; 
found:      303.1671 [M]+. 
 
(2R,4S)-diethyl 2-(benzyloxymethyl)-4-(tert-butoxycarbonylamino)pentanedioate (I.265): 
 
To a solution of HMDS (66.0 mL, 311 mmol, 2.31 eq) in THF (90.0 mL) was added a 
solution of n-BuLi (2.25 M in hexanes, 126 mL, 282 mmol, 2.10 eq) dropwise at 0 °C. After 
complete addition, the mixture was allowed to warm to room temperature to be stirred for 
another 30 min at this temperature. 
Then, the resulting LiHMDS solution was cooled to −78 °C and to this solution was added 
dropwise a solution of I.264 (40.8 g, 134 mmol, 1.00 eq) in THF (525 mL) at −78 °C. After 
being stirred for 30 min, a solution of BOMCl (15.5 mL, 79.0 mmol, 2.00 eq) in THF 
(525 mL) was added dropwise to be stirred for additional 3 h at this temperature. The reaction 
mixture was quenched at –78 °C with an 1.00 M aq. HCl solution (185 mL) and the bulk of 
solvent was removed in vacuo. The residue was redissolved in diethyl ether (850 mL) and 
washed with a sat. aq. NaHCO3 solution (800 mL) and brine (400 mL), dried over MgSO4, 
filtered and concentrated. The crude product was purified by repeated column 
chromatography (silica, EtOAc:Hex 1:20 → 1:6; then EtOAc:Hex 1:100 → 1:12) to give 
I.265 as a colorless oil (2.11 g, 4 %). 
TLC (EtOAc:Hex 1:3): Rf = 0.55. 
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[α]

: +1.2 (c = 1.0, MeOH). 
1H NMR (300 MHz, CDCl3): δ = 7.37-7.26 (m, 5H) 5.04 (s, br, 1H), 4.51 (s, 2H), 4.39-4.22 
(m, 1H), 4.22-4.11 (m, 4H), 3.75-3.57 (m, 2H), 2.82-2.70 (m, 1H), 2.16-2.96 (m, 2H), 1.42 (s, 
9H), 1.30-1.22 (m, 6H). 
13C NMR (75 MHz, CDCl3): δ = 173.6, 172.3, 155.4, 137.9, 128.3 (2C), 127.6, 127.5 (2C), 
79.9, 73.1, 70.2, 61.4, 60.8, 52.2, 42.8, 31.0, 28.3 (3C), 14.1, 14.1.  
IR (neat): ṽ
 max = 1708. 
HRMS (ESI+):  m/z calcd. for C22H33NNaO7+:  446,2155 [M+Na]+; 
found:       446.2153 [M +Na]+. 
 
(2S,4R)-1-tert-butyl 2-ethyl 4-(benzyloxymethyl)-5-methoxypyrrolidine-1,2-
dicarboxylate (I.266) and (2S,4S,5R)-1-tert-butyl 2-ethyl 4-(benzyloxymethyl)-5-
methylpyrrolidine-1,2-dicarboxylate (I.249) from I.250:[70] 

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To a solution of I.250 (18.3 g, 48.4 mmol, 1.00 eq) in THF (250 mL) was added dropwise a 
solution of lithium triethylborohydride (1.00 M in THF, 58.0 mL, 58.0 mmol, 1.00 eq) at 
−78 °C over the course of 10 min. After being stirred for 30 min at this temperature, the 
reaction was quenched with a sat. aq. NaHCO3 solution (20.0 mL) and allowed to warm to 
0 °C. To the mixture was added H2O2 (25.0 mL) in one portion and stirred at 0 °C for 30 min. 
The solvent was removed in vacuo and the residue was redissolved in ethyl acetate (540 mL) 
and water (270 mL). The organic layer was separated, dried over MgSO4, filtered and 
concentrated to a colorless oil.  
To a solution of this residual oil containing I.343 (~18.0 g) in methanol (255 mL) was added 
p-toluenesulfonic acid monohydrate (1.84 g, 9.67 mmol, 0.200 eq) to be stirred for 18 h at 
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room temperature. The reaction was quenched with a sat. aq. NaHCO3 solution (22.0 mL), the 
solvent was removed in vacuo and the residue was redissolved in a mixture of diethyl ether 
(540 mL) and water (270 mL). The organic layer was separated, washed with brine (180 mL), 
dried over MgSO4, filtered and concentrated to give a colorless oil. By NMR, I.266 was 
found to be a 4:1 mixture of diastereomers. 
TLC (EtOAc:Hex 1:3): Rf = 0.23 (both diastereomers). 
1H NMR (400 MHz, CHCl3, crude mixture of diastereomers): δ = 7.39-7.20 (m, 5H), 
5.31-5.05 (m, 1H), 4.55-4.45 (m, 2H), 4.27-4.08 (m, 3H), 3.71-3.54 (m, 1H), 3.46-3.38 (m, 
4H), 2.61-2.26 (m, 2H), 1.87-1.73 (m, 1H), 1.48-1.42 (m, 9H), 1.28-1.22 (m, 3H). 
13C NMR (100 MHz, CHCl3, crude mixture of diastereomers): δ = 172.6, 172.2, 154.2, 153.9, 
138.3, 138.2, 128.5, 128.4, 128.3 (2C), 127.7 (2C), 127.5 (2C), 126.9 (2C), 87.9, 87.8, 80.9, 
80.5, 73.3, 73.2, 68.7, 68.5, 65.8, 65.3, 60.9, 60.9, 58.9, 58.2, 55.7, 55.3, 44.7, 44.0, 31.3, 
30.0, 28.3 (3C), 28.1 (3C), 14.2, 14.1. 
IR (neat): 1750, 1451. 
HRMS (ESI+):  m/z calcd. for C21H31NNaO6+:  416.2049 [M+Na]+; 
found:      416.2045 [M +Na]+. 
 
To a suspension of copper(I)bromide-dimethyl sulfide complex (46.3 g, 225 mmol, 4.65 eq) 
in diethyl ether (400 mL) was added a solution of MeMgBr (3.00 M in diethyl ether, 75.0 mL, 
225 mmol, 4.65 eq) dropwise over the course of 15 min at –40 °C and stirred for 1 h at this 
temperature. Then, the resulting yellow suspension was cooled to −78 °C and boron 
trifluoride diethyl etherate (27.8 mL, 225 mmol, 4.65 eq) was added dropwise over the course 
of 15 min. After being stirred for 30 min at −78 °C, a solution of crude I.266 (~19.0 g) in 
diethyl ether (60.0 mL) was added over the course of 10 min. The flask was rinsed with 
additional diethyl ether (15.0 mL) and the reaction mixture was stirred for 15 min at −78 °C. 
Then, the mixture was allowed to warm to room temperature and stirred for 1 h at this 
temperature. The reaction was quenched by dropwise addition of a 1:1 mixture of a sat. aq. 
NH4Cl solution and a 28 % aq. NH3 solution (260 mL). The resulting mixture was stirred for 
30 min at room temperature and was then diluted with diethyl ether (250 mL). The organic 
layer was separated, washed with water (300 mL) and brine (250 mL), dried over MgSO4 and 
concentrated in vacuo to give a residue which was redissolved in THF (120 mL).  
1.3 Experimental Section 
85 
To the mixture was successively added a sat. aq. NaHCO3 solution (21.0 mL), Boc2O (10.6 g, 
48.4 mmol, 1.00 eq) and DMAP (60.0 mg, 0.480 mmol, 0.010 eq) and the mixture was stirred 
for 4 h at room temperature. The bulk of the solvent was removed and the residue was diluted 
in a mixture of EtOEt (540 mL) and water (270 mL). The organic layer was separated, 
washed with brine (250 mL), dried over MgSO4, filtered and concentrated in vacuo. The 
resulting residue was purified by column chromatography (Silica, EtOAc:Hex 1:9 → 1:4) to 
give I.249 as a colorless oil (7.31 g, 40 %). 
TLC (EtOAc:Hex 1:2): Rf = 0.22. 
[α]

 = −42.0 (c = 1.0, MeOH). 
1H NMR (400 MHz, DMSO, 100 °C): 7.38-7.17 (m, 5H), 4.43 (d, J = 2.3 Hz, 2H), 4.17 (dd, 
J = 9.8, 4.1 Hz, 1H), 4.05 (q, J = 7.1 Hz, 2H), 3.73-3.68 (m, 1H), 3.49 (dd, J = 9.5, 7.3 Hz, 
1H), 3.35 (dd, J = 9.5, 7.3 Hz, 1H), 2.44-2.37 (m, 1H), 2.13-2.08 (m, 1H), 1.71 (dt, J = 13.5, 
4.1 Hz, 1H), 1.35 (s, 9H), 1.20 (d, J = 6.2 Hz, 3H), 1.15 (t, J = 7.1, 3H). 
13C NMR (100 MHz, DMSO, 100 °C): δ = 172.9, 153.5, 139.0, 128.5 (2C), 127.7 (2C), 
127.6, 79.3, 72.7, 71.6, 60.6, 59.2, 57.0, 45.5, 30.5, 28.5 (3C), 20.3, 14.3. 
IR (neat): ṽ
 max = 2976, 1745, 1698, 1454, 1388, 1367, 1185. 
HRMS (ESI+):  m/z calcd. for C21H32NO5+:   378.2280 [M+H]+; 
found:      378.2274 [M +H]+. 
 
(2R,3S,5S)-tert-butyl 3-(benzyloxymethyl)-5-(3-hydroxypenta-1,4-dien-3-yl)-2-
methylpyrrolidine-1-carboxylate (I.273): 
 
To a solution of I.249 (100 mg, 0.256 mmol, 1.00 eq) in THF (1.00 mL) was added dropwise 
a DIBAL-H solution (1.00 M solution in hexanes, 0.290 mL, 0.291 mmol, 1.10 eq) at −78 °C. 
After being stirred for 2 h at this temperature, a solution of vinylmagnesium bromide (1.00 M 
in THF, 0.530 mL, 0.530 mmol, 2.00 eq) was added dropwise and the resulting mixture was 
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stirred for 1 h at –78 °C. Then, the reaction mixture was allowed to warm to room 
temperature, stirred for 1.5 h at this temperature and was subsequently quenched by dropwise 
addition of a sat. aq. NH4Cl solution (0.500 mL). The solvent was removed in vacuo and the 
resulting crude solid was redissolved in a 2:1 mixture of EtOAc:water (12.0 mL). The organic 
layer was separated, washed with brine (4.00 mL), dried over MgSO4, filtered and 
concentrated. Purification by column chromatography (silica, EtOAc:Hex 1:2) afforded I.273 
as a colorless oil (81.0 mg, 79 %). 
TLC (EtOAc:Hex 1:2): Rf = 0.18. 
[α]

 = −51.3 (c = 1.0, MeOH). 
1H NMR (600 MHz, CDCl3): 7.37-7.29 (m, 5H), 5.90 (dd, J = 17.1, 10.6 Hz, 2H), 5.41 (dd, 
J = 17.1, 1.8 Hz, 2H), 5.15 (dd, J = 10.6, 1.8 Hz, 2H), 4.52-4.49 (m, 2H), 3.94 (dd, J = 9.6, 
7.6 Hz, 1H), 3.57-3.51 (m, 1H), 3.47-3.42 (m, 1H), 3.39-3.34 (dd, J = 9.3, 6.5 Hz, 1H), 2.12 
(dt, J = 13.4, 7.6 Hz, 1H), 1.93-1.88 (m, 1H), 1.58-1.53 (m, 1H), 1.43 (s, 9H), 1.25 (d, J = 
6.0 Hz, 3H). 
13C NMR (150 MHz, DMSO): δ = 140.3, 138.1 (2C), 136.5, 128.4 (2C), 127.7, 127.5 (2C), 
115.9 (2C), 114.7, 80.6, 77.8, 73.2, 71.5, 67.5, 58.5, 44.3, 31.7, 28.3 (3C), 20.7. 
IR (neat): ṽ
 max = 1716, 1366, 1152. 
HRMS (ESI+):  m/z calcd. for C23H33NNaO4+: 410.2307 [M+Na]+; 
found:      410.2301 [M +Na]+. 
 
(2S,4S,5R)-4-(benzyloxymethyl)-1-(tert-butoxycarbonyl)-5-methylpyrrolidine-2-
carboxylic acid (I.271): 
 
To a solution of I.249 (11.0 mg, 29.1 µmol, 1.00 eq) in THF (0.200 mL) was added a 2.50 M 
aq. LiOH solution (0.200 mL, 0.468 mmol, 12.0 eq) and the resulting mixture was heated to 
reflux for 18 h. The mixture was allowed to cool to room temperature and upon removal of 
the solvent in vacuo, the residue was diluted with a mixture of a sat. aq. NH4Cl solution 
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(4.00 mL), a 2.00 M aq. HCl solution (5.00 mL) and Et2O (10.0 mL). The organic layer was 
separated, washed with brine (4.00 mL), dried over MgSO4 and concentrated. The crude 
product was purified by column chromatography (silica, EtOAc:Hex 1:1 → 2:1) to give I.271 
as a colorless oil (3.70 mg, 36 %). 
TLC (EtOAc:Hex 2:1): Rf = 0.09. 
1H NMR (400 MHz, CDCl3, mixture of rotation isomers): 7.35-7.25 (m, 5H), 4.50-4.45 (m, 
2H), 4.37-4.23 (m, 1H), 3.98-3.79 (m, 1H), 3.51-3.34 (m, 2H), 2.54-1.97 (m, 3H), 1.49-1.37 
(m, 9H), 1.27-1.21 (m, 3H). 
13C NMR (100 MHz, DMSO, mixture of rotation isomers): δ = 177.9, 174.3, 156.7, 153.2, 
138.1, 137.9, 128.4 (2C), 128.4 (2C), 127.7 (2C), 127.6 (2C), 127.5, 127.4, 81.8, 80.4, 73.2, 
73.1, 71.6, 71.3, 58.9, 58.7, 57.4, 57.0, 45.4, 45.0, 31.0, 29.7, 28.4 (3C), 28.2 (3C), 20.1, 19.7. 
IR (neat): ṽ
 max = 1741, 1550. 
HRMS (ESI-):  m/z calcd. for C19H26NO5−:   348.1816 [M−H]−; 
found:      348.1812 [M−H]−. 
 
(2R,3S,5S)-tert-butyl 3-(benzyloxymethyl)-5-(hydroxymethyl)-2-methylpyrrolidine-1-
carboxylate (I.272) and ((2S,4S,5R)-4-(benzyloxymethyl)-1,5-dimethylpyrrolidin-2-
yl)methanol (I.274): 
 
To a suspension of LiAlH4 (8.63 mg, 0.227 mmol, 1.10 eq) in THF (0.500 mL) was added 
dropwise a solution of I.249 (78.0 mg, 0.207 mmol, 1.00 eq) in THF (0.500 mL) at 0 °C. The 
resulting mixture was allowed to warm to room temperature to be stirred for 18 h at this 
temperature. Then, THF (6.00 mL) was added and the reaction mixture was heated to reflux 
for 3 h. The mixture was allowed to cool to room temperature and the solvent was removed in 
vacuo. The mixture was redissolved in a sat. aq. Rochelle salt solution (20.0 mL) and 
extracted with EtOAc (3 x 20.0 mL). The combined extracts were washed with brine 
(15.0 mL), dried over MgSO4 and concentrated. The crude product mixture was purified with 
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column chromatography (silica, EtOAc:Hex 1:4 → 1:3) to afford I.272 as a colorless oil 
(14.0 mg, 20 %) and I.274 as a colorless oil (30.2 mg, 59 %). 
I.274 was isolated by concentrating earlier fractions of the chromatographic purification step. 
TLC (EtOAc:Hex 1:2): Rf = 0.22. 
[α]

 =  −21.2 (c = 1.0, MeOH). 
1H NMR (400 MHz, DMSO): δ = 7.39-7.19 (m, 5H), 4.44 (s, 2H), 3.69 (s, br, 1H), 3.50-3.32 
(m, 5H), 3.23-3.18 (m, 1H), 2.14-2.05 (m, 1H), 1.99-1.89 (m, 1H), 1.58 (dt, J = 12.7, 8.2 Hz, 
1H), 1.25 (s, 9H), 1.14 (d, J = 6.2 Hz, 3H). 
13C NMR (100 MHz, DMSO): δ = 154.5, 139.1, 128.6 (2C), 127.7 (2C), 127.7, 78.7, 72.8, 
72.4, 63.7, 59.7, 57.0, 45.0, 30.2, 28.7 (3C), 21.5. 
IR (neat): ṽ
 max = 2971, 1686, 1662, 1390, 1172, 1089. 
HRMS (ESI+):  m/z calcd. for C19H30NO4+:   336.2175 [M+H]+; 
found:      336.2194 [M +H]+. 
 
I.272 was isolated by concentrating later fractions of the chromatographic purification step. 
TLC (EtOAc:Hex 1:2): Rf = 0.15. 
[α]

 = −9.1 (c = 1.0 MeOH). 
1H NMR (600 MHz, CDCl3): δ = 7.36-7.29 (m, 5H), 4.53-4.49 (m, 2H), 4.45 (t, J = 8.4 Hz, 
1H), 4.13 (dd, J = 8.9, 3.6 Hz, 1H), 4.06-4.02 (m, 1H), 3.75-3.71 (m, 1H), 3.50-3.42 (m, 1H), 
2.29-2.22 (m, 1H), 2.20-2.14 (m, 1H), 1.47 (s, 3H), 1.38 (dd, J = 22.4, 10.5 Hz, 1H), 1.30 (d, 
J = 6.6 Hz, 3H), 1.26 (s, br, 1H). 
13C NMR (150 MHz, CDCl3): δ = 138.0, 128.4 (2C), 127.7, 127.6 (2C), 73.3, 71.7, 67.6, 
58.1, 57.7, 49.5, 35.8, 26.5, 21.6. 
IR (neat): ṽ
 max = 2869, 1371, 1149. 
HRMS (EI+):  m/z calcd. for C15H23NO2+:   249.1729 [M]+; 
found:      249.1726 [M]+. 
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(2R,3S,5S)-tert-butyl 3-(benzyloxymethyl)-5-(hydroxymethyl)-2-methylpyrrolidine-1-
carboxylate (I.272): 
 
To a solution of I.249 (117 mg, 0.310 mmol, 1.00 eq) in THF (1.50 mL) was added a solution 
of LiBH4 (2.00 M solution in THF, 0.170 mL, 0.341 mmol, 1.10 eq) over the course of 5 min 
at 0 °C. Then, the mixture was allowed to warm to room temperature, stirred for 18 h at this 
temperature and concentrated. The resulting solid was redissolved in water (20.0 mL) and 
extracted with EtOEt (3 x 20.0 mL). The combined extracts were washed with brine 
(15.0 mL), dried over MgSO4 and concentrated. Upon purification by column 
chromatography (silica, EtOAc:Hex 1:3), I.272 was obtained as a colorless oil (50.1 mg, 
48 %). 
TLC (EtOAc:Hex 1:2): Rf = 0.22. 
[α]

 =  −21.2 (c = 1.0, MeOH). 
1H NMR (400 MHz, DMSO): δ = 7.39-7.19 (m, 5H), 4.44 (s, 2H), 3.69 (s, br, 1H), 3.50-3.32 
(m, 5H), 3.23-3.18 (m, 1H), 2.14-2.05 (m, 1H), 1.99-1.89 (m, 1H), 1.58 (dt, J = 12.7, 8.2 Hz, 
1H), 1.25 (s, 9H), 1.14 (d, J = 6.2 Hz, 3H). 
13C NMR (100 MHz, DMSO): δ = 154.5, 139.1, 128.6 (2C), 127.7 (2C), 127.7, 78.7, 72.8, 
72.4, 63.7, 59.7, 57.0, 45.0, 30.2, 28.7 (3C), 21.5. 
IR (neat): ṽ
 max = 2971, 1686, 1662, 1390, 1172, 1089. 
HRMS (ESI+):  m/z calcd. for C19H30NO4+:   336,2175 [M+H]+; 
found:      336,2194 [M +H]+. 
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1-Hydroxy-3H-benz[d][1,2]iodoxole-1,3-dione (I.345) and 1,1,1-tris(acetoxy)-1,1-
dihydro-1,2-benziodoxol-3(1H)-one (I.346):[96] 
 
In a 4.00 L three-necked flask equipped with a mechanical stirrer and a thermometer, a 
mixture of iodobenzoic acid (I.344, 200 g, 0.810 mol, 1.00 eq), water (2.60 L) and oxone® 
(704 g, 1.15 mol, 1.42 eq) was stirred at 70 °C without sealing the third joint. After 3 h, the 
mixture was allowed to cool to room temperature and was then cooled to 0 °C for 2 h. The 
resulting precipitate was filtered off, washed with cold water (2.00 L), acetone (2.00 L), 
hexanes (0.500 L) and diethyl ether (0.500 L) and dried to give I.345 as a colorless solid 
(172 g, 76 %) which was used without further purification. 
mp: 230 °C. 
1H NMR (400 MHz): δ = 8.15 (d, J = 7.8 Hz, 1H), 8.01 (d, J = 7.8 Hz, 1H), 7.98 (t, 
J = 7.8 Hz, 1H), 7.84 (t, J = 7.8 Hz, 1H). 
13C NMR (75 MHz, DMSO): δ = 168.4, 147.4, 133.8, 132.3, 131.3, 131.0, 125.9. 
IR (neat): 1640. 
To a suspension of IBX (I.345) prepared as described above (120 g, 429 mmol, 1.00 eq) in 
Ac2O (450 mL) was added p-TsOH monohydrate (1.63 g, 8.57 mmol, 0.020 eq) and the 
resulting mixture was heated to 80 °C for 2 h. The mixture was allowed to cool to room 
temperature and was then cooled to 0 °C for 2 h. The resulting solid was filtered off, washed 
with diethyl ether (3.00 L) and hexanes (2.00 L) and dried. DMP (I.346) was afforded as a 
colorless solid (180 g, 99 %) and was pure enough to be used without further purification. 
mp: ca. 100 °C (explosive decomposition). 
1H NMR (400 MHz, CDCl3): δ = 8.33–8.24 (m, 2H), 8.11–8.04 (m, 1H), 7.90 (td, J = 0.9, 
7.4 Hz, 1H), 2.32 (s, 3H), 1.99 (s, 6H). 
13C NMR (75 MHz, CDCl3): δ = 175.8, 174.1, 166.2, 142.3, 135.9, 133.9, 131.9, 126.6, 
126.0, 20.5, 20.4. 
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IR (neat): ṽ
 max = 1700, 1671. 
 
(2R,3S,5S)-tert-butyl 3-(benzyloxymethyl)-5-formyl-2-methylpyrrolidine-1-carboxylate 
(I.272) using DMP (I.346): 
 
To a suspension of DMP (I.346) prepared as described above (45.5 mg, 107 µmol, 1.20 eq) 
and sodium bicarbonate (11.3 mg, 134 µmol, 1.50 eq) in CH2Cl2 (1.00 mL) was added a 
solution of I.272 (30.0 mg, 89.4 µmol, 1.00 eq) in CH2Cl2 (1.00 mL) dropwise at room 
temperature. The mixture was stirred for 2 h at room temperature, then diluted with a mixture 
of diethyl ether (15.0 mL) and 1.30 M NaOH (7.50 mL) and stirring was continued for another 
15 min. The organic layer was then separated, washed with a 1.30 M NaOH solution 
(15.0 mL) and water (15.0 mL), dried over MgSO4, filtered and concentrated to give I.275 as 
a colorless oil (15.8 mg, 53 %). 
TLC (EtOAc:Hex 1:2): Rf = 0.61. 
[α]

 =  −27.2 (c = 1.0, MeOH). 
1H NMR (400 MHz, DMSO, 100 °C): δ = 9.41 (d, J = 2.46 Hz, 1H), 7.34-7.22 (m, 5H), 4.46 
(s, 2H), 4.17-4.08 (m, 1H), 3.74-3.67 (m, 1H), 3.42-3.35 (m, 2H), 2.08-1.99 (m, 2H), 1.91-
1.82 (m, 1H), 1.37 (s, 9H), 1.21 (d, J = 6.3 Hz, 3H). 
13C NMR (100 MHz, DMSO, 100 °C): δ = 201.0, 159.5, 139.0, 128.6 (2C), 127.7, 127.7 
(2C), 79.7, 72.8, 71.7, 65.4, 57.0, 45.2, 28.5 (3C), 27.9, 20.9. 
IR (neat): ṽ
 max = 2974, 1735, 1684, 1388, 1364, 1171. 
HRMS (ESI+):  m/z calcd. for C19H27NNaO4+: 356.1838 [M+Na]+; 
found:      356.1831 [M +Na]+. 
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(2R,3S,5S)-tert-butyl 3-(benzyloxymethyl)-5-formyl-2-methylpyrrolidine-1-carboxylate 
(I.275) and (2R,3S,5S)-tert-butyl 3-(benzyloxymethyl)-5-(1-hydroxyallyl)-2-
methylpyrrolidine-1-carboxylate (I.269): 
 
To a solution of oxalyl chloride (0.150 mL, 1.57 mmol, 1.20 eq) in CH2Cl2 (3.00 mL) was 
added a solution of DMSO (0.210 mL, 2.89 mmol, 2.50 eq) in CH2Cl2 (0.800 mL) at −72 °C 
over the course of 10 min. To the resulting mixture was added a solution of I.272 (440 mg, 
1.31 mmol, 1.00 eq) in CH2Cl2 (1.20 mL) over a period of 15 min to be stirred for 30 min at 
−72 °C. Then, DIPEA (0.910 mL, 5.25 mmol, 4.00 eq) was added over 5 min and the mixture 
was allowed to warm to room temperature. The resulting mixture was diluted with 5.00 mL of 
CH2Cl2 and washed with a 5 % aq. HCl solution (3x 10.0 mL), water (3x 10.0 mL) and brine 
(10.0 mL). The solvent was removed in vacuo and the resulting yellow oil containing I.275 
was pure enough to be used without further purification (384 mg, 88 %). 
TLC (EtOAc:Hex 1:2): Rf = 0.61. 
[α]

 =  −27.2 (c = 1.0, MeOH). 
1H NMR (400 MHz, DMSO, 100 °C): δ = 9.41 (d, J = 2.46 Hz, 1H), 7.34-7.22 (m, 5H), 4.46 
(s, 2H), 4.17-4.08 (m, 1H), 3.74-3.67 (m, 1H), 3.42-3.35 (m, 2H), 2.08-1.99 (m, 2H), 
1.91-1.82 (m, 1H), 1.37 (s, 9H), 1.21 (d, J = 6.3 Hz, 3H). 
13C NMR (100 MHz, DMSO, 100 °C): δ = 201.0, 159.5, 139.0, 128.6 (2C), 127.7, 127.7 
(2C), 97.7, 72.8, 71.7, 65.4, 57.0, 45.2, 28.5 (3C), 27.9, 20.9. 
IR (neat): ṽ
 max = 2974, 1735, 1684, 1388, 1364, 1171. 
HRMS (ESI+):  m/z calcd. for C19H27NNaO4+: 356.1838 [M+Na]+; 
found:      356.1831 [M +Na]+. 
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To a solution of I.275 (383 mg, 1.15 mmol, 1.00 eq) and LiCl (97.4 mg, 2.30 mmol, 2.00 eq) 
in THF (3.00 mL) was added dropwise a solution of vinylmagnesium bromide (1.00 M in 
THF, 2.30 mL, 2.30 mmol, 2.00 eq) at −78 °C. The mixture was stirred for 15 min at this 
temperature and was then allowed to warm up to be stirred for 12 h at room temperature. 
Subsequently, the mixture was heated to reflux for 1.5 h and was then allowed to cool to room 
temperature. The reaction was quenched with a sat. aq. NH4Cl solution (2.50 mL) and the 
bulk of the solvent was removed in vacuo. The residue was diluted with a sat. aq. NH4Cl 
solution (50.0 mL) and water (50.0 mL) and was extracted with CH2Cl2 (3 x 75.0 mL). The 
combined extracts were washed with brine (100 mL), dried over MgSO4 and concentrated. 
Purification by column chromatography (silica, EtOAc:Hex 1:4 → 1:3) gave I.269 as a 3:2 
mixture of diastereomers (394 mg, 95 %). A 25.0 mg sample of the mixture was separated by 
reversed phase HPLC (Varian Dynamax 250x21.4 mm Microsorb 60-8 C18 column equipped 
with a Dynamax HPLC guard column operating on a Varian PrepStar HPLC system; 
H2O/MeOH; 15.5 mL/min) to afford a minor diastereomer (8.10 mg) and a major 
diastereomer as colorless oils. 
Minor diastereomer: 
HPLC (gradient program: t = 0 min 72% MeOH, t = 2 min 72% MeOH, t = 30 min 90 % 
MeOH, t = 35 min 90 % MeOH): Rt = 14.73 min. 
[α]	

 =  −89.0 (c = 1.0, MeOH). 
1H NMR (400 MHz, DMSO, 100 °C, mixture of rotation isomers): δ = 7.39-7.19 (m, 5H), 
5.81-5.53 (m, 1H), 5.18-5.03 (m, 2H), 4.79-4.60 (m, 1H), 4.44-4.39 (m, 2H), 3.88-3.17 (m, 
1H), 3.38-3.32 (m, 1H), 3.31-3.26 (m, 2H), 3.25-3.20 (m, 1H), 2.04-1.82 (m, 2H), 1.60-1.43 
(m, 1H), 1.39-1.35 (m, 9H), 1.19-1.13 (m, 3H). 
13C NMR (100 MHz, DMSO, 100 °C, mixture of rotation isomers): δ = 154.7, 154.6, 139.0, 
138.9, 138.2, 138.1, 128.7 (2C), 128.6 (2C), 127.8 (2C), 127.8 (2C), 127.7, 127.7, 116.2, 
114.6, 79.0, 78.6, 72.5, 72.4, 72.2, 71.9, 70.2, 70.1, 62.4, 61.2, 58.0, 57.1, 44.6, 44.0, 28.6 
(3C), 28.5 (3C), 27.0, 26.9, 20.6, 20.5. 
IR (neat): ṽ
 max = 2973, 1688, 1660, 1391, 1365, 1114. 
HRMS (ESI+):  m/z calcd. for C21H31NNaO4+: 384.2151 [M+Na]+; 
found:      384.2146 [M +Na]+. 
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Major diastereomer: 
HPLC (gradient program: t = 0 min 72% MeOH, t = 2 min 72% MeOH, t = 30 min 90 % 
MeOH, t = 35 min 90 % MeOH): Rt = 18.89 min. 
[α]	

 =  −77.8 (c = 1.0, MeOH). 
1H NMR (400 MHz, DMSO, 100 °C): δ = 7.39-7.17 (m, 5H), 5.75 (ddd J = 17.2, 10.6, 5.0 
Hz, 1H), 5.16 (dt, J = 17.2, 1.8 Hz, 1H), 5.02 (dt, J = 10.6, 1.8 Hz, 1H), 4.63-4.61 (m, 1H), 
4.45 (s, 2H), 3.74-3.70 (m, 1H), 3.59-3.54 (m, 2H), 3.42 (dd, J = 9.6, 5.9 Hz, 1H), 2.98 (s, br, 
1H), 1.97-1.91 (m, 2H), 1.67-1.61 (m, 1H), 1.40 (s, 9H), 1.19 (d, J = 6.2 Hz, 3H). 
13C NMR (100 MHz, DMSO, 100 °C): δ = 154.3, 140.5, 139.3, 128.5 (2C), 127.7 (2C), 
127.6, 114.4, 78.8, 72.8, 72.6, 70.4, 62.1, 58.1, 45.0, 28.7, 26.2, 20.5. 
IR (neat): ṽ
 max = 2972, 1665, 1392, 1365, 1113. 
HRMS (ESI+):  m/z calcd. for C21H31NNaO4+: 384.2151 [M+Na]+; 
found:      384.2146 [M +Na]+. 
 
(2S,4S,5R)-ethyl 4-(benzyloxymethyl)-5-methylpyrrolidine-2-carboxylate (I.277) from 
I.249: 
 
To a solution of I.249 (2.50 g, 6.62 mmol, 1.00 eq) and thioanisole (0.800 mL, 6.62 mmol, 
1.00 eq) in CH2Cl2 (10.0 mL) was added trifluoroacetic acid (9.84 mL, 132 mmol, 20.0 eq) 
via syringe and stirred for 3 h at room temperature. The resulting slight orange solution was 
quenched by dropwise addition of a sat. aq. Na2CO3 solution (30.0 mL) and then poured into a 
sat. aq. NaHCO3 solution (270 mL). The mixture was extracted with CH2Cl2 (5 x 150 mL) 
and the combined extracts were washed with brine (300 mL), dried over MgSO4, filtered and 
concentrated. The colorless crude product was purified via column chromatography (silica, 
CHCl3/MeOH/NEt3 100:1:1 → 100:2:1) to give I.277 as a colorless oil (1.78 g, 97 %). 
TLC (CHCl3:MeOH 100:5): Rf = 0.2. 
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[α]

 =  −12.1 (c = 1.0, MeOH). 
1H NMR (600 MHz, CDCl3): δ = 7.36-7.27 (m, 5H), 4.51-4.47 (m, 2H), 4.15 (q, J = 7.2 Hz, 
2H), 3.89-3.81 (m, 1H), 3.46 (dd, J = 9.2, 5.9 Hz, 1H), 3.36 (dd, J = 9.2, 6.8 Hz, 1H), 
3.15-3.03 (m, 1H), 2.46-2.40 (m, 1H), 2.20 (s, br, 1H), 1.98-1.94 (m, 1H), 1.76-1.69 (m, 1H), 
1.25 (t, J = 6.8 Hz, 3H), 1.17 (d, J = 6.2 Hz, 3H). 
13C NMR (150 MHz, CDCl3): δ = 175.5, 138.4, 128.3 (2C), 127.5, 127.4 (2C), 73.1, 72.1, 
60.9, 58.4, 56.7, 46.6, 34.1. 20.8, 14.2. 
IR (neat): ṽ
 max = 2960, 2859, 1728, 1367, 1204. 
HRMS (ESI+):  m/z calcd. for C16H23NO3+:   277.1678 [M]+; 
found:      277.1685 [M]+. 
 
(2S,4S,5R)-ethyl 4-(benzyloxymethyl)-5-methylpyrrolidine-2-carboxylate (I.277) from 
I.250: 
 
To a solution of I.250 (18.3 g, 48.4 mmol, 1.00 eq) in THF (250 mL) was added dropwise a 
solution of lithiumtriethylborohydride (1.00 M in THF, 58.0 mL, 58.0 mmol, 1.00 eq) at 
−78 °C over the course of 10 min. After being stirred for 30 min, the reaction was quenched 
with a sat. aq. NaHCO3 solution (20.0 mL) and allowed to warm to 0 °C. To the mixture was 
added H2O2 (25.0 mL) in one portion and stirred at 0 °C for 30 min. The solvent was removed 
in vacuo and the residue was redissolved in a 2:1 mixture of ethyl acetate and water (810 mL). 
The organic layer was separated, dried over MgSO4, filtered and concentrated to a colorless 
oil. 
To a solution of this residual oil containing I.343 (~18.0 g) in methanol (255 mL) was added 
p-toluenesulfonic acid monohydrate (1.84 g, 9.67 mmol, 0.200 eq) to be stirred for 18 h at 
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room temperature. The reaction was quenched with a sat. aq. NaHCO3 solution (22.0 mL), the 
solvent was removed in vacuo and the residue was redissolved in a mixture of diethyl ether 
(540 mL) and water (270 mL). The organic layer was separated, washed with brine (180 mL), 
dried over MgSO4, filtered and concentrated to give a colorless oil containing I.266. 
To a suspension of copper(I)bromide-dimethyl sulfide complex (46.3 g, 225 mmol, 4.65 eq) 
in diethyl ether (400 mL) was added dropwise a solution of MeMgBr (3.00 M in diethyl ether, 
75.0 mL, 225 mmol, 4.65 eq) over the course of 15 min at –40 °C and stirred for 1 h at this 
temperature. Then, the resulting yellow suspension was cooled to −78 °C and boron 
trifluoride diethyl etherate (27.8 mL, 225 mmol, 4.65 eq) was added dropwise over the course 
of 15 min. After being stirred for 30 min at −78 °C, a solution of the residual colorless oil 
from the previous reaction (~19.0 g) in diethyl ether (60.0 mL) was added over the course of 
10 min. The flask was rinsed with additional diethyl ether (15.0 mL) and the reaction mixture 
was stirred for 15 min at −78 °C. Then, the mixture was allowed to warm to room temperature 
and stirred for 1 h at this temperature. The reaction was quenched by a dropwise addition of a 
1:1 mixture of a sat. aq. NH4Cl solution and a 28 % aq. NH3 solution (260 mL). The resulting 
mixture was stirred for 30 min at room temperature and was then diluted with diethyl ether 
(250 mL). The organic layer was separated, washed with water (300 mL) and brine (250 mL), 
dried over MgSO4 and concentrated in vacuo to give a residue that was redissolved in a 
mixture of CH2Cl2 (50.0 mL) and trifluoroacetic acid (50.0 mL).  
To the mixture was added thioanisole (5.69 mL, 48.4 mmol, 1.00 eq) to be stirred for 2 h at 
room temperature. The reaction mixture was quenched by dropwise addition of a sat. aq. 
Na2CO3 solution (100 mL) and was then poured into a sat. aq. NaHCO3 solution (800 mL). 
The mixture was extracted with CH2Cl2 (5 x 250 mL), the combined extracts were 
concentrated and after purification with column chromatography (silica, CHCl3:MeOH:NEt3 
100:1:1), I.277 was obtained as a colorless oil (5.43 g, 40 %). 
TLC (CHCl3:MeOH 100:5): Rf = 0.2. 
[α]

 =  −12.1 (c = 1.0, MeOH). 
1H NMR (600 MHz, CDCl3): δ = 7.36-7.27 (m, 5H), 4.51-4.47 (m, 2H), 4.15 (q, J = 7.2 Hz, 
2H), 3.89-3.81 (m, 1H), 3.46 (dd, J = 9.2, 5.9 Hz, 1H), 3.36 (dd, J = 9.2, 6.8 Hz, 1H), 
3.15-3.03 (m, 1H), 2.46-2.40 (m, 1H), 2.20 (s, br, 1H), 1.98-1.94 (m, 1H), 1.76-1.69 (m, 1H), 
1.25 (t, J = 6.8 Hz, 3H), 1.17 (d, J = 6.2 Hz, 3H). 
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13C NMR (150 MHz, CDCl3): δ = 175.5, 138.4, 128.3 (2C), 127.5, 127.4 (2C), 73.1, 72.1, 
60.9, 58.4, 56.7, 46.6, 34.1. 20.8, 14.2. 
IR (neat): ṽ
 max = 2960, 2859, 1728, 1367, 1204. 
HRMS (ESI+):  m/z calcd. for C16H23NO3+:   277.1678 [M]+; 
found:      277.1685 [M]+. 
 
(2S,4S,5R)-ethyl 4-(benzyloxymethyl)-1-(3-ethoxy-3-oxopropyl)-5-methylpyrrolidine-2-
carboxylate (I.247): 
 
To a solution of I.277 (2.20 g, 7.93 mmol, 1.00 eq) in CH2Cl2 (8.50 mL) was added ethyl 
propiolate (I.279, 0.89 mL, 8.73 mmol, 1.10 eq) over the course of 1 min. After being stirred 
for 1 h at room temperature, all volatile substances were removed in vacuo to give crude 
I.269. An analytical sample was purified by column chromatography (silica, EtOAc:Hex 
1:10 → 1:5) to afford I.269 as a colorless oil. 
TLC (EtOAc:Hex 1:5): Rf = 0.21. 
[α]


 =  −66.4 (c = 1.0, MeOH). 
1H NMR (400 MHz, CDCl3): δ = 7.56 (d, J = 13.4 Hz, 1H), 7.37-7.27 (m, 5H), 4.54-4.39 (m, 
3H), 4.20-4.05 (m, 5H), 3.69-3.56 (m, 1H), 3.50 (dd, J = 9.5, 6.7 Hz, 1H), 3.40 (dd, J = 9.5, 
6.6 Hz, 1H), 2.60-2.43 (m, 1H), 2.13-2.02 (m, 1H), 1.95-1.78 (m, 1H), 1.31 (d, J = 6.3 Hz, 
3H), 1.26-1.19 (m, 6H). 
13C NMR (150 MHz, CDCl3): δ = 172.1, 169.2, 145.7, 138.0, 128.4 (2C), 127.7, 127.5 (2C), 
87.3, 77.2, 73.2, 70.8, 61.4, 60.1, 59.0, 45.7, 31.5, 18.8, 14.6, 14.1. 
IR (neat): ṽ
 max = 1728, 1680. 
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HRMS (ESI+):  m/z calcd. for C21H30NO5+:   376.2124 [M+H]+; 
found:      376.2118 [M+H]+. 
 
The crude material obtained as described above was redissolved in glacial acid (5.00 mL, 
87.3 mmol, 11.0 eq). To this solution was added sodium cyanoborohydride (1.00 g, 
15.9 mmol, 2.00 eq) and stirred for 30 min at room temperature. The reaction was quenched 
by dropwise addition of a 10 % aq. HCl solution (15.0 mL). After being stirred for 15 min, a 
sat. aq. Na2CO3 solution (30.0 mL) was added dropwise and the resulting mixture was poured 
into a sat. aq. NaHCO3 solution (270 mL). The mixture was extracted with CH2Cl2 
(3 x 150 mL), the combined extracts were washed with brine (300 mL), dried over MgSO4, 
filtered and concentrated to a colorless crude product which was purified by column 
chromatography (EtOAc:Hex 1:11 → 1:9) to give I.247 as a colorless oil (2.16 g, 72 %). 
TLC (EtOAc:Hex 1:5): Rf = 0.28. 
[α]

 =  −63.8 (c = 1.0, MeOH). 
1H NMR (400 MHz, CDCl3): δ = 7.35-7.19 (m, 5H), 4.53-4.45 (m, 2H), 4.13-4.04 (m, 4H), 
3.83-3.69 (m, 1H), 3.50 (dd, J = 9.0, 6.7 Hz, 1H), 3.40 (dd, J = 8.9, 7.7 Hz, 1H), 3.08-2.91 
(m, 2H), 2.78-2.67 (m, 1H), 2.54-2.42 (m, 2H), 2.36-2.24 (m, 1H), 2.08-1.97 (m, 1H), 
1.67-1.57 (m, 1H), 1.24-1.19 (m, 6H), 1.08 (d, J = 5.9 Hz, 3H). 
13C NMR (150 MHz, CDCl3): δ = 174.3, 172.3, 138.5, 128.3 (2C), 127.5 (2C), 127.4, 73.3, 
73.1, 62.2, 60.3, 60.1, 59.9, 45.3, 43.4, 34.2, 31.1, 18.1, 14.3, 14.2. 
IR (neat): ṽ
 max = 2977, 2854, 1729, 1369, 1179. 
HRMS (ESI+):  m/z calcd. for C21H32NO5+:   378.2280 [M+H]+; 
found:      378.2273 [M+H]+. 
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(2S,5R,6S,7aS)-ethyl 6-(benzyloxymethyl)-5-methyl-1-oxohexahydro-1H-pyrrolizine-2-
carboxylate (I.245): 
 
To a mixture of I.247 (1.67 g, 4.40 mmol, 1.00 eq) and toluene (18.0 mL) was added a 
solution of KHMDS (0.500 M in toluene, 2.00 mL, 8.80 mmol, 2.00 eq) at 0 °C. The mixture 
was stirred for 0.5 h at 0 °C and was then allowed to warm to room temperature to be stirred 
for 0.5 h at this temperature. The reaction was quenched with a sat. aq. NH4Cl solution 
(20.0 mL), diluted with a sat. aq. NH4Cl solution (500 mL) and extracted with CH2Cl2 
(5 x 150 mL). The aqueous phase was diluted with a sat. aq. Na2CO3 solution (100 mL) and 
extracted with CH2Cl2 (3 x 150 mL). A second time, the aqueous phase was diluted with a sat. 
aq. Na2CO3 solution (100 mL) and extracted with CH2Cl2 (2 x 150 mL). The combined 
extracts were concentrated and purified by reversed phase column chromatography 
(H2O:MeOH 5:1 → 2:1) to give I.245 as a colorless solid. 
TLC (CHCl3:MeOH 100:10): Rf = 0.33. 
[α]

 =  −36.2 (c = 1.0 MeOH). 
1H NMR (400 MHz, d6-acetone): δ = 7.35-7.24 (m, 5H), 4.51-4.47 (m, 2H), 4.16-4.09 
(m, 2H), 3.67-3.29 (m, 5H), 2.71-2.47 (m, 1H), 2.33-2.20 (m, 1H), 2.10-2.07 (m, 1H), 
2.04-1.94 (m, 1H), 1.72-1.58 (m, 1H), 1.22 (t, J = 7.1 Hz, 3H), 1.16 (d, J = 5.9 Hz, 3H). 
13C NMR (100 MHz, d6-acetone): δ = 214.9, 168.4, 138.9, 128.2 (2C), 127.3 (2C), 127.3, 
72.6, 71.5, 71.1, 61.2, 60.7, 48.7, 47.1, 30.1, 29.2, 18.2, 13.6. 
IR (neat): ṽ
 max = 2978, 1677, 1580, 1452, 1260, 1171, 1071. 
HRMS (ESI+):  m/z calcd. for C19H25NO4+:   332.1862 [M]+; 
found:      332.1856 [M]+. 
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But-3-enyl propiolate (I.254): 
H

?
H2S4 tuee
refux 48 h


(50 %)
I254
I281I280
H
 
In a 100 mL round bottom flask equipped with a Dean-Stark apparatus, a mixture of propiolic 
acid (I.280, 5.00 mL, 80.7 mmol, 1.10 eq), 3-buten-1-ol (I.281, 6.28 mL, 73.3 mmol, 
1.00 eq), sulfuric acid (0.300 mL, 5.00 mmol, 0.050 eq) and toluene (50.0 mL) was heated to 
reflux for 48 h. Then, the reaction mixture was allowed to cool to room temperature and 
diluted with a sat. aq. NaHCO3 solution (150 mL). The organic layer was separated, washed 
with brine (50.0 mL), dried over MgSO4 and concentrated. The resulting crude product was 
purified by fractional distillation to give I.254 as a colorless oil (4.60 g, 50 %). 
TLC (EtOAc:Hex 1:10): Rf = 0.20. 
bp: 50 °C/5 mbar. 
1H NMR (300 MHz, CDCl3): δ = 5.86-5.71 (m, 1H), 5.19-5.05 (m, 2H), 4.25 (t, J = 6.8 Hz, 
2H), 2.90 (s, 1H), 2.44 (qt, J = 6.8, 1.4 Hz, 2H). 
13C NMR (75 MHz, CDCl3): δ = 152.6, 133.2, 117.8, 74.7, 74.6, 65.2, 32.7. 
IR (neat): ṽ
 max = 1721, 998. 
HRMS (EI+):  m/z calcd. for C7H8O2+:   124.0524 [M]+; 
found:      124.0528 [M]+. 
 
But-3-enyl propiolate dicobalt hexacarbonyl complex (I.282): 
 
To a solution of dicobalt octacarbonyl (5.00 g, 14.6 mmol, 1.10 eq) in CH2Cl2 (50.0 mL) was 
added dropwise I.254 (1.70 ml, 13.3 mmol, 1.00 eq) at room temperature. The mixture was 
stirred for 14 h under a CO atmosphere. The resulting brownish mixture was filtered through 
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a short plug of celite, the solvent was removed under reduced pressure and the residue was 
purified by column chromatography (silica, EtOAc:Hex 1:100, then EtOAc:Hex 10:100) to 
afford I.282 as a red oil (4.71 g, 92 %). 
TLC (EtOAc:Hex 1:10): Rf = 0.22. 
1H NMR (600 MHz, CDCl3): δ = 6.20 (s, br, 1H), 5.79 (s, br, 1H), 5.09 (s, br, 2H), 4.29 
(s, br, 2H), 2.43 (s, br, 2H). 
13C NMR (150 MHz, CDCl3): δ = 198.1 (br, 6C), 169.8, 133.7, 117.4, 73.4, 73.4, 65.0, 33.1. 
IR (neat): ṽ
 max = 2050, 2026. 
 
But-3-enyl 3-(trimethylsilyl)propiolate (I.284): 
 
To a solution of 3-(trimethylsilyl)propionic acid (I.283, 3.00 g, 21.1 mmol, 1.10 eq) and 
EDCI (4.04 g, 21.1 mmol, 1.10 eq) in dichloromethane (25.0 mL) was added a solution of 
3-butene-1-ol (I.281, 1.64 mL, 19.2 mmol, 1.00 eq) and 4-pyrrolidinopyridine (0.284 g, 
1.90 mmol, 0.100 eq) in dichloromethane (20.0 mL) at −40 °C. The mixture was allowed to 
warm to −20 °C to be stirred for 2 h at this temperature. The mixture was then allowed to 
slowly warm to 0 °C over the course of 1 h to be stirred for 3 h at this temperature. The 
reaction mixture was then diluted with an aq. 2.00 M HCl solution (250 mL) and diethyl ether 
(250 mL). The organic layer was separated, washed with a sat. aq. NaHCO3 solution 
(250 mL) and brine (250 mL), dried over MgSO4, filtered and concentrated. Purification by 
column chromatography (silica, EtOEt:pentane 3:97) and careful concentration at room 
temperature afforded a solution of I.284 (2.79 g, 67 %) in pentanes, the concentration of 
which was determined by NMR. An analytical sample was further concentrated to give 
solvent-free I.284 as a colorless oil. 
TLC (EtOAc:Hex 1:10): Rf = 0.49. 
1H NMR (300 MHz, CDCl3): δ = 5.90-5.71 (m, 1H), 5.19-5.09 (m, 2H), 4.23 (t, J = 6.9 Hz, 
2H), 2.45 (app qt, J = 6.9 Hz, 2H), 0.26 (s, 9H). 
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13C NMR (75 MHz, CDCl3): δ = 153.0, 133.3, 117.7, 94.5, 94.0, 65.0, 32.7, 0.9 (3C). 
IR (neat): ṽ
 max = 1710, 1249, 841. 
HRMS (EI+):  m/z calcd. for C10H16O2Si+:   196.0920 [M]+; 
found:      196.0903 [M]+. 
 
1 -Ethoxycarbonylbut-3-enylidene(triphenyl)phosphorane (I.289):[87] 
 
A solution of ethoxycarbonylmethylene(triphenyl)phosphorane (I.288, 5.00 g, 14.4 mmol, 
1.00 eq) and allyl bromide (I.166, 3.10 mL, 35.9 mmol, 2.50 eq) in chloroform (29.0 mL) was 
heated to reflux for 6 h. The mixture was allowed to cool to room temperature and the solvent 
was removed in vacuo to provide a foam. To the residue was added water (150 mL) and the 
turbid mixture was washed with benzene (3 x 35.0 mL). Then, to the aqueous mixture was 
added a crystal of phenolphthalein, benzene (75.0 mL) and as much of an aq. 2 M NaOH 
solution until pH 8.2 was indicated (ca. 8.00 mL). The organic layer was separated and the 
aqueous layer was further extracted with benzene (3 x 40.0 mL). The combined extracts were 
washed with brine (100 mL), dried over MgSO4 and concentrated to provide I.289 as a yellow 
solid, which was used without further purification. 
TLC (EtOAc:Hex 3:1): Rf = 0.18. 
1H NMR (400 MHz, CDCl3, 4:3 mixture of rotation isomers, major isomer quoted): 
δ = 7.72-7.43 (m, 15H), 5.91-5.71 (m, 1H), 4.67-4.50 (m, 2H), 3.71 (q, J = 7.1 Hz, 2H), 2.71 
(ddt, J = 18.4, 6.2, 1.3 Hz, 2H), 0.44 (t, J = 7.1 Hz, 3H). 
13C NMR (100 MHz, CDCl3, 4:3 mixture of rotation isomers): δ = 170.1, 169.9, 141.6, 141.1, 
133.7 (d, J = 9.7 Hz, 6C), 132.9 (d, J = 10.0 Hz, 6C), 131.9 (d, J = 2.8 Hz, 3C), 131.5 (d, 
J = 2.9 Hz, 3C), 128.5 (d, J = 12.1 Hz, 6C), 128.3 (d, J = 90.6 Hz, 6C), 128.3 (d, J = 12.0 Hz, 
3C), 127.9 (d, J = 136.2 Hz, 3C), 111.6, 111.5, 57.9, 57.2, 37.0 (d, J = 119.8 Hz), 36.4 (d, 
J = 120.8 Hz), 31.5 (d, J = 12.7 Hz), 30.7 (d, J = 11.8 Hz), 14.3, 14.0. 
31P NMR (160 MHz, CDCl3, 4:3 mixture of rotation isomers): δ = 22.8, 22.4. 
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IR (neat): ṽ
 max = 3382, 2978, 1740, 1238. 
HRMS (EI+):  m/z calcd. for C25H26O2P+:   389.1670 [M+H]+; 
found:      389.1661 [M+H]+. 
 
1-Ethoxycyclopropanol (I.290), ethyl 2-cyclopropylidenepent-4-enoate (I.253),[87],[88] and 
(E)-3-(1,3-diiodopropylidene)-5-(iodomethyl)dihydrofuran-2(3H)-one (I.291): 
 
A solution of 1-ethoxy-1-trimethylsilyloxycyclopropane (I.347, 10.0 mL, 50.0 mmol, 1.00 eq) 
in methanol (75.0 mL) was stirred for 8 h at room temperature. The excess of solvent was 
removed at the rotary evaporator to leave a colorless oil, which was purified by distillation to 
give 1-ethoxycyclopropanol (I.290, 4.74 g, 93 %). 
TLC (EtOAc:Hex 1:10): Rf = 0.18. 
bp: 39 °C/9 mbar. 
1H NMR (300 MHz, CDCl3): δ = 3.75 (q, J = 7.1 Hz, 2H), 3.15 (s, br, 1H), 1.20 (t, 
J = 7.1 Hz, 3H), 0.94-0.90 (m, 4H). 
13C NMR (100 MHz, CDCl3): δ = 85.5, 50.5, 15.3, 14.2 (2C). 
IR (neat): ṽ
 max = 2973, 1622, 1597, 1436, 1098. 
HRMS (EI+):  m/z calcd. for C5H10O2+:   102.0681 [M]+; 
found:      102.0665 [M]+. 
A solution of freshly prepared 1-ethoxycyclopropanol (I.290, 1.58 g, ca. 1.80 mL, 15.5 mmol, 
1.00 eq) and benzoic acid (0.380 g, 3.10 mmol, 0.200 eq) in benzene (60.0 mL) was heated to 
reflux. To this mixture was added a solution of I.289 (6.00 g, 15.5 mmol, 1.00 eq) in benzene 
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(75.0 mL) over the course of 3 h with a syringe pump. After complete addition, the reaction 
mixture was refluxed for an additional 30 min and was then allowed to cool to room 
temperature. The solvent was removed in vacuo and the residue was diluted with diethyl ether 
(10.0 mL). Upon addition of pentane (80.0 mL), triphenylphosphinoxide precipitated. The 
mixture was filtered, concentrated and filtered through a plug of silica (EtOEt:pentane 1:10) 
to afford I.253 as a colorless oil (6.24 g, 75 %). The sensitive product was directly used in the 
next reaction without further purification. 
TLC (EtOAc:Hex 1:10): Rf = 0.31. 
IR (neat): 2982, 1715. 
HRMS (EI+):  m/z calcd. for C10H14O2+:   166.0994 [M]+; 
found:      166.0999 [M]+. 
A mixture of I.253 (1.19 g, 7.13 mmol, 1.00 eq), CuI (136 mg, 0.713 mmol, 0.100 eq), I2 
(7.24 g, 28.5 mmol, 4.00 eq), acetonitrile (115 mL) and water (28.5 mL) was heated to reflux 
for 38 h. The mixture was diluted with a sat. aq. Na2S2O3 solution (275 mL) and extracted 
with diethyl ether (3 x 275 mL). The combined extracts were washed with brine (350 mL), 
dried over MgSO4 and concentrated. Purification by column chromatography (silica, 
EtOEt:pentane 1:10 → 1:5, immediate concentration of fractions) gave I.291 (956 mg, 52 %) 
as a colorless solid. Since I.291 tends to rapidly decompose when exposed to air and slowly 
under exposure to light (as evidenced by formation of yellow and brownish colored material), 
samples were stored at −20 °C in darkness and were strictly kept under an argon atmosphere.  
Crystals suitable for single crystal X-ray crystallography were grown by slow evaporation of a 
diethyl ether solution of I.291 under a gentle stream of argon. 
TLC (EtOAc:Hex 1:2): Rf = 0.49. 
1H NMR (600 MHz, CDCl3): δ = 4.55 (dddd, J = 8.1, 7.1, 5.1, 3.9 Hz, 1H), 3.89-3.80 (m, 
2H), 3.41 (dd, J = 10.5, 3.9 Hz, 1H), 3.34-3.27 (m, 3H), 3.09 (ddt, J = 18.0, 5.1, 1.5 Hz, 1H), 
2.69 (ddt, J = 18.0, 8.1, 1.5 Hz, 1H). 
13C NMR (150 MHz, CDCl3): δ = 162.7, 133.5, 125.0, 73.3, 44.1, 42.2, 8.3, 2.8. 
IR (neat): ṽ
 max = 1691, 1632, 1203. 
HRMS (EI+):  m/z calcd. for C8H9I2O2+:   390.8692 [M-I]+; 
found:      390.8691 [M-I]+. 
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Trichloro(2-(chloromethyl)allyl)silane (I.300):[89] 
 
A 1 L three-necked flask equipped with bubbler, rubber stopper and mechanic stirrer was 
charged with triethylamine (34.7 mL, 0.250 mol, 1.25 eq), copper(I) chloride (0.198 mg, 
2.00 mmol, 0.010 eq) and diethyl ether (390 mL). Under gentle stirring, to the green colored 
suspension was added dropwise a solution of 3-chloro-2-chloromethyl-1-propene (I.299, 
23.1 mL, 0.200 mol, 1.00 eq) and trichlorosilane (25.3 mL, 0.250 mol, 1.25 eq) in diethyl 
ether (65.0 mL) over a period of 4 h at room temperature. After complete addition, the 
resulting mixture was stirred for 16 h at room temperature and then filtered under an argon 
atmosphere. The solvent was removed at atmospheric pressure and the residue was purified 
by fractional distillation (15 cm Vigreux column) to afford I.300 as a colorless oil (22.7 g, 
50 %). Since the product tends to rapidly decompose under exposure to air moisture (as 
evidenced by decomposition to a colorless, insoluble solid), it was strictly kept under an 
atmosphere of argon during all purification steps and was used in the next reaction 
immediately after purification. 
bp: 92 °C/30 mbar. 
1H NMR (300 MHz, CDCl3): δ = 5.36 (s, 1H), 5.17 (s, 1H), 4.15 (d, J = 1.0 Hz, 2H), 2.56 (d, 
J = 1.0 Hz, 2H). 
13C NMR (75 MHz, CDCl3): δ = 136.3, 118.7, 48.8, 29.6. 
IR (neat): ṽ
 max = 3091, 2961, 1834, 1641. 
 
(2-(Chloromethyl)allyl)trimethylsilane (I.301):[89] 
 
To a solution of I.300 (21.5 g, 96.0 mmol, 1.00 eq) in diethyl ether (430 mL) was added 
dropwise a solution of methylmagnesium bromide (3.00 M in diethyl ether, 112 mL, 
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336 mmol, 3.50 eq) at −78 °C. The resulting mixture was stirred for 1 h at −78 °C and was 
then allowed to slowly warm to room temperature to be stirred for 12 h at this temperature. 
The reaction mixture was poured into an ice cold sat. aq. NH4Cl solution (300 mL) and the 
organic layer was separated. The aqueous phase was further extracted with diethyl ether (2 x 
120 mL) and the combined extracts were washed with brine (180 mL), dried over MgSO4, 
filtered and concentrated at the rotary evaporator at 0 °C. The resulting crude product was 
purified by fractional distillation (15 cm Vigreux column) to afford a mixture of I.301 and 
I.348 (11.9 g, 75 %) as a colorless oil. The ratio of I.301 and I.348 was determined by NMR 
to be 87:13 and the mixture was used in the next reaction without further purification. 
bp: 40 °C/31 mbar. 
1H NMR (300 MHz, CDCl3): δ = 5.36 (s, 1H), 5.17 (s, 1H), 4.15 (d, J = 1.0 Hz, 2H), 2.56 (d, 
J = 1.0 Hz, 2H). 
13C NMR (75 MHz, CDCl3): δ = 143.1, 112.3, 50.0, 23.7, 1.5 (3C). 
IR (neat): ṽ
 max = 3082, 2955, 1632. 
HRMS (EI+):  m/z calcd. for C7H15ClSi+:   162.0632 [M]+; 
found:      162.0623 [M]+. 
 
2-((Trimethylsilyl)methyl)allyl acetate (I.255):[89] 
 
A mixture of I.301 (11.5 g, 70.5 mmol, 1.00 eq), potassium acetate (27.7 g, 282 mmol, 
4.00 eq) and DMF (100 mL) was heated to 60 °C for 48 h. The resulting mixture was allowed 
to cool to room temperature, diluted with water (250 mL) and extracted with diethyl ether 
(2 x 150 mL). The combined extracts were washed with water (2 x 200 mL) and brine 
(150 mL), dried over MgSO4, filtered and concentrated. The residue was purified by 
fractional distillation to afford acetate I.255 as a colorless oil (10.5 g, 80 %). 
bp: 80 °C/15 mbar. 
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1H NMR (300 MHz, CDCl3): δ = 4.92-4.89 (m, 1H), 4.77-4.73 (m, 1H), 4.48-4.43 (m, 2H), 
2.12 (s, 3H), 1.58-1.55 (m, 2H), 0.06 (s, 9H). 
13C NMR (75 MHz, CDCl3): δ = 170.7, 141.7, 109.6, 67.9, 23.6, 20.9, 1.5 (3C). 
IR (neat): ṽ
 max = 3081, 2954, 1741, 1644. 
HRMS (EI+):  m/z calcd. for C9H18O2Si+:   186.1076 [M]+; 
found:      186.1066 [M]+. 
 
(3,4-Dihydro-2H-pyran-6-yloxy)trimethylsilane (I.303):[90] 
 
A solution of n-BuLi (2.40 M in THF, 4.94 mL, 11.9 mmol, 1.00 eq) was added to a solution 
of diisopropylamine (1.68 mL, 11.9 mmol, 1.00 eq) in THF (5.30 mL) at 0 °C and the mixture 
was stirred for 30 min at this temperature. 
The resulting solution of LDA was cooled to −78 °C and δ-valerolactone (I.302, 1.00 mL, 
10.8 mmol, 1.00 eq) was added dropwise at this temperature. After being stirred for 1 h, 
TMSCl (1.82 mL, 14.2 mmol, 1.32 eq) was added dropwise at −78 °C and subsequently the 
mixture was allowed to warm to room temperature. After being stirred for 16 h at this 
temperature, the resulting suspension was filtered, the filter cake was washed with CH2Cl2 
(25.0 mL) and the combined filtrates were concentrated. The residual oil was purified by 
fractional distillation to give silyl enol ether I.303 as a colorless oil (1.54 g, 83 %). Since the 
material was sensitive to air moisture, it was directly used in the next reaction. 
bp: 43 °C/6 mbar. 
1H NMR (300 MHz, CDCl3): δ = 4.07 (dd, J = 5.7, 4.6 Hz, 2H), 3.87-3.79 (m, 1H), 2.06 (td, 
J = 6.4, 3.7 Hz, 2H), 1.81-1.74 (m, 2H), 0.23 (s, 9H). 
13C NMR (75 MHz, CDCl3): δ = 154.5, 74.0, 67.2, 22.4, 19.9, 0.0 (3C). 
IR (neat): ṽ
 max = 2955, 1736, 1685. 
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MS (EI+):  m/z calcd. for C8H16O2Si+:   172.09 [M]+; 
found:      172.19 [M]+. 
 
5,6-Dihydro-2H-pyran-2-one (I.256):[91a] 
 
A mixture of silyl enol ether I.303 (500 mg, 2.90 mmol, 1.00 eq), methylallyl carbonate 
(I.304, 0.660 mL, 5.80 mmol, 2.00 eq), palladium acetate (65.2 mg, 0.290 mmol, 0.100 eq) 
and acetonitrile (3.00 mL) was heated to reflux for 2 h. While heating, gas formation and 
formation of metallic palladium was observed. The resulting mixture was filtered through a 
short plug of florisil, which was washed with diethyl ether (10.0 mL). The filtrate was 
concentrated and purified by column chromatography (silica, EtOEt:pentane 1:10 → 1:1) to 
furnish I.256 as a colorless oil (277 mg, 97 %). 
TLC (EtOEt:pentane 1:2): Rf = 0.15. 
1H NMR (300 MHz, CDCl3): δ = 6.94 (dtt, J = 9.8, 4.2, 0.6 Hz, 1H), 6.01 (dt, J = 9.8, 1.9 Hz, 
1H), 4.41 (dt, J = 6.1, 0.6 Hz, 2H), 2.48-2.42 (m, 2H). 
13C NMR (75 MHz, CDCl3): δ = 163.7, 145.8, 121.6, 66.5, 20.0. 
IR (neat): ṽ
 max = 2951, 1715. 
HRMS (EI+):  m/z calcd. for C5H6O2+:   98.0368 [M]+; 
found:      98.0355 [M]+. 
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6-Methylenehexahydrocyclopenta[c]pyran-1(3H)-one (I.298) and 
6,9-dimethylenedecahydro-1H-cycloocta[c]pyran-1-one (I.305): 
 
To a solution of 5,6-dihydro-2H-pyran-2-one (I.256, 3.19 mL, 37.0 mmol, 1.00 eq), 
2-[(acetoxymethyl)allyl]trimethylsilane (I.255, 1.80 mL, 55.5 mmol, 1.50 eq) and palladium 
acetate (208 mg, 0.930 mmol, 0.025 eq) in toluene (375 mL; non dried, analytical grade 
solvent was used in this reaction since catalytic amounts of water were found to be essential 
for the reaction to proceed in good yields) was added triisopropyl phosphite (1.69 mL, 
7.41 mmol, 0.200 eq). The mixture was heated to reflux for 15 h, was subsequently allowed to 
cool to room temperature and was then concentrated. Purification by column chromatography 
(silica, EtOEt:pentane 1:20 → 1:4) gave I.298 as a colorless oil (4.79 g, 85 %) and I.305 as a 
colorless oil (426 mg, 6 %). 
I.298 was obtained by concentration of later fractions in the chromatographic purification. 
TLC (EtOAc:Hex 1:3): Rf = 0.18. 
1H NMR (300 MHz, CDCl3): δ = 4.91-4.82 (m, 2H), 4.38-4.31 (m, 1H), 4.22 (dt, J = 11.3, 
2.6 Hz, 1H), 3.08-2.91 (m, 1H), 2.85-2.55 (m, 4H), 2.13-1.95 (m, 2H), 1.67-1.55 (m, 1H). 
13C NMR (75 MHz, CDCl3): δ = 174.1, 148.0, 107.1, 67.8, 42.5, 40.0, 36.1, 34.9, 28.1. 
IR (neat): ṽ
 max = 2918, 1726. 
HRMS (EI+):  m/z calcd. for C9H12O2+:   152.0837 [M]+; 
found:      152.0836 [M]+. 
 
Bisalkene I.305 was obtained by concentration of earlier fractions in the chromatographic 
purification step. 
TLC (EtOAc:Hex 1:3): Rf = 0.30. 
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1H NMR (300 MHz, CDCl3): δ = 4.97-4.81 (m, 4H), 4.39 (dt, J = 11.1, 4.4 Hz, 1H), 4.27 
(ddd, J = 11.1, 10.0, 3.5 Hz, 1H), 2.88-2.77 (m, 1H), 2.64-2.41 (m, 5H), 2.22-2.03 (m, 4H), 
1.96-1.85 (m, 1H), 1.83-1.07 (m, 1H). 
13C NMR (75 MHz, CDCl3): δ = 174.2, 148.0, 147.9, 114.7, 114.6, 67.7, 44.8, 43.2, 37.7, 
37.4, 37.2, 34.2, 31.1. 
IR (neat): 2918, 1733. 
HRMS (EI+):  m/z calcd. for C13H18O2+:   206.1307 [M]+; 
found:      206.1303 [M]+. 
 
6-Hydroxy-6-(hydroxymethyl)hexahydrocyclopenta[c]pyran-1(3H)-one (I.320) and 
2',2'-dimethylhexahydro-1H-spiro[cyclopenta[c]pyran-6,4'-[1,3]dioxolan]-1-one (I.322): 
 
To a solution of TMAO (92.7 mg, 1.23 mmol, 1.10 eq) in acetone (19.0 mL) and water 
(39.0 mL) was successively added osmium tetroxide (2.5 % solution in tert-butanol, 
0.701 mL, 56.0 µmol, 0.050 eq) and I.298 (170 mg, 1.11 mmol, 1.00 eq) at room temperature. 
After being stirred for 16 h at this temperature, the mixture was filtered through a short plug 
of florisil, which was washed with acetone (20.0 mL) and the combined filtrates were 
concentrated. Purification by column chromatography (silica, MeOH:CH2Cl2 1:10) afforded 
I.320 as an inseparable mixture of diastereomers as a colorless oil (146 mg, 70 %). I.320 was 
directly used in the next reaction. (For storage, I.320 was kept as a frozen 1.00 M solution in 
benzene at −25 °C, since I.320 slowly decomposes if stored neat or at room temperature.) 
TLC (CHCl3:MeOH 100:10): Rf = 0.10 (both diastereomers). 
1H NMR (600 MHz, CD2Cl2, major diastereomer quoted): δ = 4.34 (dt, J = 11.2, 3.7 Hz,  
1H), 4.21 (td, J = 11.2, 2.1 Hz, 1H), 3.63 (dd, J = 26.5, 10.8 Hz, 2H), 3.13 (td, J = 11.0, 
8.6 Hz, 1H), 2.99-2.88 (m, 1H), 2.16-2.04 (m, 4H), 1.58-1.47 (m, 1H), 1.28 (dd, J = 13.3, 
10.5 Hz, 1H). 
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13C NMR (150 MHz, CD2Cl2, major diastereomer quoted): δ = 175.3, 81.4, 68.9, 67.6, 43.6, 
41.3, 39.1, 34.7, 29.4. 
IR (neat): ṽ
 max = 3390, 2930, 1706. 
HRMS (EI+):  m/z calcd. for C9H14O4+:   186.0892 [M]+; 
found:      186.0901 [M]+. 
 
To a solution of I.320 (20.0 mg, 107 µmol, 1.00 eq) and 2,2-dimethoxypropane (I.321, 
31.8 µL, 257 µmol, 2.40 eq) in acetone (5.70 mL) was added pyridinium p-toluenesulfonate 
(2.70 mg, 10.7 µmol, 0.100 eq). The resulting solution was stirred for 16 hours at room 
temperature and was then diluted with diethyl ether (15.0 mL) and washed with water 
(2 x 7.00 mL). The organic layer was dried over MgSO4, filtered and concentrated. The 
residue was purified by column chromatography (silica, MeOH:CH2Cl2 1:100 → 1:50) to 
give I.322 as an inseparable mixture of diastereomers as a colorless oil (12.1 mg, 50 % yield). 
TLC (CHCl3:MeOH 100:7): Rf = 0.41 (both diastereomers). 
1H NMR (400 MHz, CD2Cl2, major diastereomer quoted): δ = 4.29 (td, J = 11.2, 3.8 Hz, 1H), 
4.22-4.14 (m, 1H), 3.90 (dd, J = 26.7, 8.6 Hz, 2H), 2.85-2.73 (m, 1H), 2.24-1.98 (m, 4H), 
1.75-1.62 (m, 1H), 1.50-1.42 (m, 1H), 1.40-1.36 (m, 1H), 1.35-1.32 (m, 6H). 
13C NMR (100 MHz, CD2Cl2, major diastereomer quoted): δ = 174.6, 109.4, 87.5, 71.3, 67.2, 
44.5, 42.7, 41.2, 39.7, 34.2, 29.4, 26.5. 
IR (neat): ṽ
 max = 2984, 1728. 
HRMS (EI+):  m/z calcd. for C12H18O4+:   226.1205 [M]+; 
found:      226.1192 [M]+. 
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6-Methylene-7a-(phenylselanyl)hexahydrocyclopenta[c]pyran-1(3H)-one (I.314) and 
6-methylene-3,4,6,7-tetrahydrocyclopenta[c]pyran-1(5H)-one (I.315): 
 
To a solution of I.298 (2.07 g, 13.6 mmol, 1.00 eq) in THF (65.0 mL) was added dropwise a 
solution of KHMDS (0.500 M in toluene, 32.6 mL, 16.3 mmol, 1.20 eq) at −78 °C over the 
course of 10 min. The mixture was stirred for 15 min at −78 °C and was then treated with a 
solution of phenylselenyl bromide (3.85 g, 16.3 mmol, 1.20 eq) and HMPA (2.60 mL, 
15.0 mmol, 1.10 eq) in THF (60.0 mL), which was added over a period of 15 min. The 
resulting yellow colored reaction mixture was stirred at −78 °C for 15 min and was then 
allowed to warm up to be stirred for 1 h at room temperature. The reaction was then quenched 
with a sat. aq. NH4Cl solution (3.00 mL) and the solvent was removed in vacuo. The resulting 
residue was diluted with diethyl ether (300 mL), washed with brine (200 mL), dried over 
MgSO4, concentrated and purified by rapid filtration through a plug of silica (silica, 
EtOAc:Hex 1:10 → 1:4) to furnish I.314 as a colorless oil (3.35 g, 80 %). Since the material 
slowly decomposed if exposed to air, it was directly used in the next reaction step. 
TLC (EtOAc:Hex 1:3): Rf = 0.22. 
1H NMR (300 MHz, CDCl3): δ = 7.68-7.34 (m, 5H), 4.98-4.90 (m, 2H), 4.37-4.22 (m, 2H), 
3.10-3.02 (m, 1H), 2.86 (dddd, J = 15.5, 8.6, 3.1, 1.6 Hz, 1H), 2.71 (ddd, J = 17.3, 2.9, 1.6 
Hz, 1H), 2.54 (ddt, J = 11.3, 8.5, 6.4 Hz, 1H), 2.22-2.13 (m, 1H), 2.05-1.97 (m, 1H), 1.62 
(dtd, J = 14.3, 11.3, 4.6 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ = 172.4, 145.7, 137.5, 129.8 (2C), 129.1 (2C), 127.6, 108.2, 
67.4, 52.5, 44.2, 43.9, 39.7, 29.6. 
IR (neat): ṽ
 max = 3418, 2929, 1721, 1440. 
HRMS (EI+):  m/z calcd. for C15H16O2Se+:   308.0316 [M]+; 
found:      308.0308 [M]+. 
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To a solution of I.314 (1.10 g, 3.58 mmol, 1.00 eq) and pyridine (0.580 mL, 7.16 mmol, 
2.00 eq) in chloroform (35.0 mL) was added dropwise a 30 % aq. H2O2 solution (2.90 mL, 
28.6 mmol, 8.00 eq) at 0 °C. The mixture was stirred for 1 h at this temperature, was then 
diluted with dichloromethane (75.0 mL), washed with water (2 x 75.0 mL) and brine 
(75.0 mL), dried over MgSO4 and concentrated. The crude product was purified by column 
chromatography (silica, EtOAc:Hex 1:10 → 1:6) to afford I.315 (299 mg, 56 %) as a 
colorless oil. Since neat I.315 tends to spontaneously polymerize at room temperature as 
evidenced by formation of a rubber-like solid, I.315 was stored as a frozen 0.500 M solution 
in benzene at −25 °C. 
TLC (EtOAc:Hex 1:5): Rf = 0.12. 
1H NMR (300 MHz, CDCl3): δ = 5.16-5.07 (m, 2H), 4.46 (t, J = 6.35 Hz, 2H), 3.41-3.33 (m, 
4H), 2.53-2.46 (m, 2H). 
13C NMR (75 MHz, CDCl3): δ = 163.4, 157.8, 144.3, 128.8, 109.6, 66.6, 42.7, 36.7, 25.3. 
IR (neat): ṽ
 max = 2925, 1719, 1648. 
HRMS (EI+):  m/z calcd. for C9H10O2+:   150.0681 [M]+; 
found:      150.0672 [M]+. 
 
4a,7a-Dihydroxy-6-methylenehexahydrocyclopenta[c]pyran-1(3H)-one (I.318): 
 
To a solution of NMO-hydrate (5.48 mg, 46.7 µmol, 1.10 eq) in dichloromethane (1.10 mL), 
was added successively a solution of osmium tetroxide (2.5 % in tert-butanol, 22.0 µL, 
1.70 µmol, 0.040 eq), and a solution of I.315 (0.500 M in benzene, 85.0 µL, 42.5 µmol, 
1.00 eq) and water (2.50 µL, 128 µmol, 3.00 eq). The reaction mixture was stirred vigorously 
for 16 h, concentrated and directly subjected to column chromatography without any previous 
workup (silica, CHCl3:MeOH 100:1 → 100:5) to afford I.318 (5.00 mg, 64 %) as a colorless 
oil. 
TLC (CHCl3:MeOH 100:6): Rf = 0.11. 
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1H NMR (300 MHz, CDCl3): δ = 5.09-5.04 (m, 1H), 4.96-4.93 (m, 1H), 4.62 (td, J = 11.3, 
3.4 Hz, 1H), 4.23 (ddd, J = 11.3, 5.0, 3.3 Hz, 1H), 3.61 (s, br, 1H), 3.14 (s, br, 1H), 2.86 (dq, 
J = 18.1, 2.5 Hz, 1H), 2.80-2.71 (m, 2H), 2.55 (dd, J = 16.0, 1.5 Hz, 1H), 2.17-2.11 (m, 1H), 
2.02 (dt, J = 15.1, 3.4 Hz, 1H). 
13C NMR (150 MHz, CDCl3): δ = 175.4, 142.3, 110.6, 78.7, 77.7, 66.8, 45.5, 45.3, 32.6. 
IR (neat): ṽ
 max = 3426, 1718, 1069. 
HRMS (EI+):  m/z calcd. for C9H12O4+:   184.0736 [M]+; 
found:      184.0759 [M]+. 
 
3,4,5,7-Tetrahydro-1H-spiro[cyclopenta[c]pyran-6,2'-oxiran]-1-one (I.317): 
 
A solution of I.315 (0.500 M in benzene, 85.0 µL, 42.5 µmol, 1.00 eq) was concentrated and 
immediately rediluted with chloroform (0.500 mL). To this solution was added sodium 
bicarbonate (4.28 mg, 51.0 µmol, 1.20 eq) and subsequently m-CPBA (8.80 mg, 51.0 µmol, 
1.20 eq) at 0 °C and stirred for 1 h at this temperature. The mixture was allowed to warm up 
and stirred for 16 h at room temperature. Then, a sat. aq. Na2S2O3 solution (0.100 mL) was 
added and the resulting mixture was stirred for 15 min at room temperature. The slurry was 
diluted with dichloromethane (5.00 mL) and a sat. aq. NaHCO3 solution (5.00 mL). The 
organic layer was separated, treated with 100 mg of MgSO4 and 100 mg of activated charcoal, 
cooled to 0 °C and filtered over a pad of celite. The pad was washed with dichloromethane 
(2 x 5.00 mL) and the combined filtrates were concentrated to give I.317 as a colorless oil 
(6.10 mg, 86 %). 
TLC (EtOAc:Hex 1:2): Rf = 0.40. 
1H NMR (200 MHz, CDCl3): δ = 4.47 (t, J = 3.3 Hz, 2H), 3.09-2.92 (m, 4H), 2.77-2.63 (m, 
2H), 2.55-2.46 (m, 2H). 
13C NMR (150 MHz, CDCl3): δ = 162.8, 156.4, 129.9, 66.6, 51.8, 42.6, 36.6, 29.7, 25.3. 
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IR (neat): ṽ
 max = 3052, 2986, 1747. 
HRMS (EI+):  m/z calcd. for C9H10O3+:   166.0630 [M]+; 
found:      166.0628 [M]+. 
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CHAPTER II: A SYMMETRY-BASED APPROACH 
TOWARDS NEW ION CHANNEL BLOCKERS 
2.1 Introduction 
2.1.1 Project Background and Aims  
 
Pentameric proteins play a huge role in nature, especially in neuronal transduction. Several of 
these belong to the family of ion channels, which mediate intracellular communication. In 
general, these channels can be controlled by a number of different stimuli, which trigger their 
opening and closing, e.g. by the binding of a ligand (ligand-gated ion channels), the difference 
in the membrane potential (voltage-gated ion channels), the action of light (light-gated ion 
channels), the influence of heat (temperature-gated ion channels) and the sensation of stretch, 
pressure or shear forces (mechanosensitive ion channels) or by several of these.[97] A selection 
of pentameric proteins is depicted in Figure II.1. 
 
 
 
 
 
 
 
 
 
 
Figure II.1: Selection of pentamerically assembled proteins: a) Shiga toxin (PDB code: 1R4Q);[98] b) nicotinic 
acetylcholine receptor (PDB code: 2BG9);[99] c) MscL channel (PDB code: 2OAR);[100] d) ELIC channel (PDB code: 
2VL0).[101] 
a) b) c) d) 
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Since the ion channel-mediated stream of ions is directly related to action potentials, the 
control of ion channels allows controlling neuronal activities and therefore intercellular 
communication. The action potential in context with exemplary ion channels is illustrated in 
Figure II.2. 
 
Figure II.2: The action potential: a) The transmembrane potential of a neuron at rest; b) a neurotransmitter binds 
to a ligand-gated ion channel, for example a glutamate receptor (iGluR), and evokes an excitatory postsynaptic 
potential; c) voltage-gated sodium channels (NaV) respond and further depolarize the membrane, but quickly 
deactivate; d) voltage-gated potassium channels (KV) follow suit and repolarize the membrane, even beyond its 
resting potential (→e)); f) the hyperpolarization is removed through the concerted action of channels that are open 
at the resting potential and by ATP-driven ion pumps.[102] 
 
The initial depolarization of the cell membrane is caused by ligand-gated cationic ion 
channels, such as ionotropic glutamate receptors (e.g. iGluR) or nicotinic acetylcholine 
receptors. Pore opening is triggered by the binding of the respective neurotransmitter and 
results in an ion flux along the concentration gradient. This leads to a net influx of positive 
charge, which changes the membrane potential to a value of ca. −40 mV. At this point, 
voltage-gated sodium channels are being activated, resulting in a strong influx of sodium and 
thus a quick depolarization and even an overshoot to values of ca. +50 mV. Now, the sodium 
channels close and, upon a brief span, voltage-sensitive potassium channels activate to 
repolarize the membrane even beyond its resting potential. By the operation of ion pumps and 
several channels, the resting potential of ca. −70 mV is being restored.[102]  
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Depending on whether they make the transmembrane potential less or more negative when 
being opened, ion channels can have both excitatory and inhibitory effects on neurons. In 
general, nonselective cation channels and sodium channels are depolarizing, whereas 
potassium channels hyper- or repolarize. Chloride channels, such as GABAA or glycine 
receptors, are inhibitory on AP firing.[103] 
Having such specific tasks in the process of the action potential, it is not surprising that ion 
channel agonists, antagonists and blockers are of great pharmacological significance and a 
large number of these have important applications as drugs, e.g. in the field of anesthesia.[104]  
Ligand-gated ion channels are activated by the binding of a neurotransmitter such as GABA 
(II.1), acetylcholine (II.2), L-glutamic acid (II.3), glycine (II.4) or 5-HT (II.5), which is 
released from the presynaptic terminal (Figure II.3).[105] 
 
Figure II.3: Structures of the most important neurotransmitters acting on the ligand-gated ion channels. 
 
As described in Figure II.2, the binding of such a neurotransmitter results in an ion flux 
through the postsynaptic membrane, thus generating a change in the membrane potential and 
triggering the action potential. Neurotransmitters are released from synaptic vesicles in the 
terminal rest of presynaptic axons and bind to receptor proteins, which are coupled to the 
respective ion channels on the recipient neuron (Figure II.4).[106]  
        
Figure II.4: The location of action of neurotransmitters: a) Artwork of a neuron;[106] b) Artwork of the synaptic 
cleft.[107] 
a) b) 
Soma 
Axon 
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Among the group of pentameric ligand-gated ion channels, which includes glycine, nicotinic 
acetylcholine, 5-HT3 and the GABAA receptors, the GABAA receptor controls neuronal 
activity by regulating the influx of chloride ions. Thus, GABAA counteracts the 
hyperpolarization of the membrane and hence action potential formation and therefore has an 
inhibitory function. More specifically, it plays a key role in inhibitory interneurons in the 
brain by regulating the spike timing and with that the activity pattern of neuronal circuits. 
GABAergic interneurons are considered to be essential for neuronal oscillations in the β and γ 
bands of the EEG, which have been associated with basic cognitive functions like object 
perception, selective attention, working memory and consciousness. These neurons have also 
been found to be crucial for the formation and the retrieval of cell assemblies required for 
encoding, consolidating and recalling information.[108]  
The GABAA receptor consists of five subunits building a central pore. Each subunit 
comprises four transmembrane domains (M1-M4) with both the N- and C- terminus located 
extracellularly. The transmembrane domains M1 and M3 are oriented towards the adjacent 
subunits as well as to the lipid bilayer, M4 is buried in the membrane and M2 faces the lumen 
of the pore (Figure II.5).[109] 
            
Figure II.5: Structure of the GABAA receptor: a) Schematic structure of the transmembrane domains M1-M4 
bearing a disulfide-bridge which is characteristic for the cys-loop superfamily;[110] b) Schematic structure of 
pentamerically arranged transmembrane domains;[110] c) Side view on a modeled structure of the α1β2γ2 GABAA 
receptor.[109] 
 
There are several isoforms for each of the five subunits and all of them contain a conserved 
disulfide-bridge in the extracellular domain (Figure II.5 a)). The most abundant example is the 
α1β2γ2 (wild type) GABAA receptor, which consists of two α1, two β2 and one γ2 subunit. Due 
to minor differences in these subunit isoforms, the heteromeric α1β2γ2 GABAA receptor is not 
a) b) c) 
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exactly fivefold symmetric on a macroscopic scale. However, on a microscopic scale, i.e. in 
the channel lumen, all participating amino acids are identical, for which reason the channel 
can be considered pseudo-fivefold symmetric. 
To date, no crystal structure of the GABAA receptor has been reported in literature. However, 
Ulens and coworkers demonstrated that the ELIC channel is a suitable model to investigate 
GABA recognition and channel modulation by allosteric modulators.[111] A crystal structure 
of GABA (II.1) bound to the ELIC channel is shown in Figure II.6. 
                
Figure II.6: Position of GABA in the ELIC channel (PDB code: 2YOE): a) Whole view on the crystal structure; 
b) zoom on the binding site.[111] 
 
A well-known open channel blocker of the GABAA channel is picrotoxin (II.6, Figure II.7), 
which is a 1:1 mixture of the natural products picrotin (II.7) and picrotoxinin (II.8).[112] II.6 
was first isolated from the South Asian climbing plant Anamirta cocculus in 1812 and is to 
date one of the most potent open channel blockers of the GABAA receptor.[113]  
 
Figure II.7: Chemical structure of the open channel blocker picrotoxin (II.6). 
 
The binding site of picrotoxin (II.6) in GABAA has been discussed controversially and 
remains unclarified,[114] although it could be shown that II.6 interacts via a hydrogen bond to 
Thr 261.[115] II.6 is believed to bind either to an allosteric site or to the channel lumen.[116] In 
addition, a crystal structure of picrotoxinin (II.8) bound to the GluCl channel, which, like 
a) b) 
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GABAA belongs to the Cys-loop superfamily, was reported by Gouaux and coworkers in 
2011 (Figure II.8) and shows II.8 bound in the channel lumen.[117] 
 
 
 
 
Figure II.8: Crystal structure of picrotoxinin (II.8) bound to the GluCl channel (PDB code: 3RI5): a) side view; 
b) top view.[117] 
 
Searching for opportunities to control ion channels and thus neuronal activities, a new 
symmetry-based approach towards the design of potential drugs was explored in this work. It 
was speculated that symmetric compounds matching the inherent fivefold symmetry of 
pentameric ion channels could potentially pentavalently interact with the protein and thus 
function as potent open channel blockers (Figure II.9).  
 
Figure II.9: Generic chemical structure of cyclopentadienides, cucurbit[5]urils and pillar[5]arenes. 
 
Thus, pentasubstituted cyclopentadienides (II.9, II.10), functionalized cucurbit[5]urils (II.11, 
II.12) or substituted pillar[5]arenes (II.13, II.14, II.15, II.16, II.17) were chosen as attractive 
synthetic targets. Model studies with these compounds on pentameric proteins are described 
in the next section. 
a) b) 
CHAPTER II: A Symmetry-Based Approach towards New Ion Channel Blockers 
122 
2.2 Results and Discussion 
2.2.1 Model Studies of Fivefold Symmetric Compounds with Pentameric 
Proteins 
 
Based on known crystal structures of pentameric proteins, preliminary model studies with the 
selected pentasymmetric compounds were carried out to assess if they could access the 
channel lumen, to give insights about proportions and to reveal potential interactions for 
pentavalent binding.[118] Pentasymmetric molecules were manually placed inside the channel 
lumen and the binding mode was obtained after fixing the enzyme coordinates and 
minimizing the energy of the system using the MAB force field as implemented in the 
software MOLOC.[118]  
If, for example, a pillar[5]arene II.15 bearing carboxylic acid substituents was optimized at 
the selectivity filter of the ELIC channel, the carboxylic acid groups seem to be able to 
interact with Glu231 through hydrogen bonding. However, due to the large diameter of the 
pillar[5]arene core (d(CH2−CH2) = 9.1 Å), the substituents can hardly reach the site of action 
without sterical repulsions (Figure II.10). 
 
      
Figure II.10: Illustration of the surface of the ELIC channel (PDB code: 2VL0) with a pillar[5]arene at the 
selectivity filter: a) Side view showing the position of the fivefold symmetric molecule in the channel; b) top view, 
emphasizing the pentameric nature of the channel. 
 
Cyclopentadienide II.10, on the other hand, seems to be able to bind deep in the selectivity 
filter without forming repulsive contacts (Figure II.11). Again, the potential interactions were 
found with Glu231 through hydrogen bonding. 
a) b) 
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Figure II.11: Illustration of the ELIC channel (PDB code: 2VL0) with a cyclopentadienide binding at the selectivity 
filter: a) Illustration of the surface; b) top view; c) side view on the channel. 
 
In order to compare the potential binding mode of II.10 with that of picrotoxinin (II.8) on the 
GluCl channel, II.10 was optimized at the extracellular domain thereof. Indeed, the 
compound seems to be able to bind at the binding site of picrotoxin via hydrogen bonding. 
Although the diameter of II.10 (d(N−N) = 7.2 Å) is larger than the diameter of picrotoxinin  
(II.8, d(O20−O12) = 4.6 Å), no sterical repulsion was found (Figure II.12). 
 
           
Figure II.12: The GluCl channel (PDB code: 3RHW) with a cyclopentadienide at the selectivity filter: a) Illustration 
of the surface; c) top view; d) side view on the channel. 
 
Due to their greater size, pillar[5]arenes were anticipated to fit best in a channel with a large 
channel lumen, where enough space would be left to allow the substituents to rotate towards 
amino acid residues. When, accordingly, pillar[5]arene with carboxylic acid substituents II.15 
was positioned in the extracellular domain of the MscL channel, only limited sterical 
repulsion was observed. These studies also revealed potential interactions at Lys33 
(Figure II.13). 
 
a) c) b) 
Glu231 
a) b) c) 
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Figure II.13: Pillar[5]arene II.15  with carboxylic acid substituents inside the MscL channel: a) Full view; b) zoom 
on carboxylic acid residues to illustrate potential interactions with the protein at Lys33. 
 
Similar results were found when the pillar[5]arene was replaced by 
decahydroxycucurbit[5]uril (II.12). Again, the fivefold symmetric molecule could potentially 
interact with Lys33 (Figure II.14). 
 
          
Figure II.14: Decahydroxycucurbit[5]uril inside the MscL channel: a) Full view; b) close view. 
 
In summary, simple preliminary model studies were performed with molecules chosen 
according to a symmetry-based approach on a selection of pentameric proteins, which indeed 
revealed the possibility of pentavalent interactions. Thus, a synthesis program towards a series 
of fivefold symmetric compounds was launched to determine their potential in neuronal 
control, the details of which are described in the next section. 
a) b) 
a) b) 
Lys33 
lys 33 
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2.2.2  Synthesis of Pentasymmetric Potential Ion Channel Blockers 
 
2.2.2.1 Synthesis of fivefold symmetric cyclopentadienides 
A literature-known pentamethyl ester-substituted cyclopentadienide was the first target 
molecule among the fivefold symmetric compounds, the synthesis of which is depicted in 
Scheme II.1.[119]  
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Scheme II.1: Synthesis of pentamethyl ester-substituted cyclopentadienides II.22 and II.23. 
 
Upon heating a 1:3 mixture of dimethyl malonate (II.18) and dimethyl acetylene dicarboxylic 
acid (II.19) in the presence of pyridine, a triple-conjugate addition sequence followed by a 
fourth, intramolecular Michael addition furnished a 57:7 mixture of isomers II.20 and II.21. 
This mixture was directly subjected to heating in the presence of potassium acetate, resulting 
in the formation of potassium salt II.22. This compound could be converted into the 
corresponding acid II.23 by treatment with aqueous HCl. The formation of II.22 is indeed 
intriguing and a proposed mechanism is shown in Scheme II.2. 
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Scheme II.2: Speculated mechanism for the formation of II.22. 
 
Presumably, upon deprotonation of II.20, intermediate II.24 undergoes a retro-Michael 
addition resulting in linear intermediate II.25. This anionic species could undergo 
intramolecular conjugate addition as shown in mesomeric structure II.26. The resulting five-
membered ring II.27 could eliminate II.28 to form the aromatic product. Since deprotonation 
of II.21 would also result in formation of intermediate II.24, this speculated mechanism 
would explain why using a mixture of isomers II.20 and II.21 gives the same yield of II.22 as 
if pure II.20 was employed. 
When the conversion of pentaester II.22 to its corresponding pentaamide II.29 was 
attempted,[120] the formation of an unexpected product was observed (Scheme II.3).  
 
Scheme II.3: Attempted synthesis of pentaamide II.29. 
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Scheme II.4: Reaction of II.22 with hydrazine. 
 
Indeed, the attempted reaction furnished a pseudo-fivefold symmetric compound and 
hydrazine adduct II.31 was formed in almost quantitative yield. 
Subsequently, the synthesis of nitrile-substituted cyclopentadienide (pccp) salts was targeted 
through a combination of literature-known procedures (Scheme II.5).  
 
Scheme II.5: Synthesis of Et4N pccp II.37. 
 
Reacting sodium cyanide and carbon disulfide (II.32) in DMF resulted in the formation of 
solvate salt II.33,[121] which upon standing at room temperature in chloroform for six days 
underwent spontaneous desulfurization to afford disulfide II.34.[122] Compound II.34 was 
oxidatively dimerized to give II.35 using thionyl chloride.[123] Treatment with deprotonated 
methylcyano acetate II.36 finally delivered pentasymmetric nitrile II.37.[124] By this four-step 
process, the use of highly reactive reagents such as chlorine gas as reported in other 
procedures could be avoided.[125]  
Oxidative dimerization of II.35 required some optimization since the product proved to be 
sensitive towards byproducts of the reaction process such as SO2 and HCl, as evidenced by 
formation of a complex product mixture. These problems could be encountered by a modified 
workup- and purification procedure. Specifically, it was found that upon addition of an 
aqueous NaHCO3 solution, the product can be precipitated from the reaction mixture and can 
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be further purified by simple recrystallization. In the course of the optimization, an 
unprecedented solvate of II.35 could be obtained upon recrystallization of II.35 from toluene 
(Figure II.16). 
     
Figure II.16: Crystal structure of II.35∙0.5toluene: a) Single pair of II.35 and toluene; b) unit cell, view along the 
ac-axis (orientation of methyl group statistically disordered, hydrogens removed for clarity). 
 
II.35 exists in a bent conformation (∢C1-S1-C4 = 97.1°) and is coordinated to 0.5 equivalents of 
toluene at the distance of 3.4 Å, indicating π-stacking interaction between toluene and the 
dicyanoethylene moiety. The orientation of the methyl group in toluene is statistically 
disordered. 
The conversion of II.35 into II.37 is intriguing and a speculated mechanism is depicted in 
Scheme II.5. The proposed mechanism is based on observations during previous studies 
which reported disulfide II.43 as a byproduct of this reaction (Scheme II.6).[124] However, 
further mechanistic studies should be carried out in order to ultimately confirm the proposed 
mechanism. 
a) b) 
C1 
S1 
C4 
CHAPTER II: A Symmetry-Based Approach towards New Ion Channel Blockers 
130 
 
Scheme II.6: Speculated mechanism for the formation of II.37. 
 
Upon an initial nucleophilic attack of anion II.38 to II.35, intermediate II.39 could undergo 
ring opening to give sulfide II.40. Compound II.40 was speculated by Simmons et al. to 
intercept a second equivalent of II.35 to form II.41 and subsequently, upon ring opening, 
II.42.[124] Deprotonation with a second equivalent of base (→ II.43) would result in an 
intramolecular conjugate addition, which, upon loss of one equivalent of II.44, would result 
in the formation of six-membered heterocycle II.45. The methyl ester could be lost by a 
Krapcho-type mechanism, thus resulting in the formation of II.46. Intermediates of the type 
of II.46 were proposed by Simmons et al. to undergo thermal disrotatory ring closure 
(→ II.47), followed by thiirane ring opening and desulfurization to yield II.37.[124] 
In order to gain access to a larger variety of fivefold symmetric compounds, derivatization of 
II.37 was investigated next. Unfortunately, II.37 turned out to be extremely unreactive, an 
observation which was attributed to the fact that II.37, although bearing five electron-
withdrawing groups, is still relatively electron rich and also aromatically stabilized. The 
results of the attempted functionalizations are summarized in Table II.1. 
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Entry Reagent Solvent Temperature Time Yield 
1 NaBH4, CoCl2 THF reflux 24 h (II.48) -[a]  
2 Silica, BnOH CHCl3 reflux 24 h (II.49) -[a]  
3 LiAlH4 THF reflux 18 h (II.48) -[b]  
4 NaN3, HCl H2O reflux 24 h (II.50) -[b]  
5 MeMgBr THF reflux 24 h (II.22) -[b]  
6 N2H4 H2O reflux 24 h (II.51) -[a]  
 [a] no reaction observed, reisolation of starting material; [b] formation of a complex mixture of polar materials. 
Table II.1: Selected conditions for the attempted functionalization of II.37. 
 
When II.37 was heated in THF with sodium borohydride in the presence of cobalt(II) chloride 
to obtain amine II.48, no reaction was observed and starting material was recovered 
(Table II.1, Entry 1). The same result was obtained in an attempt to synthesize II.49, when 
II.37 was heated in chloroform in the presence of silica and benzyl alcohol (Table II.1, 
Entry 2). When a mixture of II.37 and LAH was heated to reflux in THF, a complex mixture 
of polar material was obtained (Table II.1, Entry 3). An attempted cycloaddition with in situ 
generated hydrazoic acid to give II.50 resulted in a mixture of black, insoluble material 
(Table II.1, Entry 4). A similar observation was made when II.37 was reacted with 
methylmagnesium bromide in refluxing THF to obtain II.22 (Table II.1, Entry 5). When a 
mixture of II.37 and hydrazine hydrate was heated to reflux for 24 h, again, no formation of 
II.51 was observed and starting material was recovered (Table II.1, Entry 6) 
Even though functionalization of II.37 remained unsuccessful, sufficient amounts of II.37 
could be produced to carry out initial biological tests (vide infra, Section 2.2.3). However, 
II.37 was found to be only poorly soluble in water, thus limiting its potential application in 
physiological media. In order to encounter this problem, pccp salts with different counter ions 
such as sodium were prepared (Scheme II.7). 
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Scheme II.7: Synthesis of Na pccp (II.10). 
 
Compound II.52 could be synthesized in analogy to II.37 by treatment with deprotonated 
methyl cyanoacetate (II.38) in the presence of a second equivalent of sodium hydride. Sodium 
salt II.10 was then prepared by simple treatment of  triethylammonium salt II.52 with sodium 
hydride, a procedure similar to that sketched by the group of Wright.[126] Subsequent 
purification by reversed-phase column chromatography was found to be the optimal method 
to provide pure and crystalline material, which was submitted to biological testing (vide infra, 
Section 2.2.3). The crystal structure of II.10 is shown in Figure II.17. 
 
Figure II.17: Crystal structure of II.10∙2acetone (a cutout of the unit cell is shown and hydrogens are removed for 
clarity). 
 
Compound II.10 crystallized as an acetone solvate with the formula II.10∙2acetone in the 
monoclinic crystal system in the space group C2/m. Sodium ions are coordinated by acetone 
carbonyls and pccp nitriles in an octahedral fashion. Pccp anions stack in a staggered 
conformation. 
Having produced a number of fivefold symmetric cyclopentadienides, the synthesis of 
cucurbit[5]urils was investigated subsequently and the results of these studies are presented in 
the next section. 
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2.2.2.2 Synthesis of cucurbit[5]urils 
Starting from a known protocol to synthesize glycoluril, subsequent synthesis of 
cucurbit[5]urils was achieved by modified literature procedures (Scheme II.8). 
 
Scheme II.8: Synthesis of decahydroxycucurbit[5]uril (II.12). 
 
Heating a mixture of urea (II.53) and glyoxal (II.54) in aqueous HCl resulted in formation of 
glycoluril (II.55).[127] Treatment of II.55 with formaldehyde in the presence of aqueous 
sulfuric acid provided a mixture of cucurbit[n]urils of different ring sizes. Upon fractional 
crystallization, the complex mixture could be separated and II.11 was isolated in 8 % 
yield.[128] Conversion of II.11 into decahydroxycucurbit[5]uril (II.12) was achieved by 
treatment with potassium peroxodisulfate.[129] It was found that the reaction produced a 
complex mixture of isomers, the separation of which could be accomplished by reversed-
phase HPLC purification. The structures of II.11 and II.12 were confirmed by X-ray 
crystallography (Figures II.18 and II.19), with the crystal structure of II.11 identical to a 
reported structure of II.11 (CCDC-code: 883370).[130] 
        
Figure II.18: Crystal structure of II.11: a) Depiction of a single molecule of II.11 without solvent; b) view along the 
c-axis in the unit cell, water and HCl molecules are shown. 
a) b) 
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Compound II.11 crystallized in the monoclinic space group C2/m. The unit cell includes six 
units of II.11∙4H2O∙HCl. It should be noted that water and HCl molecules are present in the 
molecular cavity of II.11, thus indicating a possible solvent exchange as guest in the cavity of 
II.11.[131] 
        
Figure II.19: Preliminary illustration of the crystal structure of II.12: a) Depiction of a single molecule without 
solvent; b) view along the a-axis in the unit cell, potassium ions, sulfate ions and water molecules are shown. 
 
Preliminary data showed that II.12 co-crystallized with K2SO4 as a water solvate in the 
triclinic space group P(-1). Potassium ions are coordinated on each side in a pentagonal 
fashion by the cucurbit[5]uril carbonyl groups. Further refinement of the structure is currently 
in progress. 
Whereas II.12 showed excellent solubility in water (> 100 mM), II.11 was only poorly 
soluble, thus restricting its use for biological applications. In order to render II.11 more 
water-soluble, a complex of II.11 with sperminium chloride was prepared in one step 
(Scheme II.9).[132] 
 
Scheme II.9: Synthesis of water-soluble cucurbit[5]uril complex II.57. 
 
a) b) 
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A stoichiometric mixture of spermine (II.56) and II.11 was heated in the presence of aqueous 
HCl and upon removal of solvent, II.57 was obtained in quantitative yield. The solubility of 
complex II.57 in water was determined to be 1 mM. 
The potential for functionalization of the cucurbit[5]urils is rather limited and only few 
examples for such transformations have been described in literature.[129] Some further 
attempts have been carried out in the scope of this work (for detailed screening table, see 
Appendix 8), which, however, proved to be unsuccessful. In contrast, the pillar[5]arenes can 
easily be functionalized, thus rendering themselves ideal candidates in the symmetry 
approach. Their synthesis is described in the next section. 
 
2.2.2.3 Synthesis of pillar[5]arenes 
The synthesis of pillar[5]arene (II.13) was smoothly realized by following Nakamoto´s 
improved procedure. Based on the reported compound, a water-soluble carboxylic acid-
substituted pillar[5]arene (II.15) was synthesized (Scheme II.10).  
 
Scheme II.10: Synthesis of carboxylic acid-substituted pillar[5]arene (II.15). 
 
When 1,4-dimethoxybenzene (II.58) was treated with paraformaldehyde and boron trifluoride 
diethyl etherate as Lewis acid, a mixture of polymerized material and 
CHAPTER II: A Symmetry-Based Approach towards New Ion Channel Blockers 
136 
decamethylpillar[5]arene (II.59) was obtained, from which II.59 could be isolated by 
filtration and recrystallization.[133] Upon O-deprotection, the resulting pillar[5]arene II.13 was 
alkylated using ethyl bromoacetate (II.60) to afford ethyl ester-substituted pillar[5]arene 
(II.14) in a poor 12 % yield.[134] Finally, saponification afforded carboxylic acid-substituted 
pillar[5]arene (II.15),[134] which, upon recrystallization, gave crystals suitable for X-ray 
analysis. The preliminary crystal structure of II.15 is shown in Figure II.20. 
      
Figure II.20: Preliminary representation of the crystal structure of carboxylic acid-substituted pillar[5]arene II.15: 
a) Illustration of a single molecule (DMSO molecules and hydrogen atoms are removed for clarity); b) unit cell, 
view along the b-axis (DMSO molecules are shown, hydrogen atoms are removed for clarity). 
 
Carboxylic acid-substituted pillar[5]arene (II.15) crystallized in the monoclinic space group 
C2/c. A unit cell contains four molecules of II.15 and 12 molecules of DMSO. Further 
refinement of the structure is still in progress. 
Further derivatives of II.13 were accessible by cyclization of 1,4-bis(2-bromoethoxy)benzene 
(II.62). When this reaction was performed on large scale, bromoethoxy-substituted 
pillar[6]arene (II.64) could be isolated as a second reaction product (Scheme II.11). 
 
Scheme II.11: Synthesis of bromoethoxy-substituted pillar[5]arene (II.63) and pillar[6]arene (II.64). 
 
a) b) 
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Subjecting 1,4-bis(2-hydroxyethyl)benzene (II.61) to an Appel reaction smoothly resulted in 
formation of dibromide II.62, which was converted into the corresponding pillar[n]arenes by 
treatment with paraformaldehyde in the presence of boron trifluoride diethyl etherate, 
analogous to the synthesis of II.13.[135] Interestingly, a 59:9 mixture of the respective 
pillar[5]arene II.63 and the pillar[6]arene II.64 was obtained, the structures of which could be 
confirmed by X-ray analysis of single crystals (Figures II.21 and II.22). 
         
Figure II.21: Crystal structure of bromoethoxy-substituted pillar[5]arene (II.63): a) Illustration of a single molecule; 
b) unit cell, view along the b-axis. 
 
Bromoethoxy-substituted pillar[5]arene II.63 crystallized as an acetone solvate in the triclinic 
space group P21/c. The unit cell contains four equivalents of II.63∙acetone with the solvent 
residing inside the cavity of II.63. The −CH2− moieties building the rims of the five-
membered rings arrange in a planar fashion (∢Ar−CH2−Ar = 108° for all −CH2− rims). 
     
Figure II.22: Preliminary representation of the crystal structure of bromoethoxy-substituted pillar[6]arene (II.64): 
a) Illustration of a single molecule (solvent molecules are removed for clarity); b) unit cell, view along the a-axis, 
solvent molecules are not resolved. 
 
Bromoethoxy-substituted pillar[6]arene (II.64) crystallized in the triclinic space group P(−1). 
In contrast to the structures of pillar[5]arenes, the –CH2− rims are twisted and thus do not 
form the characteristic pillar-shaped structure. An explanation for this could be a significant 
a) b) 
a) b) 
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release of strain. In a hypothetical pillar-shaped structure in which the –CH2− rims arrange in 
a planar fashion, the bond angles of the methylene bridges would adopt values of 120°. 
However, in II.64 the bond angles ∢Ar−CH2−Ar adopt values of 111.0°, 113.8°, 114.7°, 115.1°, 
115.9° and 116.5°, which are closer to the tetrahedral angle of 109°. According to a detailed 
literature search, this is the first example of a crystal structure of a pillar[6]arene to date. 
Further refinement of the structure is still in progress. 
Bromoethoxy-substituted pillar[5]arene (II.63) was now converted into water-soluble 
compounds suitable for biological experiments. Starting from II.63, decatrimethylammonium 
salt II.17 was prepared in one step (Scheme II.12).  
 
Scheme II.12: Synthesis of trimethylammonium bromide-substituted pillar[5]arene (II.17). 
 
Heating of II.63 in the presence of an ethanolic trimethylamine solution afforded 
trimethylammonium bromide-substituted pillar[5]arene (II.17) in a quantitative yield.[135] 
X-ray analysis of a single crystal confirmed the structure of II.17 (Figure II.23). 
        
Figure II.23: Preliminary representation of the crystal structure of trimethylammonium bromide-substituted 
pillar[5]arene (II.17): a) Illustration of a single molecule (solvent molecules and counter ions are removed for 
clarity); b) unit cell, view along the ab-axis (water molecules and bromide counter ions are shown, hydrogens are 
removed for clarity). 
 
a) b) 
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Compound II.17 crystallized as an aqueous solvate, in which the bromide counter ions as well 
as water molecules are highly disordered. The monoclinic cell with the space group P21/c 
contains four molecules of II.17, which are oriented in an approximate 60° angle towards 
each other. Further refinement of the structure is still in progress. 
Finally, conversion of II.63 into an aminofunctionalized pillar[5]arene (II.16) was 
approached, which was achieved by following a modified literature procedure (Scheme II.13).  
 
Scheme II.13: Synthesis of decaamine II.16. 
 
Decabromide II.63 was converted into decaazide II.65 by a simple SN2 displacement in 
quantitative yield.[136] The subsequent reduction to the corresponding amine II.16 proved to 
be difficult and in initial attempts, complex mixtures of amino- and azide-functionalized 
pillar[5]arenes were obtained. After some optimization, it was found that the reaction works 
best if the hydrogenation catalyst is added portionwise over a period of four days.  
With a set of fivefold symmetric compounds of different sizes featuring a number of diverse 
functional groups in hands, first biological studies were carried out, the preliminary results of 
which are described in the next section. 
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2.2.3  Outline on Biological Studies 
 
Biological studies were carried out in collaboration. The results that are briefly summarized in 
this section were obtained by Valentina Carta and Roland Baur in the laboratory of Prof. Dr. 
Erwin Sigel at the Institute of Biochemistry and Molecular Medicine, University of Bern. 
Pharmacological activity of the herein reported fivefold symmetric molecules was 
investigated using the two-electrode voltage-clamp technique in Xenopus oocytes expressing 
GABAA receptors. The results of the tested compounds are summarized in Figure II.24. 
 
Figure II.24: Biological activity of fivefold symmetric compounds on the GABAA receptor (+++ IC50 < 10 µM; 
+ IC50 < 100 µM; − IC50> 100 µM; *compound seems to act as an allosteric modulator). 
2.2 Results and Discussion 
141 
Among the cyclopentadienides, II.30 and II.22 were found to be inactive on the α1β2γ2 (wild 
type) GABAA receptor, whereas II.31 was shown to be a weak inhibitor (IC50< 100 µM). 
II.10, on the other hand, was found to be highly active (IC50 < 10µM). Interestingly, it both 
stimulates and inhibits GABAA currents. All pillar[5]arenes (II.13, II.17, II.16, II.14, II.15) 
and the cucurbit[5]urils II.11 and II.57 were found to be inactive. However, 
decahydroxycucurbit[5]uril (II.12) seemed to act as a low affinity positive allosteric 
modulator on the α1β2γ2 (wild type) GABAA receptor, since II.12 stimulated currents 
mediated by the channel. Further studies on this interesting observation are currently carried 
out by Valentina Carta in the Sigel laboratories. 
Subsequently, the mode of action of II.10 was studied in more detail. Current traces 
illustrating typical experiments on α1β2γ2 (wild type) GABAA receptors that were expressed in 
Xenopus oocytes are shown at GABA concentrations eliciting about 1% or 10% of the 
maximal current amplitude (EC1or EC10) in Figures II.25 and II.26, respectively. The outward 
currents observed at very high concentrations of II.10 are due to direct effects of II.10 on 
membranes (not shown). 
 
Figure II.25: TEVC recording of Xenopus oocytes expressing the α1β2γ2 (wild type) GABAA receptor: Experiments 
were carried out at a GABA (II.1) concentration eliciting about 1% of the maximal current amplitude (EC1; 1µM). 
Drug application was during 3 min. The lower bar indicates the application of II.1, the upper bar the application of 
Na pccp (II.10).The numbers indicate the concentration of II.10 in µM. 
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Subsequently, the concentration inhibition curve of II.10 obtained for α1β2γ2 was compared 
with that of α1β1γ2 and α1β2δ GABAA receptors (Figure II.28).  
 
 
Figure II.28: Concentration-inhibition curve obtained from α1β2γ2, α1β1γ2 and α1β2δ GABAA receptors. 
 
It was found that II.10 acts on all investigated GABAA receptor isoforms and did show some 
selectivity. II.10 shows the most potent inhibition on the α1β2δ isoform (IC500.7± 0.3 µM), 
whereas the effect on the α1β1γ2 isoform is less potent (IC5013 ± 5 µM). The IC50 of II.10 on 
α1β2γ2 (wild type) receptors was determined to be 1.4 ± 0.5µM.  
In Drosophila, the mutation RDL in the GABAA receptor has been described to confer 
resistance to the insecticide dieldrin and partial resistance to picrotoxin (II.6). The RDL 
mutation Ala301Ser is located in the transmembrane region M2. It was interesting to compare 
Drosophila wild type and RDL mutant GABAA receptor in the irrespective responses to 
picrotoxin (II.6) and Na pccp (II.10). Results of these experiments are shown in Figure II.29.  
           
Figure II.29: Concentration-inhibition curves in Drosophila wild type GABAA receptors and mutant receptors 
carrying the RDL resistance mutation: a) Picrotoxin (II.6); b) Na pccp (II.10). 
a) b) 
Na pccp (M) 
Na pccp (M) picrotoxin (M) 
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While there is an about 7-fold shift in the IC50 in response to the mutation for II.6, there is a 
less than 2-fold shift for II.10. This suggests that II.10 still will affect insects carrying this 
mutation. 
In order to gain further insights into the detailed mode of action and the binding site of II.10, 
cysteine mutations in the M2 domain were introduced into amino acids, which are oriented 
towards the channel lumen and the behavior of II.10 and II.6 was monitored. In order to 
increase the effect by the mutation, the cysteine-reactive compound MTSET was used. 
Preliminary results indicate different binding modes for II.10 compared to II.6. These 
experiments are presently being carried out by Valentina Carta in the laboratory of the Sigel 
group.  
 
2.2.4 Summary, Conclusions and Outlook 
 
Based on the idea of the symmetry approach, a library of fivefold symmetric compounds has 
been synthesized. The compound library includes water-soluble cyclopentadienide, 
cucurbit[5]uril and pillar[5]arene derivatives (Figure II.30). In preliminary studies, the 
compounds were tested for their biological activity on the GABAA receptor.  
 
 
Figure II.30: Chemical structure and shape on the basis of selected crystal structures of fivefold symmetric small 
molecules prepared for the symmetry approach. 
 
Pleasingly, it was found that some of the fivefold symmetric compounds are biologically 
active and indeed, pentameric ion channels are targets of these molecules. More specifically, 
it was II.10 that was found to be highly biologically active on the GABAA receptor. At high 
concentrations, II.10 acts as an open channel blocker of the GABAA receptor with an 
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efficiency of inhibition comparable to that of picrotoxin (IC50 = 1.3 µM). In cooperation with 
the group of Prof. Dr. Sigel at the Institute of Biochemistry and Molecular Medicine, 
University of Bern, its detailed mode of action and its potential application as an insecticide is 
currently being investigated. 
Thus, the initial idea of the symmetry-based approach towards new ion channel blockers, 
which was affirmed by model studies, led to the development of a highly biologically active 
compound, which indeed targets a pentameric ion channel. 
Future work will have to consist of the development of synthetic routes for the preparation of 
analogues of the cucurbit[5]urils and the pillar[5]arenes to access further frameworks and 
more functional groups. In the course of these studies, it would be reasonable to investigate 
the potential of the formation of five-membered rings of other macrocyclic compounds such 
as the bambus[n]urils (II.66) [137] and the as[n]arenes (II.67) [138] (Figure II.31). 
 
Figure II.31: Chemical structures of generic bambus[5]urils (II.66) and as[5]arenes (II.67) as potential future 
fivefold symmetric carbon frameworks for the symmetry approach. 
 
Furthermore, the compounds will be tested on many more pentameric proteins in order to 
fully evaluate their biological profiles. These studies are currently carried out in various 
collaborations, the results of which will be presented in due course. 
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2.3 Experimental Section 
 
General experimental details: 
Unless specified otherwise, all reactions were performed with magnetic stirring under an 
atmosphere of argon and in oven-dried glassware. Isolated products were dried on a high 
vacuum line at a pressure of 10–2 mbar using an ATB-Loher oil pump by Flender. Diethyl 
ether and tetrahydrofuran (THF) were distilled prior to use from sodium and benzophenone. 
Dimethylformamide (DMF), 1,2-dimethoxyethane (DME), 1,2-dichloroethane (DCE), 
chloroform (CHCl3), ethanol (EtOH), methanol (MeOH), acetonitrile (MeCN) and acetone 
(Me2CO) were purchased from Acros Organics as 'extra dry' reagents under inert gas 
atmosphere and over molecular sieves. All other reagents were purchased from commercial 
sources and used without further purification. Petroleum ether is referred to as hexanes and 
relates to fractions of isohexanes, which boil between 40 °C and 80 °C. Reactions were 
monitored by TLC using E. Merck 0.25 mm silica gel 60 F254 glass plates. TLC plates were 
visualized by exposure to UV light (254 nm) and subsequent treatment with an aqueous 
solution of CAM, an aqueous solution of potassium permanganate, an aqueous acidic solution 
of vanillin, a solution of ninhydrin or a mixture of silica and finely grounded iodine, followed 
by heating the plate with a heat gun. If appropriate, reactions were additionally monitored by 
proton nuclear magnetic resonance (1H-NMR) using a Varian 200 spectrometer or LCMS 
using an Agilent Technologies 1260 infinity machine equipped with an Agilent ZORBAX 
Eclipse Plus C18 reversed phase analytical 4.6 mm x 150 mm column. Flash column 
chromatography was performed as described by Still et al. employing silica gel (60 Å, 
40-63 µm, Merck) at a pressure of approx. 1.3-1.5 bar generated by a gentle nitrogen flow.[94]  
Reversed phase (RP) column chromatography was performed on Waters silica gel 
(Preparative C18, 125Å, 55-105 µm) with the same techniques as described above. Analytical 
RP TLC was performed using pre-coated glass plates (silica gel C18 RP-18W/UV254) from 
Macherey-Nagel. Yields refer to isolated and spectroscopically pure compounds. 
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Instrumentalization: 
Infrared (IR) spectra were recorded on a Perkin Elmer Spectrum BX II (FTIR System), 
equipped with an attenuated total reflection (ATR) measuring unit. IR data is reported in 
frequency of absorption (cm−1).  
Proton nuclear magnetic resonance (1H-NMR) spectra were recorded on a Varian 300, Varian 
400, Inova 400 or Varian 600 spectrometer. Chemical shifts ( scale) are expressed in parts 
per million (ppm) and are calibrated using residual protic solvent as an internal reference 
(CDCl3:  = 7.26 ppm, (D3C)2CO:  = 2.05 ppm, (CD3)2SO:  = 2.50 ppm, 
CD3OD = 3.31 ppm, D2O = 4.79 ppm).[95] Unless noted otherwise, data was recorded at 
27 °C. Data for 1H-NMR spectra are reported as follows: chemical shift ( ppm) (multiplicity, 
coupling constants (Hz), integration). Couplings are expressed as: s = singlet, d = doublet, 
t = triplet, q = quartet, m = multiplet, br = broad, app = apparent or combinations thereof. 
Carbon nuclear magnetic resonance (13C-NMR) spectra were recorded on the same 
spectrometers at 75, 100 and 150 MHz, respectively. Carbon chemical shifts ( scale) are also 
expressed in parts per million (ppm) and are referenced to the central carbon resonances of the 
solvents (CDCl3:  = 77.16 ppm, (D3C)2CO:  = 29.84 ppm, (CD3)2SO:  = 39.52 ppm, 
CD3OD = 49.00 ppm).[95] 
Mass spectroscopy (MS) experiments were performed on a Thermo Finnigan MAT 95 
(electron ionization, EI), on a Thermo Finnigan LTQ FT (electrospray ionization, ESI) or on a 
Jeol JMS-700 (fast atom bombardment, FAB) instrument. 
Melting points were measured on an EZ-Melt automated melting point apparatus made by 
Stanford Research Systems and are uncorrected. 
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Octamethyl cyclohepta-2,4-dien-1,1,2,3,4,5,6,7-octacarboxylate (II.20) and Octamethyl 
cyclohepta-3,5-dien-1,1,2,3,4,5,6,7-octacarboxylate (II.21):[119] 
 
To a solution of dimethyl acetylenedicarboxylate (II.19, 33.1 mL, 270 mmol, 3.00 eq) and 
dimethyl malonate (II.18, 10.3 mL, 90.0 mmol, 1.00 eq) in diethyl ether (60.0 mL) was added 
dropwise a mixture of pyridine and acetic acid (1:1 mixture by weight, 2.50 mL) and an 
exothermic reaction started, evidenced by intense refluxing of the solvent. When the intensity 
of reflux had ceased, the dark red mixture was heated to reflux for 2 h and was then allowed 
to cool to room temperature. The resulting precipitate was filtered off, washed with diethyl 
ether (30.0 mL) and dried to give a 57:7 mixture of II.20 and II.21 as a slightly buff yellow 
solid (32.1 g, 64 %), which was used without further purification. 
mp: 215-219 °C. 
1H NMR (300 MHz, CDCl3, major isomer quoted): δ = 5.17 (d, J = 1.4 Hz, 1H), 3.90 (s, 6H), 
3.76-3.74 (m, 7H), 3.73-3.71 (m, 12H). 
13C NMR (75 MHz, CDCl3, major isomer quoted): δ = 170.2, 169.3, 167.9 (2C), 166.0 (2C), 
165.5, 164.5, 144.7, 140.5 (2C), 134.4, 63.8, 53.9, 53.3 (2C), 53.2 (2C), 52.8 (2C), 52.7, 47.8, 
44.3. 
IR (neat): ṽ
 max = 1726, 1238.  
HRMS (ESI+):  m/z calcd. for C23H26KO16+:   597.0858 [M+K]+;  
found:      597.0857 [M+K]+. 
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Potassium 1,2,3,4,5-pentacarbomethoxycyclopentadienide (II.22):[119] 
 
A mixture of II.20 and II.21 as obtained from the previous reaction (27.5 g, 49.2 mmol, 
1.00 eq), water (140 mL) and potassium acetate (45.5 g, 464 mmol, 9.40 eq) was heated to 
reflux for 2 h with vigorous stirring. After hot filtration, the mixture was allowed to cool to 
room temperature and subsequently cooled to 4 °C over four days. The resulting precipitate 
was collected, washed with ice water (5.00 mL) and dried to afford II.22 as a yellow solid 
(17.5 g, 90 %). 
mp: 217-218 °C. 
1H NMR (400 MHz, D2O): δ = 3.63 (s, 15H). 
13C NMR (100 MHz, D2O): δ = 169.0 (5C), 116.7 (5C), 52.3 (5C). 
IR (neat): ṽ
 max = 1678, 1456, 1172.  
HRMS (ESI−):  m/z calcd. for C15H15O10−:   355.0671 [M−K]−;  
found:      355.0663 [M−K]−. 
 
Potassium amino(4,6-dicarbamoyl-1,3-dioxo-2,3-dihydrocyclopenta[c]pyrrol-5(1H)-
ylidene)methanolate (II.30): 
 
Potassium salt II.22 (4.50 g, 11.4 mmol, 1.00 eq) was dissolved in a 30 % aq. ammonium 
hydroxide solution (75.0 mL) and was allowed to stand at room temperature for three months. 
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The product slowly crystallized, was then collected, washed with water and dried to afford 
II.30 as large yellow crystals (820 mg, 23 %), which were suitable for X-ray crystallography. 
mp: 310 °C (dec.). 
1H NMR (400 MHz, d6-DMSO): δ = 9.38 (s, br, 1H), 7.89 (s, br, 2H), 6.53 (s, br, 4H). 
13C NMR (100 MHz, d6-DMSO): δ = 171.0, 170.0 (2C), 165.8 (2C), 134.4, 119.1 (2C), 115.0 
(2C). 
IR (neat): ṽ
 max = 3463, 1650, 1426.  
HRMS (ESI−):  m/z calcd. for C10H7N4O5−:   263.0422 [M]−;  
found:      263.0420 [M] −. 
 
Potassium bis(1,4-dioxo-3,4-dihydro-1H-cyclopenta[d]pyridazin-5(2H)-
ylidene)(hydrazinyl)methanolate (II.31): 
 
A mixture of II.22 (2.96 g, 7.50 mmol, 1.00 eq) and a 24 % aq. hydrazine hydrate solution 
(50.0 mL, 242 mmol, 32.0 eq) was allowed to stand at room temperature for 2 months. The 
resulting precipitate was filtered off, washed with hot water (2 x 25.0 mL) and dried to afford 
II.31 as an amorphous powder (2.45 g, 99 %). 
mp: ca. 340 °C (dec.). 
1H NMR (400 MHz, d6-DMSO): δ = 15.57 (s, 1H), 14.27 (s, 1H), 13.90 (s, 1H), 11.48 
(s, 1H), 11.34 (s, 1H), 4.77 (s, br, 2H). 
13C NMR (100 MHz, d6-DMSO): δ = 165.7, 160.8, 160.1, 153.1 (2C), 123.1, 121.9, 115.2, 
112.6, 105.2. 
IR (neat): ṽ
 max = 2975, 1607, 1474, 1413.  
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HRMS (ESI−):  m/z calcd. for C10H7N6O5−:   291.0483 [M]−;  
found:      291.0481 [M]−. 
 
Sodium cyanodithioformiate·3DMF (II.33)[121] and disodium dimercaptomaleonitrile 
(II.34):[122] 
 
A mixture of sodium cyanide (73.5 g, 1.50 mol, 1.00 eq) and DMF (440 mL, 5.68 mol, 
3.80 eq) was cooled to 0 °C and CS2 (II.32, 90.5 mL, 1.50 mmol, 1.00 eq) was added 
dropwise over a period of 15 min. After complete addition, the mixture was allowed to warm 
up to be stirred for 30 min at room temperature, upon which time crystallization occurred. The 
resulting red-brown slurry was diluted with isobutanol (185 mL), heated to 115 °C until the 
product had completely dissolved (10 min), filtered and allowed to cool to room temperature. 
The mixture was cooled to −10 °C, the resulting crystalline product was filtered off, washed 
with diethyl ether (500 mL) and dried. Sodium cyanodithioformiate·3DMF (II.33) was 
obtained as large red-brown needles (510 g, 99 %), which was used in the subsequent reaction 
without further purification. 
Sodium cyanodithioformiate·3DMF (II.33, 445 g, 1.30 mol) was suspended in chloroform 
(1.40 L) and stirred until a clear solution was obtained. Then, the mixture was allowed to 
stand at room temperature for six days. The resulting solid was filtered off, washed with 
chloroform (350 mL) and diethyl ether (1.30 L) and dried. Methanol (260 mL) was added and 
the mixture was heated until a suspension containing small, insoluble particles was obtained. 
After hot filtration, the filtrate was allowed to cool to room temperature and the product was 
precipitated by addition of diethyl ether (1.50 L) and vigorous stirring. Disodium 
dimercaptomaleonitrile (II.34) was obtained as a yellow powder, which was filtered off and 
dried (110 g, 92 %). An analytical sample was further purified by recrystallization from 
ethanol.  
mp: ca. 300 (dec.). 
13C NMR (100 MHz, d6-DMSO): δ = 126.5 (2C), 124.1 (2C). 
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IR (neat): ṽ
 max = 3348, 2193, 1438, 1113.  
 
Tetracyano-1,4-dithiin (II.35):[123] 
 
A suspension of II.34 (64.0 g, 344 mmol, 1.00 eq) in DME (225 mL) was cooled to –5 °C 
(internal temperature) and a solution of thionyl chloride (24.9 mL, 344 mmol, 1.00 eq) in 
DME (30.0 mL) was added with a syringe pump over the course of 60 min. The resulting 
yellow suspension was allowed to warm to room temperature over a period of 60 min, filtered 
and the filter cake was washed with DME (3 x 60.0 mL). The combined filtrates were poured 
into a mixture of a sat. aq. NaHCO3 solution (1.00 L) and ice water (2.00 L). The resulting 
precipitate was filtered off, washed with water (3 x 400 mL) and dried. (Note: If not all 
compounds employed in this reaction were carefully purified prior to use and if the 
temperature was not carefully controlled, instead of a buff yellow solid a dark brown or black 
solid may be obtained, from which only small quantities of II.35 can be attained.) 
Recrystallization of the crude product from 1,2-dichloroethane provided II.35 as a dark 
yellow crystalline solid (25.8 g, 80 %).  
mp: 206 °C. 
13C NMR (100 MHz, d6-DMSO): δ = 125.9 (4C), 112.8 (4C). 
IR (neat): ṽ
 max = 2229, 1519, 1158.  
A small sample was recrystallized from toluene to afford a toluene solvate of II.35 as large, 
dark brown needles, which were suitable for X-ray crystallography. 
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Tetraethylammonium pccp (II.37):[124] 
 
To a suspension of sodium hydride (3.12 g, 123 mmol, 2.00 eq) in DME (450 mL) was added 
methyl cyanoacetate (II.36, 5.50 mL, 61.7 mmol, 1.00 eq) at 0 °C. After gas evolution had 
ceased (1 h), II.35 (13.4 g, 61.7 mmol, 1.00 eq) was added and the mixture was allowed to 
warm to room temperature. After being stirred for 2 h at this temperature, the mixture was 
heated to reflux for 3 h. The resulting red colored mixture was allowed to cool to room 
temperature and concentrated to dryness. Water (650 mL) was added and the mixture was 
filtered. To the filtrate was added tetraethylammonium chloride (10.2 g, 61.7 mmol, 1.00 eq) 
and the mixture was stirred for 20 min at room temperature. The resulting yellow precipitate 
was filtered off and dried. The solid was redissolved in concd. nitric acid (175 mL) at 0 °C 
and filtered. To the filtrate was added ice water (1350 mL) and the resulting precipitate was 
filtered off and dried to afford II.37 as a slightly yellow powder (7.60 g, 77 %).  
mp: 359-361 °C. 
13C NMR (100 MHz, d6-DMSO): δ = 113.5 (5C), 102.2 (5C), 51.8 (t, J = 3.0 Hz, 4C), 
7.5 (4C). 
IR (neat): ṽ
 max = 2215, 1469.  
HRMS (ESI−):  m/z calcd. for C10N5−:   190.0154 [M−Et4N]−;  
found:      190.0157 [M−Et4N]−. 
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Triethylammonium pccp (II.52):[124] 
 
To a suspension of sodium hydride (3.12 g, 123 mmol, 2.00 eq) in DME (450 mL) was added 
methyl cyanoacetate (II.36, 5.50 mL, 61.7 mmol, 1.00 eq) at 0 °C. After gas evolution had 
ceased (1 h), II.35 (13.4 g, 61.7 mmol, 1.00 eq) was added and the mixture was allowed to 
warm to room temperature. After being stirred for 2 h at this temperature, the mixture was 
heated to reflux for 3 h. The resulting red colored mixture was allowed to cool to room 
temperature and concentrated to dryness. Water (650 mL) was added and the mixture was 
filtered. To the filtrate was added triethylammonium chloride (8.50 g, 61.7 mmol, 1.00 eq) 
and the mixture was stirred for 20 min at room temperature. The resulting brown precipitate 
was filtered off and dried. The solid was redissolved in concd. nitric acid (175 mL) at 0 °C 
and filtered. To the filtrate was added ice water (1.35 L) and the resulting precipitate was 
filtered off and dried to furnish II.52 as a brown colored solid (5.50 g, 61 %).  
mp: 115 °C (dec.). 
13C NMR (100 MHz, d6-DMSO): δ = 113.5 (5C), 102.2 (5C), 46.2 (3C), 9.1 (3C). 
IR (neat): ṽ
 max = 2218, 1470.  
HRMS (ESI−):  m/z calcd. for C10N5−:   190.0154 [M−ΗNEt3]−;  
found:      190.0156 [M−HNEt3]−. 
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Sodium pccp (II.10): 
 
To a suspension of II.52 (1.10 g, 3.80 mmol, 1.00 eq) in diethyl ether (60.0 mL) was added 
sodium hydride (106 mg, 4.18 mmol, 1.10 eq) at 0 °C. After gas evolution had ceased, the 
mixture was allowed to warm to room temperature and then heated to reflux for additional 
17 h. The mixture was concentrated to dryness and purified by RP column chromatography 
(water:MeOH 99:1 → 90:10) to afford II.10 as a yellow solid (761 mg, 94 %).  
mp: 369-370 °C. 
13C NMR (100 MHz, d6-DMSO): δ = 113.5 (5C), 102.2 (5C). 
IR (neat): ṽ
 max = 2226, 1656, 1482.  
HRMS (ESI−):  m/z calcd. for C10N5−:   190.0154 [M−Na]−;  
found:      190.0159 [M−Na]−. 
Crystals suitable for X-ray analysis were obtained by slowly evaporating the solvent of a 
solution of II.10 in acetone, which afforded an acetone solvate of II.10 as a colorless solid. 
 
Glycoluril (II.55):[127] 
 
To a mixture of urea (II.53, 100 g, 1.67 mol, 2.60 eq) and water (200 mL) was added a 40 % 
aq. glyoxal solution (II.54, 73.5 mL, 640 mmol, 1.00 eq) and concd. aq. HCl (37 % in water, 
8.90 mL, 64.0 mmol, 0.100 eq). The mixture was heated to 85 °C for 1 h, after which time a 
precipitate had formed. The mixture was then allowed to cool to room temperature. The 
precipitate was filtered off, washed with water (200 mL) and acetone (500 mL) and was dried 
in vacuo to give glycoluril (II.55) as a colorless solid (60.0 g, 66 %). 
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mp: ca. 310 °C (dec.). 
1H NMR (300 MHz, d6-DMSO): δ = 7.12 (s, 4H), .2 (s, 2H). 
13C NMR (75 MHz, d6-DMSO): δ = 161.7 (2C), 65.0 (2C). 
IR (neat): ṽ
 max = 3158, 1681.  
HRMS (ESI+):  m/z calcd. for C4H6N4O2+:   142.0491 [M]+;  
found:      142.0489 [M]+. 
 
Cucurbit[5]uril (II.11):[128] 
 
A mixture of glycoluril (II.55, 56.8 g, 0.400 mol, 1.00 eq) and halfconcd. aq. sulfuric acid 
(9.00 M, 200 mL, 1.42 mol, 3.55 eq) was heated to 70 °C. At this temperature, a 40 % aq. 
formaldehyde solution (70.0 mL, 0.920 mol, 2.30 eq) was added over the course of 15 min. 
After being stirred at 75 °C for 24 h, the temperature was raised to 100 °C and the mixture 
was stirred for 12 h at this temperature. The resulting mixture was allowed to cool to room 
temperature and was diluted with water (0.500 L) and acetone (10.0 L). The resulting 
precipitate was filtered off, washed with acetone (1.00 L) and dried.  
Then, water (2.00 L) was added and the resulting suspension was stirred vigorously for 
15 min at room temperature. The mixture was filtered and to the filtrate was added acetone 
(8.00 L) to form a precipitate. The resulting solid was filtered off and diluted with a 1:1 
mixture of water/methanol (2.00 L). The mixture was filtered and the filtrate was concentrated 
to form a precipitate, which was dried. The dried powder was dissolved in a 1 M aq. H2SO4 
solution (65.0 mL) and upon slow cooling to 0 °C, cucurbit[5]uril (II.11) was furnished as a 
colorless, crystalline solid (5.33 g, 8 %). 
mp: 286 (dec.). 
1H NMR (600 MHz, d6-DMSO): δ = 5.52-5.43 (m, 20H), 4.52 (d, J = 15.1 Hz, 10H). 
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13C NMR (150 MHz, d6-DMSO): δ = 155.6 (10C), 68.4 (10C), 49.7 (10C). 
IR (neat): ṽ
 max = 1733, 1470, 1182.  
HRMS (FAB+):  m/z calcd. for C30H30N20O10+:  848.2792 [M+NH4]+;  
found:      848.2750 [M+NH4]+. 
 
Sperminium chloride @ cucurbit[5]uril (II.57):[132] 
 
A mixture of spermine (II.56, 20.2 mg 0.100 mmol, 1.00 eq) and cucurbit[5]uril (II.11, 
83.1 mg, 0.100 mmol, 1.00 eq) was suspended in a 16 % aq. HCl solution (3.75 mL, 
18.8 mmol, 188 eq). The mixture was heated to 95 °C for 1 h and was then concentrated by 
evaporation of the solvent at 120 °C to afford II.57 as a colorless powder. 
mp: 278 (dec.). 
1H NMR (600 MHz, D2O): δ = 5.65-5.46 (m, 20H), 4.37-4.25 (m, 10H), 3.35-2.99 (m, 16H), 
2.09-2.03 (m, 5H), 1.71-1.65 (m, 5H). 
13C NMR (100 MHz, D2O): δ = 156.4 (10C), 69.0 (10C), 50.0 (10C), 46.9 (2C), 44.5 (2C), 
36.5 (2C), 23.7 (2C), 22.7 (2C). 
IR (neat): ṽ
 max = 1730, 1474, 1184.  
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Decahydroxycucurbit[5]uril (II.12):[129] 
+2S28 H2 85 .C 6 h
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A suspension of cucurbit[5]uril (II.11, 1.00 g, 1.20 mmol, 1.00 eq) and K2S2O8 (4.69 g, 
17.3 mmol, 14.4 eq) in water (60.0 mL) was degassed by irradiation with ultrasound while 
bubbling argon through the mixture for 20 min. Then, the mixture was heated to 85 °C for 
6 h. Upon heating, a colorless solution was obtained, which became turbid after 90 min at the 
given temperature. The mixture was allowed to cool to room temperature, filtered and the 
filtrate was concentrated to a volume of 4.00 mL and cooled to 5 °C, by what K2SO4 
precipitated. The remaining liquor was separated and concentrated to give a colorless solid, 
which was purified by HPLC  (Varian Dynamax 250x21.4 mm Microsorb 60-8 C18 column 
equipped with a Dynamax HPLC guard column operating on a Varian PrepStar HPLC 
system; H2O/MeCN; 60.0 mL/min) to afford II.12 as a colorless solid (252 mg, 18 %). 
HPLC (gradient program: t = 0 min 1 % MeCN, t = 30 min 30% MeCN, t = 36 min 30 % 
MeCN, t = 40 min 100 % MeCN): Rt = 3.19 min. 
mp: 228 (dec.). 
1H NMR (600 MHz, D2O): δ = 5.32 (d, J = 15.9 Hz, 10H), 4.45 (d, J = 5.3 Hz, 10H). 
13C NMR (100 MHz, D2O): δ = 153.8 (10C), 93.7 (10C), 40.7 (10C). 
IR (neat): ṽ
 max = 1699, 1466, 1161.  
HRMS (ESI+):  m/z calcd. for C30H30KN20O20+:  1029.1582 [M+K]+;  
found:      1029.1581 [M+K]+. 
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Decamethoxypillar[5]arene (II.59):[133] 
 
To a solution of 1,4-dimethoxybenzene (II.58, 6.91 g, 50.0 mmol, 1.00 eq) in DCE (100 mL) 
was added paraformaldehyde (4.50 g, 150 mmol, 3.00 eq) in one portion. To this mixture was 
added dropwise boron trifluoride diethyl etherate (6.25 mL, 50.0 mmol, 1.00 eq) over the 
course of 10 min. The slightly green colored reaction mixture was heated to 30 °C for 30 min 
and was then allowed to cool to room temperature. The resulting black colored mixture was 
poured into methanol (500 mL) and the resulting precipitate was filtered off, washed with 
methanol (50.0 mL) and dried. The crude material was diluted with chloroform (150 mL) 
stirred for 15 min and filtered. The black filter cake was washed with hot chloroform 
(2 x 100 mL) and the combined filtrates were concentrated to a volume of 70.0 mL. Upon 
cooling to –25 °C, a precipitate formed, which was filtered off, washed with chloroform 
(10.0 mL) and acetone (100 mL) and dried. Concentrating the mother liquor and subsequent 
cooling to –25 °C afforded a second crop of product. II.59 was obtained as a grey colored 
solid (combined yield: 3.77 g, 50 %). 
TLC (CHCl3:MeOH 100:1): Rf = 0.43. 
mp: 248-256 °C. 
1H NMR (300 MHz, CDCl3): δ = 6.89 (s, 10H), 3.76 (s, 10H), 3.74 (s, 30H). 
13C NMR (75 MHz, CDCl3): δ = 150.4 (10C), 128.2 (10C), 113.3 (10C), 55.4 (10C), 29.3 
(5C). 
IR (neat): ṽ
 max = 1497, 1209, 1046.  
HRMS (ESI+):  m/z calcd. for C45H54NO10+:   768.3748 [M+NH4]+;  
found:      768.3743 [M+NH4]+. 
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Pillar[5]arene (II.13):[133] 
 
To a mixture of II.59 (3.77 g, 5.02 mmol, 1.00 eq) and chloroform (280 mL) was added 
dropwise boron tribromide (9.77 mL, 103 mmol,  20.5 eq). The mixture was stirred for 72 h at 
room temperature and was then diluted with ice water (200 mL). The resulting precipitate was 
filtered off and washed with a 0.500 M aq. HCl solution (50.0 mL) and chloroform (50.0 mL). 
The crude material was dried and then recrystallized from acetone (200 mL) to give 
pillar[5]arene (II.13) as a grey colored solid (3.05 g, 99 %). 
mp: ca. 385 °C (dec.). 
1H NMR (400 MHz, d6-acetone): δ = 7.93 (s, 10H), 6.65 (s, 10H), 3.57 (s, 10H). 
13C NMR (100 MHz, d6-acetone): δ = 146.6 (10C), 127.1 (10C), 117.4 (10C), 29.7 (5C). 
IR (neat): ṽ
 max = 3214, 1691, 1430, 1197.  
HRMS (ESI+):  m/z calcd. for C35H34NO10+:   628.2183 [M+NH4]+;  
found:      628.2175 [M+NH4]+. 
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Ethoxycarbonylmethoxy-substituted pillar[5]arene (II.14):[134] 
 
To a suspension of II.13 (2.42 g, 3.96 mmol, 1.00 eq) in THF (30.0 mL) and DMF (30.0 mL) 
was added sodium hydride (3.20 g, 127 mmol, 32.0 eq) and the mixture was stirred for 0.5 h 
at room temperature. Then, ethyl bromoacetate (II.60, 9.00 mL, 81.2 mmol, 20.5 eq) was 
added and the resulting mixture was heated to 60 °C for 48 h. After being allowed to cool to 
room temperature, the mixture was concentrated. The residue was diluted with CH2Cl2 
(100 mL) and water (100 mL). The organic layer was separated, dried over MgSO4 and 
purified by column chromatography (silica, DCM:acetone 100:0 → 95:5) to give II.14 as a 
colorless solid (699 mg, 12 %). 
TLC (CH2Cl2:acetone 95:5): Rf = 0.35. 
mp: 194 °C. 
1H NMR (400 MHz, CDCl3): δ = 7.04 (s, 10H), 4.55 (dd, J = 15.8, 7.9 Hz, 20H), 4.17-4.02 
(m, 20H), 3.86 (s, 10H), 0.96 (t, J = 7.1 Hz, 30H). 
13C NMR (100 MHz, CDCl3): δ = 169.3 (10C), 148.9 (10C), 128.7 (10C), 114.4 (10C), 65.7 
(10C), 60.8 (10C), 29.2 (5C), 13.8 (10C). 
IR (neat): ṽ
 max = 1760, 1191.  
HRMS (ESI+):  m/z calcd. for C75H94NO30+:   1488,5861 [M+NH4]+;  
found:      1488,5852 [M+NH4]+. 
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Carboxylic acid-substituted pillar[5]arene (II.15):[134] 
 
A mixture of II.14 (300 mg, 0.204 mmol, 1.00 eq), NaOH, (612 mg, 15.3 mmol, 75.0 eq), 
ethanol (30.0 mL) and water (30.0 mL) was heated to reflux for 24 h. Then, the reaction 
mixture was allowed to cool to room temperature and diluted with an aq. 2.00 M HCl solution 
(60.0 mL). The resulting precipitate was filtered off, washed with water (5 x 10.0 mL) and 
dried to afford II.15 as a colorless solid (194 mg, 80 %). 
mp: 300 °C. 
1H NMR (400 MHz, d6-DMSO): δ = 12.88 (s, br, 10H), 7.07 (s, 10H), 4.65 (d, J = 15.9 Hz, 
10H), 4.37 (d, J = 15.9 Hz, 10H), 3.70 (s, 10H). 
13C NMR (100 MHz, d6-DMSO): δ = 170.9 (10C), 148.9 (10C), 128.5 (10C), 114.7 (10C), 
65.5 (10C), 29.0 (5C). 
IR (neat): ṽ
 max = 1732, 1499, 1203.  
HRMS (ESI+):  m/z calcd. for C55H54NO30+:   1208.2731 [M+NH4]+;  
found:      1208.2723 [M+NH4]+. 
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1,4-bis(2-bromoethoxy)benzene (II.62):[135] 
 
To a mixture of 1,4-bis(2-hydroxyethyl)benzene (II.61, 10.0 g, 50.4 mmol, 1.00 eq) and 
triphenylphosphine (31.5 g, 120 mmol, 2.38 eq) in acetonitrile (300 mL) was added carbon 
tetrabromide (39.8 g, 120 mmol, 1.00 eq) over the course of 5 min in small portions at 0 °C. 
The reaction mixture was allowed to warm to room temperature and was stirred for another 
4 h at this temperature. Then, 200 mL of ice water was added and the resulting precipitate was 
filtered off, washed with a mixture of methanol:water (3:2, 50.0 mL) and dried. The crude 
product was recrystallized by dilution in methanol (500 mL), heating to reflux for 15 min, hot 
filtration and cooling the filtrate to −25 °C for 16 h. II.62 was obtained as colorless flakes 
(13.1 g, 81%). 
TLC (CH2Cl2:Hex 2:1): Rf = 0.51. 
mp: 102 °C. 
1H NMR (300 MHz, CDCl3): δ = 6.86 (s, 4H), 4.42 (t, J = 6.3 Hz, 4H), 3.61 (t, J = 6.3 Hz, 
4H). 
13C NMR (75 MHz, CDCl3): δ = 152.8 (2C), 116.1 (4C), 68.7 (2C), 29.2 (2C). 
IR (neat): ṽ
 max = 1505, 1216.  
HRMS (EI+):  m/z calcd. for C10H12Br2O2+:  321.9204 [M]+;  
found:      321.9201 [M]+. 
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Bromoethoxy-substituted pillar[5]arene (II.63)[135] and bromoethoxy-substituted 
pillar[6]arene (II.64) 
 
To a solution of II.62 (8.43 g, 26.0 mmol, 1.00 eq) in DCE (500 mL) was added 
paraformaldehyde (781 mg, 26.0 mmol, 1.00 eq) in one portion. To this mixture was added 
dropwise boron trifluoride diethyl etherate (3.25 mL, 26.0 mmol, 1.00 eq) over the course of 
10 min. The slightly green colored reaction mixture was stirred for 3 h and was then 
concentrated to a grey powder. Purification by column chromatography (silica, 
CH2Cl2:Hex 1:1 → 2:1) gave II.63 as a colorless solid (4.25 g, 49 %). Crystals suitable for X-
ray crystallography were grown by slow evaporation of a chloroform solution containing 
II.63. 
TLC (CH2Cl2:Hex 2:1): Rf = 0.44. 
mp: 95 °C. 
1H NMR (300 MHz, CDCl3): δ = 6.91 (s, 10H), 4.22 (t, J = 5.7 Hz, 20H), 3.84 (s, 10H), 3.62 
(t, J = 5.7 Hz, 20H). 
13C NMR (75 MHz, CDCl3): δ = 149.7 (10C), 129.1 (10C), 116.1 (10C), 69.0 (10C), 30.6 
(10C), 29.4 (5C). 
IR (neat): ṽ
 max = 1494, 1201.  
HRMS (ESI−):  m/z calcd. for C55H60Br11O10−:  1748.5204 [M+Br]−;  
found:      1748.5956 [M+Br]−. 
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As a second product, II.64 was obtained, which could be isolated by the concentration of later 
fractions in the chromatographic purification step. Crystals suitable for X-ray crystallography 
were obtained by slow evaporation of an acetone solution containing II.64. 
TLC (CH2Cl2:Hex 2:1): Rf = 0.22. 
mp: 110 °C. 
1H NMR (300 MHz, CDCl3): δ = 6.78 (s, 12H), 4.16 (t, J = 5.9 Hz, 24H), 3.87 (s, 12H), 3.55 
(t, J = 5.9 Hz, 24H). 
13C NMR (75 MHz, CDCl3): δ = 150.2 (12C), 128.5 (12C), 115.8 (12C), 69.0 (12C), 30.6 
(6C), 30.2 (12C). 
IR (neat): ṽ
 max = 1496, 1404, 1208.  
HRMS (ESI−):  m/z calcd. for C66H72Br13O12-:  2082.4408 [M+Br]−;  
found:      2082.5112 [M+Br]−. 
 
Trimethylammonium bromide-substituted pillar[5]arene (II.17):[135] 
 
To a solution of II.63 (250 mg, 0.150 mmol, 1.00 eq) in ethanol (12.5 mL) was added a 
trimethylamine solution (33 % in ethanol, 1.61 mL, 5.95 mmol, 40.0 eq) and the mixture was 
heated to reflux for 16 h. Then, the resulting mixture was allowed to cool to room 
temperature, concentrated and diluted with water (5.00 mL). The resulting slurry was filtered 
and the filtrate was concentrated to give II.17 as a colorless solid (339 g, 100 %). 
mp: 100 °C. 
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1H NMR (400 MHz, D2O): δ = 6.81 (s, 10H), 4.31 (s, 20H), 3.79 (s, 10H), 3.66 (s, 20H), 3.08 
(s, br, 90H). 
13C NMR (100 MHz, D2O): δ = 149.3 (10C), 129.8 (10C), 116.4 (10C), 64.8 (10C), 63.4 
(10C), 53.9 (30C), 29.5 (5C). 
IR (neat): ṽ
 max = 3398, 1481, 1200.  
HRMS (ESI+):  m/z calcd. for C85H150Br8N10O102+:  1055.2466 [M−2Br]2+;  
found:      1055.2466 [M−2Br]2+. 
 
Azidoethoxy-substituted pillar[5]arene (II.65):[136] 
 
To a solution of II.63 (1.00 g, 0.595 mmol, 1.00 eq) in DMF (50.0 mL) was added sodium 
azide (1.95 g, 30.0 mmol, 50.5 eq) in one portion and the mixture was heated to 100 °C for 
16 h. Then, the resulting mixture was allowed to cool to room temperature and was poured 
into ice water (800 mL). The resulting precipitate was filtered off, washed with water 
(200 mL) and dried to give II.65 as a colorless solid (775 mg, 100 %). 
TLC (CH2Cl2:Hex 2:1): Rf = 0.15. 
1H NMR (300 MHz, CDCl3): δ = 6.83 (s, 10H), 4.00 (t, J = 4.8 Hz, 20H), 3.84 (s, 10H), 3.54 
(t, J = 4.8 Hz, 20H). 
13C NMR (75 MHz, CDCl3): δ = 149.9, (10C), 128.9 (10C), 115.7 (10C), 67.5 (10C), 50.9 
(10C), 29.7 (5C). 
IR (neat): ṽ
 max = 2086, 1497, 1201.  
HRMS (ESI+):  m/z calcd. for C55H62N30O11+:  1318.5214 [M+H2O]+;  
found:      1318.5432 [M+H2O]+. 
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Aminoethoxy-substituted pillar[5]arene (II.16):[136] 
 
A mixture of II.65 (1.26 g, 0.968 mmol, 1.00 eq), Pd/C (10 % Pd, 100 mg, 0.968 mmol, 
1.00 eq) and methanol (60.0 mL) was stirred at 50 °C in a pressure apparatus under hydrogen 
atmosphere at 4 bar for 24 h. Then, the mixture was allowed to cool to room temperature and 
the pressure was released to add another portion of Pd/C (10 % Pd, 100 mg, 0.968 mmol, 
1.00 eq). The mixture was then again agitated at 50 °C under a 4 bar hydrogen atmosphere for 
24 h. This procedure was repeated three times until a total reaction time of 96 h was reached 
and a total of 400 mg Pd/C had been added. The reaction mixture was allowed to cool to room 
temperature, filtered through a short pad of celite and concentrated to give II.16 as a colorless 
solid (911 mg, 91 %). 
mp: 100 °C. 
1H NMR (400 MHz, CD3OD): δ = 6.74 (s, 10H), 4.79 (s, br, 20H), 3.84-3.68 (m, 30H), 2.91 
(t, J = 5.2 Hz, 20H). 
13C NMR (100 MHz, CD3OD): δ = 149.9 (10C), 128.8 (10C), 115.0 (10C), 70.3 (10C), 40.8 
(10C), 29.2 (5C). 
IR (neat): ṽ
 max = 1496, 1403, 1204.  
HRMS (ESI+):  m/z calcd. for C55H81N10O10+:  1041.6137 [M+H]+;  
found:      1041.6129 [M+H]+. 
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CHAPTER III: SELF-ASSEMBLY OF HIGHLY 
SYMMETRIC MOLECULES 
3.1 Introduction 
3.1.1 Appearance of the Platonic Solids in Daily Life and in Science 
 
Highly symmetric structures have fascinated mankind for thousands of years and their 
mathematical and geometrical description has been one of the earliest scientific tasks, which 
has attracted genii like Pythagoras, Plato, Euclid and Archimedes.  
Especially the Platonic solids stand out due to their clarity and aesthetical appeal 
(Figure III.1). The Platonic solids are defined as convex polyhedra with faces of identical 
shape in the vertices of which the same number of faces and edges converge. Thus, they 
include the tetrahedron, the octahedron, the cube, the icosahedron and the dodecahedron.[139] 
 
Figure III.1: The Platonic solids.[139] 
 
These highly symmetric polyhedra were not only subject of abstract scientific research, but 
also played a big role in other cultural areas such as arts and religion. The Pythagoreans, for 
example, idolized the Platonic solids as sacred ideas, in which the cosmos itself is 
displayed.[139] 
 In Scotland, archaeologists found crenated stone objects with the geometry of the Platonic 
solids which they called “carved stone balls” (Figure III.2). They have been dated between 
5000−2500 BC and their exact purpose is to date unknown. [140] 
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Figure III.2: The carved stone balls in the Ashmolean Museum, Oxford.[139] 
 
The comprehensive understanding of geometry that is reflected in these ancient objects is 
astounding. The carved stone balls not only represent all five Platonic solids, but by the way 
they were crenated also picture the inscribed polar coordinate Platonic solid. For example, the 
cube which is depicted on Figure III.2 on the top left side shows meridians, the cutting points 
of which trace the octahedron which is inscribed into it. 
The Platonic solids are, however, not a matter exclusively found in ancient arts, but are also 
featured in contemporary works. The dodecahedron was used as a stylistic device for 
surrealism in one of Salvador Dali´s most popular compositions “The sacrament of the last 
supper”. With its defined geometry based on pentagons, the Platonic solid underlined that the 
composition was designed using the golden ratio (Figure III.3). 
 
Figure III.3: Salvador Dali: “The sacrament of the last supper” (1955).[141] 
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The fascination for these geometric objects had also advanced into early science. Plato, for 
example, employed them for his elemental theory, in which he associated the classical 
elements to each Platonic solid (fire to the tetrahedron, earth to the cube, water to the 
icosahedron, air to the octahedron and ether to the dodecahedron).[139] Johannes Kepler, on the 
other hand, attempted to explain the proportions of the natural world, or more specifically of 
the solar system, by associating spheres of inscribed platonic solids to the planetary orbits, 
which in context with his theory of the harmony of the world attracted huge interest 
(Figure III.4).[142] 
          
Figure III.4: Kepler´s model of the solar system: a) schematic 2D drawing; b) picture of a 3D model.[139] 
 
The aforementioned geometries also play a huge role in Nature and are therefore topic of 
current research. Viruses, for example, build their capsids by self-assembly of smaller 
proteins to spherical structures with icosahedral geometry. An X-ray structure and an artwork 
of the cowpea mosaic virus are shown exemplarily in Figure III.5.[143] 
        
Figure III.5: Structure of the cowpea mosaic virus: a) Cryo-electron microscopy picture; b) artwork model.[143] 
 
a) b) 
a) b) 
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Consequently, the self-organization of a disordered system of complementary small molecules 
that recognize each other through non-covalent interactions to form supramolecular structures 
without external guidance can be interpreted as a bio-inspired method. In fact, the self-
assembly of such “programmed” molecules is a huge field of research, and the number of 
reported structures made by this approach progressively increases every year. This method 
allows to access supramolecular structures in a single step starting from simple precursors. 
The structure of these supramolecular frameworks can be “coded” in the design of these 
simple precursors with defined reactive groups such as metals and ligands.[144]   
The self-assembly approach to access metal-based molecules offers an alternative to the 
classical synthetic route. Predetermined building blocks with defined distances and angles 
between their reactive groups assemble in a highly convergent way under thermodynamic 
conditions and thus require fewer steps than the corresponding covalent synthesis. The 
kinetically labile coordinative bonds induce a self-healing process by forming an equilibrium 
between the constituents and the final product by a number of association and dissociation 
steps and therefore generate relatively defect-free structures, representing the thermodynamic 
minimum of this process.[145] Nature has been using the same principals of non-covalent 
binding for the construction of various cell components, such as pentameric ion channels, 
microtubules, ribosomes, mitochondria and chromosomes, which mostly use hydrogen 
bonding to form specific structures.  
The synthesis of highly symmetric chemical structures and especially of those with the 
geometry of the Platonic solids has been an important task in organometallic chemistry. 
Except for the challenge in synthesis design from a chemical point of view, interest lies also 
in the field of biology, e.g. for the translocation of drugs across membranes and material 
science, e.g. construction of devices on molecular level.[146] These highly symmetric metal-
organic structures have been termed metal-organic polyhedra.[147] 
The self-assembly of a dodecahedron or an icosahedron represents an especially intriguing 
and challenging task and only few examples of such metal-organic polyhedra have been 
reported to date. One such example was disclosed by the group of Stang and coworkers who 
succeeded in the synthesis of a metal-organic dodecahedron via an edge-directed approach 
(Figure III.6).[148] 
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Figure III.6: Stang´s edge-directed approach towards a dodecahedral metal-organic polyhedron: a) artwork 
model; b) chemical structure of the molecules representing the vertices (III.1) and edges (III.2); c) TEM image of 
the reaction product.[148] 
 
More specifically, reacting tri(4′-pyridyl)methanol (III.1) with linear bidentate unit III.2 
resulted in the formation of a metal-organic polyhedron with dodecahedral geometry. The 
reaction product was i.a. characterized by transition electron microscopy, confirming the size 
and thus the structure of the proposed reaction product.[148] 
Another example of a metal-based structure featuring the dodecahedron as geometrical unit 
was disclosed by the group of Wright, who reported a metal-organic framework structure of 
[Na46pccp48][Na]2[MeNO2]x[Et2O]y (Figure III.7). 
 
Figure III.7: Artwork model of the metal-organic framework structure of [Na46pccp48][Na]2[MeNO2]x[Et2O]y (CCDC-
code: 822358).[149] 
 
Slow crystallization by diffusing diethyl ether into a MeNO2 solution of Na pccp (III.14) 
resulted in the formation of crystals that contained a metal-organic framework, in which 
sodium was coordinated in a fashion that polyhedra with dodecahedral geometry were 
formed. Interestingly, the framework was found to be highly labile and rapidly lose solvent to 
interconvert to solvent-free Na pccp (III.14).[149] 
A striking example for an assembled icosahedron from UO22+ cations and carboxylic acid-
substituted calix[5]arenes was described by deMendoza and coworkers in 2012. Slow 
a) b) c) 
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crystallization in the presence of a weak base such as pyridine resulted in the formation of the 
highly symmetric polyhedron (Figure III.8).[150] 
 
Figure III.8: Icosahedral assembly of calix[5]arenes and uranyl cations (CCDC-code: 856284).[150] 
 
The capsules consist of 12 calix[5]arenes building the vertices and 20 uranyl units forming the 
faces of the polyhedron. Furthermore, it was speculated that the uranyl oxygens positioned at 
the faces interact with guests encapsulated in the inside of the cages, thus allowing for 
interesting host-guest chemistry. 
 
3.1.2 Project Background and Aims  
 
Having appropriate fivefold symmetric building blocks in hands (vide supra, Chapter II, 
Section 2.2.2), it appeared consequent to investigate their coordination chemistry and their 
potential to compose highly symmetric polyhedral structures comprising the highest 
symmetry group Ih.[151]  Especially, structures of dodecahedral geometry were of high interest, 
since they are composed of 12 fused five-membered rings.  
In order to design appropriate metal-containing building blocks to form the organo-metallic 
coordination polyhedron, the exact geometry within the dodecahedron had to be investigated. 
Important angles are illustrated in Figure III.9. 
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Figure III.9: Angles in a dodecahedron: a) 108°; b) 90°; c) 87°. 
 
The angle merging the fivefold symmetric faces and the threefold symmetric vertices adopts a 
value of approximately 87°. Accordingly, metal units would have to consist of complexes 
capable to coordinate ligands in an 87° angle (Figure III.10). Inspired by modeling studies on 
silver pccp salts[152] and the coordination framework of Na pccp reported by Wright and 
coworkers (vide supra, Section 3.1.1, Figure III.7),[149] pccp salts were chosen as the 
molecules to form the faces of the dodecahedron. Thus, this approach represents a face-
directed self-assembly of the highly symmetric structure. 
 
Figure III.10: Assembled dodecahedron following a face-directed approach. 
 
Facially substituted octahedral structures seemed an obvious choice as threefold symmetric 
building blocks. One such example is [(CO)3Cr(NCMe)3] (III.4), which had already been 
shown to form stable complexes with anionic ligands.[153] Based on these building blocks, 
preliminary model studies were carried out using a PyMol code provided by Kateri DuBay in 
the Trauner group.[154] Molecules with C5 and C3 symmetry were placed to the vertices and 
faces of a dodecahedron and its dual icosahedron in order to assess whether these are 
geometrically able to assemble into the highly symmetric polyhedra (Figure III.11).  
a) b) c) 
108° 
90° 87° 
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Figure III.11: Model of a dodecahedral arrangement of [Cr(CO)3]20[pccp]1212−: a) Full view; b) zoom on a metal 
center, showing the 87° angle. 
 
Pleasingly, the building blocks were found to be suitable to assemble a dodecahedral structure 
according to the face-directed approach. Distances and angles of the chosen building blocks 
seem to indeed “encode” the information required to assemble dodecahedral frameworks.  
Hence, synthetic studies on the depicted self-assembly were started, the results of which are 
described in the next section. 
 
3.2 Results and Discussion 
3.2.1 Synthetic Studies on the Self-Assembly of a Molecular Dodecahedron 
 
With fivefold symmetric building block Et4N pccp (III.3) already in hands (vide supra, 
Chapter II, Section 2.2.2, Scheme II.5), the synthesis of the transition metal building blocks 
was approached first. The synthesis of threefold symmetric chromium complex III.4 was 
completed following a literature procedure (Scheme III.1).[155]  
 
Scheme III.1: Synthesis of tris(acetonitrile)tricarbonylchromium(0) (III.4). 
a) b) 
87° 
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Heating chromium hexacarbonyl (III.5) in acetonitrile resulted in the formation of facially 
substituted acetonitrile complex III.4. Compound III.4 could be prepared on large scale, but 
had to be stored and weighed in a glove box due to its high sensitivity to air and its 
pyrophoric nature. 
With the desired metal complex and the ligand in hands, first experiments towards a 
dodecahedral self-assembly were carried out. Acetonitrile was the solvent of choice for the 
reaction. Specifically, it was speculated to facilitate the formation of an equilibrium between 
the constituents and the product, thus enabling self-healing under thermodynamic conditions. 
Additional experiments were carried out in the presence of buckminster fullerene (III.6), 
which was envisioned to act as a template for the desired self-assembly. Furthermore, the 
metal complex was found to slowly decompose if heated in oxygen-containing solvents such 
as acetone. Products were characterized by IR spectroscopy, dynamic light scattering or single 
crystal X-ray crystallography, as appropriate. A selection of conditions employed for the 
assembly of III.3 and III.4 is summarized in Table III.1.  
 
  
 
 
Entry Additive Solvent Temperature Time Yield Observation 
1 - MeCN reflux 16 h - starting material 
2 -  MeCN r.t. 6 d - starting material 
3 - MeCN reflux 6 d - complex mixture 
4 - THF reflux 48 h - complex mixture 
5 - DMSO 100 °C 48 h - complex mixture 
6 C60 (III.6) o-C6H4Cl2 reflux 96 h - starting material 
Table III.1: Selected conditions for the attempted self-assembly of III.3 and III.4. 
 
III.6
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When a mixture of III.3 and III.4 was heated in acetonitrile for 16 h or was stirred at room 
temperature for six days, no reaction was observed and starting material was recovered 
(Table III.1, Entries 1 and 2). If the temperature was increased to reflux while being stirred for 
six days, a complex mixture of products was formed (Table III.1, Entry 3). Similar results 
were obtained when the reaction was carried out in THF or DMSO as solvent (Table III.1, 
Entries 4 and 5). When heating a mixture of III.3, III.4 and buckminster fullerene (III.6) in 
1,2-dichlorobenzene for four days and subsequently cooling the reaction mixture, starting 
material was recovered (Table III.1, Entry 6). In the course of purification efforts, an 
unprecedented solvate structure of III.6 was obtained (Figure III.12). A full screening table of 
conditions employed for the self-assembly can be found in Appendix 8 (Table App.8a). 
 
Figure III.12: View along the b-axis in the unit cell of III.6∙3C6H4Cl2 (based on preliminary data). 
 
It was speculated that results could be improved, if chromium was replaced by other group 6 
transition metals such as molybdenum and tungsten (Scheme III.2). A tungsten 
3-thiopheneacetonitrile complex III.12 had been shown to be a stable and versatile reagent 
and was thus of special interest as building block for the self-assembly.[156]  
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Scheme III.2: Facially substituted octahedral group 6 transition metal complexes prepared for the dodecahedral 
self-assembly with III.3. 
 
Analogous to the synthesis of III.4, III.8 and III.10 were prepared by heating the 
corresponding hexacarbonyl complexes III.7 and III.9 in acetonitrile.[155] In situ generated 
III.10 was further converted into III.12 by addition of 3-thiopheneacetonitrile (III.11) to a 
previously heated acetonitrile solution of III.9.[156] 
These building blocks were subjected to the same reaction conditions as described for III.4, 
but no complexes with III.3 as a ligand were ever observed and either starting material was 
recovered or complex mixtures were obtained (for detailed screening tables see Appendix 8, 
Tables App.8b, App.8c, App.8d). However, in the course of these studies and extensive 
purification efforts, crystalline material suitable for single crystal X-ray crystallography was 
obtained and thus the crystal structure of starting pccp salt III.3 was elucidated for the first 
time (Figure III.13). 
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Figure III.13: Cc-structure of III.3: a) single ion pair; b) illustration of two unit cells, view along the c-axis. 
 
Compound III.3 crystallizes in a primitive monoclinic unit cell in the space group Cc and 
shows a very similar packing as HNEt3 pccp (III.13).[126] The pccp anions form layers, which 
are stacking along the c-axis in a staggered fashion. In the course of extensive purification 
efforts, a second isomorph of III.3 could also be obtained (Figure III.14). 
 
Figure III.14: View along the c-axis of the Pc-isomorph of III.3. 
 
The second isomorph crystallizes in the space group Pc and shows a distinctly different 
packing, resulting from linearly stacked pccp units, which appear in addition to the staggered 
units as observed in the Cc structure. 
At this point, further pccp salts as starting materials were explored. Being aware that the self-
assembled dodecahedron would accumulate 12 negative charges and would thus experience 
considerable coulomb repulsion, counter ion effects were speculated to play a crucial role in 
the reaction. This assumption has also been supported by preliminary DFT calculations (vide 
infra, Appendix 7). When reaction partners for the self-assembly and the corresponding 
transition metal unit carrying pccp as ligand were optimized in the absence of solvent and 
counter ions, this substitution process was found to be endothermic. However, the 
accumulated charges can be neutralized by forming tight ion pair salts of pccp. In order to 
a) b) 
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retain the fivefold symmetry, a symmetry-matched counter ion would be required in the 
envisioned system such as the ferrocenium cation or the decamethylferrocenium cation. The 
resulting “neutral” dodecahedron is depicted in Figure III.15. 
 
Figure III.15: Proposed self-assembled dodecahedron with symmetry-matched counter ion. 
 
Ferrocenium salts were readily available from the corresponding ferrocenes. The ferrocenium 
pccp salts were prepared by simple salt metathesis. In order to evaluate the role of the counter 
ion for the self-assembly in more detail, in addition to these new pccp salts several more 
known pccp salts were prepared (Scheme III.3).  
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Scheme III.3: Structure and syntheses of pccp salts employed in the self-assembly approach. 
 
In addition to III.13 and III.14, the synthesis of which has already been described before 
(vide supra, Chapter II, Section 2.2.2), silver salt III.15 was synthesized, following a 
literature-known procedure.[152] Treatment of III.3 with silver nitrate in methanol resulted in 
the precipitation of III.15. When III.3 was stirred in the presence of ferrocenium 
tetrafluoroborate or decamethyl ferrocenium tetrafluoroborate, respectively, the corresponding 
ferrocenium pccp salts III.16 and III.17 formed smoothly and could be isolated in good 
yields. Interestingly, in preliminary NMR studies no 13C signals of the pccp counter ion in salt 
III.16 were observed. In contrast, the 13C signals in a NMR solution of identical concentration 
were observed in the case of salt III.17. This finding was speculated to rely on a close 
proximity of pccp to the paramagnetic metal in solution, which might indicate III.16 to exist 
as a tight ion pair. The crystal structure of III.17 is shown in Figure III.16. 
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Figure III.16: Crystal structure of III.17: a) Close view on two ion pairs; b) view along the a-axis. 
 
Compound III.17 crystallizes in the orthorhombic space group Cmc21. Ferrocenium and pccp 
form a close ion pair (dpccp-cp* = 3.3 Å) with C5v symmetry, which arranges in an orthogonal 
orientation towards vicinal pairs. Pccp resides directly over the adjacent ferrocene ring in a 
staggered configuration in respect to the substituents. 
These new pccp salts were subjected to a large number of conditions to self-assemble with 
threefold symmetric transition metal complexes III.4, III.8, III.10 and III.12 (vide supra, 
Scheme III.2, for detailed screening tables see Appendix 8, Tables App.8a-App.8i). 
Unfortunately, no formation of transition metal complexes with pccp was observed. However, 
when III.17 was reacted with III.4, formation of an interesting product was found (Scheme 
III.4). 
 
Scheme III.4: Synthesis of the unusual metallocene (C5Me5)2Cr0.33Fe0.67C10N5 (III.18). 
 
When a mixture of III.17 and III.3 was heated in acetone for 24 h, formation of a yellow 
solid was observed, which was identified as decamethylferrocene. The resulting green 
solution was separated and subjected to fractional crystallization to afford a green crystalline 
a) b) 
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solid, which was identified as (C5Me5)2Cr0.33Fe0.67C10N5 (III.18). The structure of III.18 was 
confirmed by X-ray crystallography (Figure III.17).  
      
Figure III.17: Crystal structure of III.18: a) Close view on two ion pairs; b) view along the ac-axis, emphasizing the 
linear stacking, hydrogens removed for clarity. 
 
The compound crystallizes in a monoclinic crystal system in the space group P21/c. Pccp and 
the metallocene form ion pairs with staggered conformation. Discrete ion pairs arrange 
towards each other in a shifted but linear fashion, thus generating infinite linear metallocene 
pccp rods appearing as coated “polydecker sandwiches”. 
In subsequent attempts, further non-group 6 threefold symmetric transition metal complexes 
were investigated for the self-assembly (Scheme III.5). In order to be able to perform the 
self-assembly in water as solvent, which due to its high dielectric coefficient was speculated 
to facilitate the assembly of charged polyhedra, complexes were employed that were known 
to be air and water stable. 
a) b) 
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Scheme III.5: Synthesis of further threefold symmetric building blocks. 
 
Cobalt(II)nitrate hexahydrate (III.19) was stirred in the presence of TACN trihydrochloride 
(III.20), sodium nitrate and a buffer of sodium acetate and sodium hydroxide while air was 
bubbled through the reaction mixture to afford cobalt TACN complex III.21.[157] The nitrates 
were exchanged with chlorides by heating III.21 in an aqueous HCl solution to provide 
III.22.[157] Furthermore, rhenium aqua complex III.24 was prepared by heating a 
rheniumpentacarbonyl bromide III.23 in water.[158] As a second threefold symmetric rhenium 
carbonyl complex, tribromide III.25 was synthesized by heating a mixture of III.23 and 
tetraethylammonium bromide in diglyme for 5 h.[159] In addition, experiments were carried 
out with commercially available ruthenium complex III.26. 
These new complexes were subjected to a multitude of conditions to trigger a self-assembly 
and to form the corresponding highly symmetric structures (for detailed screening table see 
Appendix 8, Tables App.8e-App.8i). Unfortunately, these attempts remained fruitless and no 
complexes of threefold symmetric transition metal building blocks with pccp as ligand were 
ever observed. However, in the course of these studies, formation of tetranuclear, tetrahedral 
rhenium complex III.27 was found.[160] An example of a reaction in which III.27 was formed 
is shown in Scheme III.6.  
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Scheme III.6: Formation of tetranuclear rhenium complex III.27. 
 
When a mixture of rhenium aqua complex III.24 and sodium pccp (III.14) was heated in 
DMF to 80 °C for 24 h and was subsequently subjected to water-diffusion into the reaction 
mixture for 14 days, a colorless solid formed, which was identified by X-ray crystallography 
to be tetranuclear rhenium complex III.27. Compound III.27 crystallized as a DMF/water 
solvate, which is depicted in Figure III.18. 
 
      
Figure III.18: Crystal structure of III.27∙3H2O∙DMF: a) Single unit; b) view along the b-axis of the unit cell, water 
and acetone molecules are shown. 
 
The compound crystallized in the triclinic crystal system in the space group P3221, in which 
each unit cell includes three units of III.27·3H2O·DMF. The X-ray structure revealed the 
tetranuclear rhenium core unit to possess Td symmetry. In the course of further studies to 
access highly symmetric structures, a second X-ray structure containing III.27 was obtained 
(Figure III.19). 
 
a) b) 
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Figure III.19: Crystal structure of III.27∙dioxane∙acetone: a) Close view; b) view along the c-axis. 
 
In this solvate structure, which crystallizes in the tetragonal crystal system in the space group 
P42212, dioxane forms a hydrogen bond to the µ-OH moiety in III.27 (d(O−O) = 2.6 Å). The 
unit cell contains four units of  III.27·dioxane·acetone. 
Pccp has been described in the literature as weakly coordinating ion,[161] which could possibly 
explain the fact that no metal pccp coordination was observed in the above mentioned 
attempts. Although some few metal pccp complexes have been described in literature,[162] the 
formation of coordinative bonds with the pccp ligand seems to be limited to highly specific 
systems.  
In order to further investigate the face-directed approach towards highly symmetric structures, 
some preliminary experiments with other fivefold symmetric ligand nodes such as sodium 
croconate (III.28) were carried out. However, these studies did not lead to formation of highly 
symmetric complexes. Interestingly, when III.28 was reacted with cobalt TACN complex 
III.21 and the mixture was exposed to air, yellow crystals of a new compound formed 
(Scheme III.7). 
 
Scheme III.7: Synthesis of cobalt oxalate complex III.29. 
 
a) b) 
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A mixture of cobalt TACN complex III.21, sodium croconate III.28 and water was heated to 
reflux for 72 h. Subsequently, the flask was opened and allowed to stand for 14 days at room 
temperature, upon which time oxalate complex III.29 was isolated as small yellow crystals as 
a result of oxidation by oxygen (Figure III.20). 
      
Figure III.20: X-ray structure of [Co(TACN)(NO2)(C2O4)] complex (III.29). 
 
The compound crystallizes in the orthorhombic crystal system in the space group Pbca. The 
unit cell contains four molecules of III.29, which form an intermolecular hydrogen bond 
between an N-H moiety within the TACN ligand and a nitrite oxygen (dN−O = 2.9 Å).  
At this point, it was envisioned to synthesize further threefold symmetric and fivefold 
symmetric building blocks and to investigate alternative reaction pathways for the self-
assembly. The results that were gathered in these studies are summarized in the next section. 
 
 
 
 
 
 
 
 
a) b) 
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3.2.2 Summary, Conclusions and Outlook 
 
In summary, over 150 conditions for the self-assembly of threefold symmetric transition 
metal complexes with pccp as ligand were screened. The formation of highly symmetric 
polyhedra with dodecahedral geometry remained unsuccessful. After extensive experimental 
efforts, pccp does not seem to be an appropriate ligand for the metals that were chosen for the 
self-assembly.  
In the course of these studies, the syntheses and crystal structures of new pccp salts with 
fivefold symmetric counter ions were discovered. In addition, two crystal structures of III.3 
could be elucidated for the first time. In some cases, formation of tetrahedral tetranuclear 
rhenium complex III.27 was observed, which comprises the structure of the tetrahedron and 
thus the geometry of a Platonic solid.  
Future work will have to consist of the development of new compounds with fivefold or 
threefold symmetry, respectively, which have the potential to self-assemble. For example, it 
can be speculated that decahydroxycucurbit[5]uril (III.30) can form a borate-ester with 
threefold symmetric boronic acid building blocks such as III.31 and thus assemble to the 
desired dodecahedral framework (Scheme III.8).  
 
Scheme III.8: Potential reaction partners III.30 and III.31 for a self-assembly. For modeling, known compound 
III.32 (CCDC code: 204942) was used. 
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A model of a hypothetical dodecahedral assembly of III.30 with III.32 is depicted in 
Figure III.21. 
 
 
Figure III.21: Model of a dodecahedral arrangement of a threefold symmetric boronic acid-substituted building 
block III.32 and decahydroxycucurbit[5]uril (III.30). 
 
Overall, the synthetic approaches towards highly symmetric polyhedra gave valuable insights 
in the coordination chemistry of pccp and yielded a number of new crystal structures of 
known compounds as well as of unreported compounds. The hunt for the crystal structure of a 
polyhedron with dodecahedral geometry will continue in the Trauner laboratories. 
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3.3 Experimental Section 
 
General experimental details: 
Unless specified otherwise, all reactions were performed with magnetic stirring under an 
atmosphere of argon and in oven-dried glassware. Isolated products were dried on a high 
vacuum line at a pressure of 10–2 mbar using an ATB-Loher oil pump by Flender. 
Dimethylformamide (DMF), methanol (MeOH), acetonitrile (MeCN), acetone (Me2CO) and 
bis(2-methoxyethyl) ether (diglyme) were purchased from Acros Organics as 'extra dry' 
reagents under inert gas atmosphere and over molecular sieves. All other reagents were 
purchased from commercial sources and used without further purification. Petroleum ether is 
referred to as hexanes and relates to fractions of isohexanes, which boil between 40 °C and 
60 °C. If appropriate, reactions were monitored by TLC using E. Merck 0.25 mm silica gel 
60 F254 glass plates. TLC plates were visualized by exposure to UV light (254 nm) and 
subsequent treatment with an aqueous solution of CAM, an aqueous solution of potassium 
permanganate, an acidic solution of vanillin, a solution of ninhydrin or a mixture of silica and 
finely grounded iodine, followed by heating the plate with a heat gun. If appropriate, reactions 
were additionally monitored by Proton nuclear magnetic resonance (1H-NMR) using a Varian 
200 spectrometer or LCMS using an Agilent Technologies 1260 infinity machine equipped 
with an Agilent ZORBAX Eclipse Plus C18 reversed phase analytical 4.6 mm x 150 mm 
column. Yields refer to isolated and spectroscopically pure compounds. 
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Instrumentalization: 
Infrared (IR) spectra were recorded on a Perkin Elmer Spectrum BX II (FTIR System), 
equipped with an attenuated total reflection (ATR) measuring unit. IR data is reported in 
frequency of absorption (cm−1).  
UV/VIS spectra were recorded on a Cary 500 8.01 spectrophotometer made by Varian. 
Samples were measured neat without thermostatting in a range of 200 nm to 2600 nm with a 
scan rate of 600 nm min−1. UV/VIS data is reported in wavelength (nm). 
Proton nuclear magnetic resonance (1H-NMR) spectra were recorded on a Varian 300, Varian 
400, Inova 400 or Varian 600 spectrometer. Chemical shifts ( scale) are expressed in parts 
per million (ppm) and are calibrated using residual protic solvent as an internal reference 
(CDCl3:  = 7.26 ppm, (D3C)2CO:  = 2.05 ppm, (CD3)2SO:  = 2.50 ppm, 
D2O = 4.79 ppm).[95] Unless noted otherwise, data was recorded at 27 °C. Data for 1H-NMR 
spectra are reported as follows: chemical shift ( ppm) (multiplicity, coupling constants (Hz), 
integration). Couplings are expressed as: s = singlet, d = doublet, t = triplet, q = quartet, 
m = multiplet, br = broad, app = apparent or combinations thereof. Carbon nuclear magnetic 
resonance (13C-NMR) spectra were recorded on the same spectrometers at 75, 100 and 
150 MHz, respectively. Carbon chemical shifts ( scale) are also expressed in parts per 
million (ppm) and are referenced to the central carbon resonances of the solvents (CDCl3: 
 = 77.16 ppm, (D3C)2CO:  = 29.84 ppm, (CD3)2SO:  = 39.52 ppm).[95] 
Mass spectroscopy (MS) experiments were performed on a Thermo Finnigan MAT 95 
(electron ionization, EI), on a Thermo Finnigan LTQ FT (electrospray ionization, ESI) or on a 
Jeol JMS-700 (fast atom bombardment, FAB) instrument. 
Melting points were measured on an EZ-Melt automated melting point apparatus made by 
Stanford Research Systems and are uncorrected. 
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Tetraethylammonium pccp (III.3): 




III3
Et4
 
Tetraethylammonium pccp (III.3) was prepared according to the procedure described in 
Chapter II, Section 2.3, compound II.37.  
 
Tris(acetonitrile)tricarbonylchromium(0) (III.4):[155] 
 
A mixture of cobalt hexacarbonyle (III.5, 20.0 g, 90.9 mmol, 1.00 eq) and acetonitrile 
(250 mL) was heated to gentle reflux for 24 h (95 °C oil bath temperature). In order to rinse 
sublimed cobalt hexacarbonyl back into the flask, the temperature was gradually increased 
after 24 h until strong reflux was reached and the mixture was stirred for 24 h at this 
temperature (140 °C oil bath temperature). Then, the mixture was allowed to cool to room 
temperature and the bulk of solvent was removed on the rotary evaporator. To the residue was 
added pentane (150 mL) and diethyl ether (100 mL), by what a monophasic solvent system 
was achieved, from which the product crystallized as a yellow powder. The solid was filtered 
under a stream of argon, washed with pentane (100 mL) and dried to yield III.4 as a yellow 
solid (22.5 g, 95 %).  
Since III.4 decomposes violently (spontaneous ignition) if exposed to air, it was stored and 
weighed in a glove box. 
 IR (neat): ṽ
 max = 2016, 1874, 1821, 1418, 1033. 
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Tris(acetonitrile)tricarbonylmolybdenum(0) (III.8):[155] 
 
A flask containing molybdenum hexacarbonyl (III.7, 1.00 g, 3.79 mmol, 1.00 eq) was cooled 
to −78 °C and evacuated. Then, acetonitrile (30.0 mL) was added (freezes) and the flask was 
flushed with argon. The resulting mixture was allowed to warm to room temperature and then 
heated to gentle reflux for 24 h (95 °C oil bath temperature). In order to rinse sublimed 
molybdenum hexacarbonyl back into the flask, the temperature was gradually increased after 
24 h until strong reflux was reached and the mixture was stirred for 48 h at this temperature 
(140 °C oil bath temperature). Then, the mixture was allowed to cool to room temperature and 
the bulk of solvent was removed on the rotary evaporator. To the residue was added pentane 
(18.0 mL) and diethyl ether (12.0 mL), by what a monophasic solvent system was achieved, 
from which the product crystallized as a dark yellow powder. The solid was filtered under a 
stream of argon, washed with pentane (15.0 mL) and dried to yield III.8 as a dark yellow 
solid (1.08 g, 94 %).  
Since III.8 rapidly decomposes if exposed to air, it was stored and weighed in a glove box or 
freshly prepared solutions of III.8 were directly used in subsequent reactions. 
IR (neat): ṽ
 max = 1920, 1796. 
 
Tris(acetonitrile)tricarbonyltungsten(0) (III.10):[155] 
C
C
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C
C
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eC refux 6 days
(95 %)
 
A flask containing tungsten hexacarbonyl (III.9, 1.00 g, 2.84 mmol, 1.00 eq) was cooled to 
−78 °C and evacuated. Then, acetonitrile (30.0 mL) was added (freezes) and the flask was 
flushed with argon. The resulting mixture was allowed to warm to room temperature and then 
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heated to gentle reflux for 24 h (95 °C oil bath temperature). In order to rinse sublimed 
molybdenum hexacarbonyl back into the flask, the temperature was gradually increased after 
24 h until strong reflux was reached and the mixture was stirred for 48 h at this temperature 
(140 °C oil bath temperature). Then, the mixture was allowed to cool to room temperature and 
the bulk of solvent was removed on the rotary evaporator. To the residue was added pentane 
(18.0 mL) and diethyl ether (12.0 mL), by what a monophasic solvent system was achieved, 
from which the product crystallized as a dark yellow powder. The solid was filtered under a 
stream of argon, washed with pentane (15.0 mL) and dried to yield III.10 as a brownish solid 
(1.05 g, 95 %).  
Since III.10 rapidly decomposes if exposed to air, it was stored and weighed in a glove box or 
freshly prepared solutions of III.10 were directly used in subsequent reactions. 
IR (neat): ṽ
 max = 1911, 1791. 
 
fac-[W(CO)3(NCCH2(3-C4H3S))3] complex (III.12):[156]  
 
A dry 50.0 mL flask was charged with tungsten hexacarbonyl (III.9, 1.00 g, 2.84 mmol, 
1.00 eq), cooled to −78 °C and evacuated. Acetonitrile (10.5 mL) was cannulated into the 
flask  (freezes) and the flask was flushed with argon. The mixture was allowed to warm to 
room temperature and was subsequently heated to reflux for 72 h. The mixture was allowed to 
cool to room temperature and then cooled to 0 °C. A solution of thiophene-3-acetonitrile 
(III.11, 970 µL, 8.53 mmol, 3.00 eq) in degassed acetonitrile (5.00 mL) was added and the 
mixture was allowed to warm up to be stirred for 2 h at room temperature. The mixture was 
filtered and the solvent was removed in vacuo. The resulting residue was washed with diethyl 
ether (25.0 mL) and dried to furnish III.12 as a pale brown solid (388 mg, 20 %). 
Since III.12 is air-sensitive, it was stored and weighed in a glove box. 
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1H NMR (400 MHz, CDCl3): δ = 7.37-7.33 (m, 3H), 7.26-7.24 (m, 3H), 7.04-7.01 (m, 3H), 
3.73 (s, 6H). 
13C NMR (150 MHz, CDCl3): δ = 196.3 (3C), 129.4 (3C), 127.2 (3C), 127.0 (3C), 123.1 
(3C), 117.6 (3C), 18.8 (3C). 
IR (neat): ṽ
 max = 2258, 1937, 1893, 1756. 
 
 
Triethylammonium pccp (III.13): 
 
Triethylammonium pccp (III.13) was prepared according to the procedure described in 
Chapter II, Section 3.2, compound II.52. 
 
Sodium pccp (III.14): 
 
Sodium pccp (III.14) was prepared according to the procedure described in Chapter II, 
Section 3.2, compound II.10. 
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Silver pccp (III.15):[152] 
 
To a solution of III.3 (513 mg, 1.60 mmol, 1.00 eq) in methanol (20.0 mL) was added silver 
nitrate (272 mg, 1.60 mmol, 1.00 eq) in one portion and the mixture was stirred for 1 h at 
room temperature. The resulting solid was filtered off, washed with methanol (2 x 10.0 mL) 
and diethyl ether (2 x 10.0 mL) and dried to give III.15 as a brown colored solid (396 mg, 
83 %). 
mp: > 400 °C. 
13C NMR (100 MHz, d6-DMSO): δ = 123.8 (5C), 112.9 (5C). 
IR (neat): ṽ
 max = 2219, 1622, 1485. 
 
Ferrocenium pccp (III.16): 
 
To a solution of ferrocene (III.33, 186 mg, 1.00 mmol, 1.00 eq) in acetone (8.00 mL) was 
added silver tetrafluoroborate (195 mg, 1.00 mmol, 1.00 eq) and the mixture was stirred for 
10 min at room temperature. Then, the suspension was filtered and the resulting blue colored 
filtrate containing III.34 was added to a solution of III.3 (320 mg, 1.00 mmol, 1.00 eq) in 
acetone (4.00 mL). The resulting deep green colored mixture was stirred for 24 h at room 
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temperature. III.16 was isolated from the mixture by allowing the solvent to evaporate over 
the course of two days until green crystals had formed, which were collected and washed with 
diethyl ether (2.00 mL). A second crop of product could be obtained by cooling the mother 
liquor to −25 °C (combined yield: 293 mg, 78 %).  
mp: 240 °C (dec.). 
13C NMR (100 MHz, d6-acetone): Due to the presence of paramagnetic iron(III), no signals 
were observed. 
IR (neat): ṽ
 max = 2215, 1469, 1393, 1052.  
UV/VIS: λmax = 252, 296, 389, 777. 
 
Decamethylferrocenium pccp (III.17): 
 
To a solution of decamethylferrocene (III.35, 326 mg, 1.00 mmol, 1.00 eq) in acetone 
(8.00 mL) was added silver tetrafluoroborate (195 mg, 1.00 mmol, 1.00 eq). The resulting 
suspension was stirred for 10 min at room temperature and filtered. The blue colored filtrate 
containing III.36 was added to a solution of III.3 (320 mg, 1.00 mmol, 1.00 eq) in acetone 
(4.00 mL). The resulting green colored mixture was stirred for 24 h at room temperature and 
then concentrated to a volume of ca. 4 mL. The residual suspension was heated to 60 °C, hot 
filtered and then allowed to cool to room temperature to give III.17 as green crystals. A 
second crop of III.17 was obtained by concentrating the mother liquor (combined yield: 
418 mg, 81 %).  
mp: 315 °C (dec.). 
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13C NMR (100 MHz, d6-acetone): 113.5, 102.8 (due to the presence of paramagnetic 
iron(III), no signals of the ferrocenium cation were observed). 
IR (neat): ṽ
 max = 2214, 1464, 1389, 1023.  
UV/VIS: λmax = 346, 390, 782. 
 
Decamethylmetallocenium (Fe0.67Cr0.33) pccp (III.18): 
 
To a mixture of III.17 (50.0 mg, 968 µmol, 3.00 eq) and III.4 (41.0 mg, 161 µmol, 5.00 eq) 
was added degassed acetone (5.00 mL) and the resulting mixture was heated to reflux for 
24 h. The mixture was allowed to cool to room temperature, cooled to 5 °C and filtered. Slow 
evaporation of solvent gave green crystals of III.18, which were washed with diethyl ether 
(1.00 mL) and dried (10.9 mg, 22 %).  
mp: 290 °C (dec.). 
13C NMR (100 MHz, d6-acetone): 113.1, 102.4 (due to the presence of paramagnetic 
iron(III), no signals of the ferrocenium cation were observed). 
IR (neat): ṽ
 max = 2213, 1464, 1390, 1053.  
UV/VIS: λmax = 304, 348, 401, 784. 
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(1,4,7-triazacyclononane)cobalt(III) trinitrite (III.21):[157] 
 
To a mixture of cobalt(II)nitrate hexahydrate (III.19, 327 mg, 1.12 mmol, 1.30 eq) and 
sodium nitrite (341 mg, 4.95 mmol, 5.90 eq) was added a buffer solution made of sodium 
hydroxide (899 mg, 22.5 mmol, 26.8 eq), acetic acid (2.57 mL, 44.9 mmol, 53.6 eq) and water 
(22.5 mL). The mixture was stirred and air was bubbled through the resulting solution. A 
mixture of 1,4,7-triazacyclononane trihydrochloride (III.20, 200 mg, 0.830 mmol, 1.00 eq), 
sodium hydroxide (101 mg, 2.51 mmol, 3.00 eq) and water (2.50 mL) was added dropwise to 
the reaction mixture. After complete addition, stirring and aeration was continued for 1 h, then 
the resulting yellow-green precipitate was collected, washed with water (100 mL) and acetone 
(5.00 mL) and dried in vacuo to afford III.21 as an amorphous powder (211 mg, 78 %). 
IR (neat): ṽ
 max = 3216. 
 
(1,4,7-triazacyclononane)cobalt(III) trichloride (III.22):[157] 
 
A suspension of [Co(TACN)(NO2)3)] (III.21, 64.0 mg, 0.179 mmol, 1.00 eq) in an aq. HCl 
solution (1.00 M, 3.50 mL, 3.57 mmol, 20.0 eq) was heated to 95 °C for 2.5 h. The resulting 
dark violet solution was concentrated to dryness. The blue-green residue was washed with 
water (3 x 1.00 mL) and acetone (1.00 mL) and dried to give III.22 as a turquoise solid 
(24.0 mg, 46 %). 
IR (neat): ṽ
 max = 3220. 
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Tris(aqua)tricarbonylrhenium(I) bromide (III.24):[158]  
 
A mixture of bromopentacarbonylrhenium bromide (III.23, 500 mg, 1.23 mmol, 1.00 eq) and 
water (5.00 mL) was heated to reflux. After 16 h, the condenser was rinsed with water 
(1.50 mL and refluxing was continued for another 8 h. Then, the mixture was allowed to cool 
to room temperature, filtered through a small plug of celite and concentrated to dryness to 
give III.24 as a slightly green colored solid (477 mg, 96 %). 
mp: 270 °C (dec.). 
IR (neat): ṽ
 max = 2025, 1941. 
 
Ditetraethylammonium tricarbonylrhenium(I) tribromide (III.25):[159] 
 
A suspension of rheniumpentacarbonyl bromide (III.23, 1.00 g, 2.46 mmol, 1.00 eq) in 
diglyme (16.0 mL) was heated to 50 °C. A second suspension of tetraethylammonium 
bromide (1.10 g, 5.26 mmol, 2.14 eq) in diglyme (51.0 mL) was heated to 70 °C and was then 
cannulated to the first suspension containing III.23. The resulting mixture was heated to 
110 °C for 5 h and was then allowed to cool to room temperature. The resulting precipitate 
was filtered off and dried. The crude mixture was purified by suspending in hot ethanol 
(8.00 mL) and filtration. The residual filter cake was washed with hot ethanol (2 x 5.00 mL) 
and dried to give III.25 as a colorless solid (1.50 g, 79 %). 
mp: 310 °C (dec.). 
IR (neat): ṽ
 max = 2000, 1866. 
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Tetrakis(tricarbonyl-µ3-hydroxo-rhenium (III.27): 
 
To a solution of sodium pccp (III.14, 23.0 mg, 111 µmol, 3.00 eq) in DMF (3.10 mL) was 
added tris(aqua)tricarbonylrhenium(I) bromide (III.24, 75.0 mg, 0.184 mmol, 5.00 eq). The 
mixture was heated to 80 °C for 24 h and was then allowed to cool to room temperature. The 
reaction mixture was filtered and the filtrate was subjected to water-diffusion for 14 days, 
upon which time crystals suitable for X-ray crystallography formed, which were collected and 
dried to afford III.27 (11.2 mg, 18 %) as a colorless solid. 
mp: 290 °C (dec.). 
IR (neat): ṽ
 max = 2027, 1921. 
1H NMR (300 MHz, d6-acetone): 6.50 (s, 4H). 
 
(1,4,7-triazacyclononane)(oxalato)cobalt(III) nitrite (III.29): 
 
A mixture of [(TACN)Co(NO2)3] (III.21, 36.5 mg, 0.102 mmol, 5.00 eq), disodium croconate 
(III.28, 11.4 mg, 0.061 mmol, 3.00 eq) and water (5.00 mL) was heated to 60 °C for 72 h. 
Then, the mixture was allowed to cool to room temperature and the flask was opened to allow 
for slow evaporation of solvent. After 14 days, crystals suitable for X-ray crystallography had 
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formed, which were collected and dried to furnish III.29 as an orange colored crystalline solid 
(28.3 mg, 86 %). 
mp: 210 °C (dec.). 
IR (neat): ṽ
 max = 3144, 1694, 1661. 
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1H NMR spectrum of I.338:  
 
13C NMR spectrum of I.338: 
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1H NMR spectrum of I.257: 
 
13C NMR spectrum of I.257: 
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1H NMR spectrum of I.250: 
 
13C NMR spectrum of I.250: 
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1H NMR spectrum of I.261: 
 
13C NMR spectrum of I.261: 
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1H NMR spectrum of I.258: 
 
13C NMR spectrum of I.258: 
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1H NMR spectrum of I.259: 
 
13C NMR spectrum of I.259: 
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1H NMR spectrum of I.341: 
 
13C NMR spectrum of I.341: 
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1H NMR spectrum of I.263: 
 
13C NMR spectrum of I.263: 
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1H NMR spectrum of I.264: 
 
13C NMR spectrum of I.264: 
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1H NMR spectrum of I.265: 
 
13C NMR spectrum of I.265: 
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1H NMR spectrum of I.266: 
 
13C NMR spectrum of I.266:  
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1H NMR spectrum of I.249: 
 
13C NMR spectrum of I.249:  
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1H NMR spectrum of I.273: 
 
13C NMR spectrum of I.273:  
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1H NMR spectrum of I.271: 
 
13C NMR spectrum of I.271:  
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1H NMR spectrum of I.272: 
 
13C NMR spectrum of I.272:  
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1H NMR spectrum of I.274: 
 
13C NMR spectrum of I.274:  
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1H NMR spectrum of I.275: 
 
13C NMR spectrum of I.275:  
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1H NMR spectrum of I.269: 
 
13C NMR spectrum of I.269:  
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1H NMR spectrum of I.269: 
 
13C NMR spectrum of I.269:  
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1H NMR spectrum of I.277: 
 
13C NMR spectrum of I.277:  
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1H NMR spectrum of I.269: 
 
13C NMR spectrum of I.269:  
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1H NMR spectrum of I.247: 
 
13C NMR spectrum of I.247:  
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1H NMR spectrum of I.245: 
 
13C NMR spectrum of I.245:  
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1H NMR spectrum of I.254: 
 
13C NMR spectrum of I.254:  
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1H NMR spectrum of I.282: 
 
13C NMR spectrum of I.282:  
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1H NMR spectrum of I.284: 
 
13C NMR spectrum of I.284:  
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1H NMR spectrum of I.289:  
 
13C NMR spectrum of I.289:  
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1H NMR spectrum of I.290:  
 
13C NMR spectrum of I.290:  
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1H NMR spectrum of I.291: 
 
13C NMR spectrum of I.291:  
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1H NMR spectrum of I.300: 
 
13C NMR spectrum of I.300:  
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1H NMR spectrum of I.301: 
 
13C NMR spectrum of I.301:  
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1H NMR spectrum of I.255: 
 
13C NMR spectrum of I.255:  
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1H NMR spectrum of I.303: 
 
13C NMR spectrum of I.303:  
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1H NMR spectrum of I.256: 
 
13C NMR spectrum of I.256:  
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1H NMR spectrum of I.298: 
 
13C NMR spectrum of I.298:  
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1H NMR spectrum of I.305: 
 
13C NMR spectrum of I.305:  
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1H NMR spectrum of I.322: 
 
13C NMR spectrum of I.322:  
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1H NMR spectrum of I.314: 
 
13C NMR spectrum of I.314:  
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1H NMR spectrum of I.315: 
 
13C NMR spectrum of I.315:  
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1H NMR spectrum of I.318: 
 
13C NMR spectrum of I.318:  
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1H NMR spectrum of I.317: 
 
13C NMR spectrum of I.317:  
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Appendix 2: Crystallographic Data of Chapter I 
The X-ray analysis was carried out by Dr. Peter Mayer in the analytics department in the 
Ludwig-Maximilians-Universität, München. The data collection was performed on an Oxford 
Diffraction Xcalibur diffractometer at −100 °C using MoKα-radiation (λ = 0.71073 Å, 
graphite monochromator). The CrysAlisPro software (version number 1.171.33.41)[163] was 
applied for the integration, scaling and multi-scan absorption correction of the data. The 
structures were solved by direct methods with SIR97[164] and refined by least-squares methods 
against F2 with SHELXL-97.[165]  
 
Single-Crystal X-ray Analysis for compound I.291 
 
 
Compound I.291 
net formula C8H9I3O2 
Mr/g mol−1 517.869 
crystal size/mm 0.19 × 0.14 × 0.09 
T/K 173(2) 
radiation MoKα 
diffractometer 'Oxford XCalibur' 
crystal system orthorhombic 
space group Pbca 
a/Å 5.8979(3) 
I1
C1
C2
C3
I2
C4 C7
C5
O1 O2
C6
I3
C8
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b/Å 13.0985(6) 
c/Å 31.4580(15) 
α/° 90 
β/° 90 
γ/° 90 
V/Å3 2430.2(2) 
Z 8 
calc. density/g cm−3 2.8309(2) 
µ/mm−1 7.687 
absorption correction 'multi-scan' 
transmission factor range 0.79863–1.00000 
refls. measured 9218 
Rint 0.0334 
mean σ(I)/I 0.0352 
θ range 4.26–26.35 
observed refls. 1876 
x, y (weighting scheme) 0.0254, 0 
hydrogen refinement constr 
refls in refinement 2460 
parameters 118 
restraints 0 
R(Fobs) 0.0270 
Rw(F2) 0.0562 
S 0.978 
shift/errormax 0.003 
max electron density/e Å−3 0.902 
min electron density/e Å−3 −0.694 
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Appendix 3: NMR Spectra and IR Spectra of Chapter II 
1H NMR spectrum of II.20/II.21: 
 
13C NMR spectrum of II.20/II.21:  
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1H NMR spectrum of II.22:  
 
13C NMR spectrum of II.22:  
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1H NMR spectrum of II.30: 
 
13C NMR spectrum of II.30:  
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1H NMR spectrum of II.31: 
 
13C NMR spectrum of II.31:  
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13C NMR spectrum of II.34:  
 
IR spectrum of II.34: 
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13C NMR spectrum of II.35:  
 
IR spectrum of II.35: 
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13C NMR spectrum of II.37:  
 
IR spectrum of II.37: 
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13C NMR spectrum of II.52:  
 
IR spectrum of II.52: 
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13C NMR spectrum of II.10:  
 
IR spectrum of II.10: 
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1H NMR spectrum of II.55: 
 
13C NMR spectrum of II.55:  
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1H NMR spectrum of II.11: 
 
13C NMR spectrum of II.11:  
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1H NMR spectrum of II.57: 
 
13C NMR spectrum of II.57:  
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1H NMR spectrum of II.12: 
 
13C NMR spectrum of II.12:  
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1H NMR spectrum of II.59: 
 
13C NMR spectrum of II.59:  
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1H NMR spectrum of II.13: 
 
13C NMR spectrum of II.13:  
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1H NMR spectrum of II.14: 
 
13C NMR spectrum of II.14:  
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1H NMR spectrum of II.15: 
 
13C NMR spectrum of II.15:  
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1H NMR spectrum of II.62: 
 
13C NMR spectrum of II.62:  
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1H NMR spectrum of II.63: 
 
13C NMR spectrum of II.63:  
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1H NMR spectrum of II.64:  
 
13C NMR spectrum of II.64:  
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1H NMR spectrum of II.17: 
 
13C NMR spectrum of II.17:  
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1H NMR spectrum of II.65: 
 
13C NMR spectrum of II.65:  
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1H NMR spectrum of II.16: 
 
13C NMR spectrum of II.16:  
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Appendix 4: Crystallographic Data of Chapter II 
The X-ray analysis was carried out by Dr. Peter Mayer in the analytics department and Prof. 
Dr. Karaghiosoff in the Ludwig-Maximilians-Universität, München. The data collection was 
performed on an Oxford Diffraction Xcalibur or KappaCCD diffractometers at −100 °C using 
MoKα-radiation (λ = 0.71073 Å, graphite monochromator). The CrysAlisPro software 
(version number 1.171.33.41)[163] was applied for the integration, scaling and multi-scan 
absorption correction of the data. The structures were solved by direct methods with 
SIR97[164] and refined by least-squares methods against F2 with SHELXL-97.[165]  
 
Single-Crystal X-ray Analysis for compound II.30 
 
Compound II.30 
net formula C10H9KN4O6 
Mr/g mol−1 320.31 
crystal size/mm 0.88× 2.19 × 0.15 
T/K 173(2) 
radiation MoKα 
diffractometer 'KappaCCD' 
crystal system triclinic 
space group P(−1) 
a/Å 7.3745(5) 
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b/Å 8.4899(6) 
c/Å 9.5893(6) 
α/° 96.261(5) 
β/° 91.385(5) 
γ/° 93.897(5) 
V/Å3 595.11(7) 
Z 2 
calc. density/g cm−3 1.788 
µ/mm−1 0.485 
absorption correction 'multi-scan' 
refls. measured 8916 
Rint 0.0279 
mean σ(I)/I 0.0264 
θ range 4.19– 26.00 
observed refls. 1937 
hydrogen refinement mixed 
refls in refinement 2328 
parameters 253 
restraints 0 
R(Fobs) 0.0333 
Rw(F2) 0.0928 
S 1.085 
shift/errormax 0.000 
max electron density/e Å−3 0.349 
min electron density/e Å−3 -0.530 
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Single-Crystal X-ray Analysis for compound II.35 
There are 0.5 toluene per formula unit; toluene is disordered and is not shown in the following 
figure. 
 
Compound II.35 
net formula C11.50H4N4S2 
Mr/g mol−1 262.314 
crystal size/mm 0.29 × 0.22 × 0.18 
T/K 173(2) 
radiation MoKα 
diffractometer 'KappaCCD' 
crystal system monoclinic 
space group C2/c 
a/Å 26.1954(4) 
b/Å 7.07390(10) 
c/Å 16.3214(2) 
α/° 90 
β/° 128.1483(8) 
γ/° 90 
V/Å3 2378.44(6) 
Z 8 
calc. density/g cm−3 1.46512(4) 
µ/mm−1 0.430 
absorption correction none 
refls. measured 9587 
S2
C2 C6 N2
N1
C5
C1
S1
C4
C8
N4
N3
C7
C3
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Rint 0.0156 
mean σ(I)/I 0.0156 
θ range 3.14–27.49 
observed refls. 2478 
x, y (weighting scheme) 0.0600, 2.1778 
hydrogen refinement undef 
refls in refinement 2726 
parameters 163 
restraints 0 
R(Fobs) 0.0340 
Rw(F2) 0.1048 
S 1.073 
shift/errormax 0.001 
max electron density/e Å−3 0.451 
min electron density/e Å−3 −0.290 
 
The hydrogen atoms of the disordered toluene molecule have not been considered in the 
refinement. 
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Single-Crystal X-ray Analysis for compound II.10 
The symmetry-generating C10N5 units as well as hydrogen atoms have been omitted for clarity 
with the exception of the respective coordinating N-atoms. Unlabeled atoms in C10N5 units are 
symmetry-generating.  
 
 
Compound II.10 
net formula C16H12N5NaO2 
Mr/g mol−1 329.289 
crystal size/mm 0.40 × 0.30 × 0.19 
T/K 173(2) 
radiation MoKα 
diffractometer 'Oxford Xcalibur' 
crystal system monoclinic 
space group C2/m 
a/Å 19.4091(14) 
b/Å 11.2357(8) 
c/Å 16.6773(14) 
α/° 90 
β/° 93.812(6) 
Na2
Na1
O2
C16
C18 C17
N2
C5
C2
C3
C6
N3
C1C4
N1
O1 C13
C15
C14O3
C19
C20
C21
O2i
C16i C17i
C18i
N5iii
N5ii N2
i
N4C10
C7
C8
C11
N5
C9
C12
N6
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γ/° 90 
V/Å3 3628.9(5) 
Z 8 
calc. density/g cm−3 1.20544(17) 
µ/mm−1 0.104 
absorption correction 'multi-scan' 
transmission factor range 0.74635–1.00000 
refls. measured 10091 
Rint 0.0344 
mean σ(I)/I 0.0365 
θ range 4.27–26.40 
observed refls. 3028 
x, y (weighting scheme) 0.0598, 0.6438 
hydrogen refinement constr 
refls in refinement 3873 
parameters 247 
restraints 0 
R(Fobs) 0.0409 
Rw(F2) 0.1196 
S 1.038 
shift/errormax 0.001 
max electron density/e Å−3 0.211 
min electron density/e Å−3 −0.238 
 
Symmetry code: i = x, −y, z; ii = 0.5−x, 0,5−y, 1−z; iii = 0.5−x, −1−y, z. 
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Single-Crystal X-ray Analysis for compound II.63 
 
Compound II.63 
net formula C58H66Br10O11 
Mr/g mol−1 1738.178 
crystal size/mm 0.21 × 0.04 × 0.02 
T/K 200(2) 
radiation MoKα 
diffractometer 'KappaCCD' 
crystal system monoclinic 
space group P21/c 
a/Å 21.4170(5) 
b/Å 12.4879(2) 
c/Å 25.0458(6) 
α/° 90 
β/° 105.0069(9) 
γ/° 90 
V/Å3 6470.1(2) 
Z 4 
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calc. density/g cm−3 1.78443(6) 
µ/mm−1 6.248 
absorption correction multi-scan 
transmission factor range 0.5960–0.7303 
refls. measured 75308 
Rint 0.0896 
mean σ(I)/I 0.0618 
θ range 3.22–25.36 
observed refls. 7736 
x, y (weighting scheme) 0.0540, 26.7326 
hydrogen refinement constr 
refls in refinement 11800 
parameters 729 
restraints 1 
R(Fobs) 0.0552 
Rw(F2) 0.1411 
S 1.018 
shift/errormax 0.002 
max electron density/e Å−3 3.208 
min electron density/e Å−3 −1.388 
 
Bromide is disordered over three sites, split model applied, sof ratio: 0.35442  : 0.45264 :  
0.19294. 
 
Solution of the structures of compounds II.11, II.15, II.22, and II.17 requires further 
refinement, which is carried out by Dr. Peter Mayer in the analytics department in the 
Ludwig-Maximilians-Universität München. Illustrations of these compounds shown in 
Chapter II are based on preliminary data, as also mentioned under the respective Figures. 
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Appendix 5: NMR and IR Spectra of Chapter III, Magnetic 
Properties of III.17 
1H NMR spectrum of III.12:  
 
13C NMR spectrum of III.12:  
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13C NMR spectrum of III.16: 
 
IR spectrum III.16: 
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13C NMR spectrum of III.17:  
 
IR spectrum of DMferrocenium pccp (III.17): 
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13C NMR spectrum III.18:  
 
IR spectrum of III.18: 
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Magnetic properties of compound III.17 
The magnetic characterizations of  III.17 was performed on a MPMS-XL5 SQUID 
magnetometer made by Quantum Design Inc.[166] by Rainer Frankovsky (group of Prof. Dr. 
D. Johrendt, Ludwig-Maximilians-Universität München) at the laboratories of Prof. Dr. T. 
Fässler (TU Munich). The magnetometer was controlled and data were collected with the 
MPMS MultiVu software[167]. For the measurement, 14 mg of substance were put into a 
gelatine capsule, which was fixed in a straw as sample holder. The generated data file was 
processed with the fully automatic SQUID processor software[168] and corrections were made 
for diamagnetic contributions of the sample holder and the diamagnetic increments of the 
ions, which can be found in[169]. 
Compound III.17 is paramagnetic between 1.8 K and 380 K. The inverse susceptibility was 
fitted with the extended Curie-Weiss law (1.8 K – 380 K)[169] to obtain an effective moment of 
2.65 µB per formula unit (Figure App.5a) and which is in good agreement with the listed value 
of 2.5 µB for Fe3+ with low spin configuration[169].  
 
 
Figure App.5a: Magnetic susceptibility (blue) vs. temperature and inverse susceptibility (black) fitted with the 
extended Curie-Weiss law (red) of III.17. 
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Appendix 6: Crystallographic Data of Chapter III 
The X-ray analysis was carried out by Dr. Peter Mayer in the analytics department in the 
Ludwig-Maximilians-Universität, München. The data collection was performed on an Oxford 
Diffraction Xcalibur or KappaCCD or Bruker D8Quest diffractometers at −100 °C using 
MoKα-radiation (λ = 0.71073 Å, graphite monochromator). The CrysAlisPro software 
(version number 1.171.33.41)[163] was applied for the integration, scaling and multi-scan 
absorption correction of the data. The structures were solved by direct methods with 
SIR97[164] and refined by least-squares methods against F2 with SHELXL-97.[165]  
 
Single-Crystal X-ray Analysis for compound III.3 
 
Compound III.3 (Cc isomorph) III.3 (Pc isomorph) 
net formula C18H20N6 C18H20N6 
Mr/g mol−1 320.392 320.392 
crystal size/mm 0.23 × 0.08 × 0.04 0.27 × 0.15 × 0.08 
T/K 173(2) 173(2) 
radiation MoKα MoKα 
diffractometer 'KappaCCD' 'Oxford Xcalibur' 
crystal system monoclinic monoclinic 
space group Cc Pc 
a/Å 13.8374(6) 12.3823(17) 
b/Å 20.8710(8) 20.721(3) 
c/Å 6.9984(3) 7.1748(12) 
α/° 90 90 
C4
C9
N4
C3
C8
N3
C2
C7
N2
C1
C6
N1
C5C10N5
C14C13
N6
C15
C16
C17
C18
C11
C12
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β/° 117.991(2) 102.583(16) 
γ/° 90 90 
V/Å3 1784.71(13) 1796.6(5) 
Z 4 4 
calc. density/g cm−3 1.19242(9) 1.1845(3) 
µ/mm−1 0.076 0.075 
absorption correction none 'multi-scan' 
refls. measured 5869 9394 
Rint 0.0396 0.0753 
mean σ(I)/I 0.0303 0.0685 
θ range 3.37–25.33 4.16–25.34 
observed refls. 1453 2789 
x, y (weighting scheme) 0.0482, 0.3533 0.0340, 0 
hydrogen refinement constr constr 
Flack parameter 0(3) −1(3) 
refls in refinement 1628 3290 
parameters 221 441 
restraints 2 2 
R(Fobs) 0.0341 0.0450 
Rw(F2) 0.0852 0.1042 
S 1.036 1.051 
shift/errormax 0.001 0.001 
max electron density/e Å−3 0.121 0.145 
min electron density/e Å−3 −0.163 −0.173 
 
Flack parameter meaningless,  1470 Friedel pairs merged, 2734 Friedel pairs  
merged. 
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Single-Crystal X-ray Analysis for compound III.17 
 
Compound III.17 
net formula C30H30FeN5 
Mr/g mol−1 516.438 
crystal size/mm 0.13 × 0.08 × 0.07 
T/K 173(2) 
radiation MoKα 
diffractometer 'KappaCCD' 
crystal system orthorhombic 
space group Cmc21 
a/Å 14.5774(4) 
b/Å 13.1067(4) 
c/Å 13.7993(5) 
α/° 90 
β/° 90 
γ/° 90 
V/Å3 2636.52(14) 
Z 4 
calc. density/g cm−3 1.30108(7) 
µ/mm−1 0.600 
absorption correction none 
C7
C7ii
C8
ii
C9
C8
C11
C10
C10
ii
C11
ii
C12
C6
ii
C5
ii
C4
C5
C6
C3
ii
C2
ii
C1
C2C3
Fe1
N2
C17
C14
C15
C18
N3
C13
C16
N1
C13
i
C16
i
N1
i
C14
i
C17
i
N2
i
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refls. measured 10568 
Rint 0.0333 
mean σ(I)/I 0.0315 
θ range 3.44–27.49 
observed refls. 2850 
x, y (weighting scheme) 0.0313, 0.7778 
hydrogen refinement constr 
Flack parameter −0.015(14) 
refls in refinement 3110 
parameters 181 
restraints 1 
R(Fobs) 0.0285 
Rw(F2) 0.0651 
S 1.067 
shift/errormax 0.001 
max electron density/e Å−3 0.409 
min electron density/e Å−3 −0.212 
 
1488 Friedel pairs measured. 
Symmetry code: i = −x, y, x; ii = 1−x, y, z 
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Single-Crystal X-ray Analysis for compound III.18 
 
Compound III.18 
net formula C30H30Cr0.33Fe0.67N5 
Mr/g mol−1 515.168 
crystal size/mm 0.17 × 0.09 × 0.07 
T/K 173(2) 
radiation MoKα 
diffractometer 'KappaCCD' 
crystal system monoclinic 
space group P21/c 
a/Å 17.9099(4) 
b/Å 16.9951(3) 
c/Å 18.4217(3) 
α/° 90 
β/° 108.0576(12) 
Fe1
Fe2
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γ/° 90 
V/Å3 5331.02(17) 
Z 8 
calc. density/g cm−3 1.28376(4) 
µ/mm−1 0.548 
absorption correction none 
refls. measured 34214 
Rint 0.0499 
mean σ(I)/I 0.0419 
θ range 3.16–25.34 
observed refls. 7155 
x, y (weighting scheme) 0.0349, 2.8816 
hydrogen refinement constr 
refls in refinement 9706 
parameters 671 
restraints 0 
R(Fobs) 0.0394 
Rw(F2) 0.0952 
S 1.028 
shift/errormax 0.001 
max electron density/e Å−3 0.297 
min electron density/e Å−3 −0.226 
 
Fe/Cr-disorder: both Fe sites are occupied by Cr as well, sof ratio Fe/Cr = 2/1. 
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Single-Crystal X-ray Analysis for compound III.27 
 
Compound III.27∙DMF∙3H2O 
net formula C18H23N2O20.5Re4 
Mr/g mol−1 1340.204 
crystal size/mm 0.186 × 0.175 × 0.151 
T/K 200(2) 
radiation 'Mo Kα 
diffractometer 'Bruker D8Quest' 
crystal system trigonal 
space group P3221 
a/Å 17.2248(2) 
b/Å 17.2248(2) 
c/Å 13.3495(4) 
α/° 90 
β/° 90 
γ/° 120 
V/Å3 3430.08(12) 
Z 3 
calc. density/g cm−3 1.94645(7) 
µ/mm−1 10.611 
absorption correction multi-scan 
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transmission factor range 0.2124–0.3378 
refls. measured 80723 
Rint 0.0338 
mean σ(I)/I 0.0151 
θ range 2.36–27.61 
observed refls. 5045 
x, y (weighting scheme) 0.0366, 11.5936 
hydrogen refinement mixed 
Flack parameter −0.050(17) 
refls in refinement 5278 
parameters 205 
restraints 0 
R(Fobs) 0.0268 
Rw(F2) 0.0746 
S 1.211 
shift/errormax 0.001 
max electron density/e Å−3 1.348 
min electron density/e Å−3 −0.735 
 
Water hydrogens are not included, all other H: constr. 
Symmetry code i = y, x, −z. 
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Single-Crystal X-ray Analysis for compound III.27 
 
Compound III.27∙dioxane∙acetone 
net formula C23H26O21Re4 
Mr/g mol−1 1383.268 
crystal size/mm 0.25 × 0.22 × 0.20 
T/K 173(2) 
radiation MoKα 
diffractometer 'Oxford Xcalibur' 
crystal system tetragonal 
space group P42212 
a/Å 14.7154(2) 
b/Å 14.7154(2) 
c/Å 15.0385(4) 
α/° 90 
β/° 90 
γ/° 90 
V/Å3 3256.48(11) 
Z 4 
calc. density/g cm−3 2.82146(10) 
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µ/mm−1 14.907 
absorption correction 'multi-scan' 
transmission factor range 0.55301–1.00000 
refls. measured 30274 
Rint 0.0382 
mean σ(I)/I 0.0241 
θ range 4.11–30.50 
observed refls. 4722 
x, y (weighting scheme) 0.0194, 5.7767 
hydrogen refinement constr 
Flack parameter 0.499(15) 
refls in refinement 4959 
parameters 213 
restraints 1 
R(Fobs) 0.0213 
Rw(F2) 0.0499 
S 1.120 
shift/errormax 0.002 
max electron density/e Å−3 0.971 
min electron density/e Å−3 −1.880 
 
Acetone disordered, split model applied, sof fixed to 0.5. 
Refined as racemic twin. 
Symmetry code: i = 1−y, 1−x, −z.  
Disordered acetone not depicted in figure.  
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Single-Crystal X-ray Analysis for compound III.29 
 
Compound III.29 
net formula C8H15CoN4O6 
Mr/g mol−1 322.161 
crystal size/mm 0.15 × 0.07 × 0.02 
T/K 173(2) 
radiation MoKα 
diffractometer 'KappaCCD' 
crystal system orthorhombic 
space group Pbca 
a/Å 13.1338(5) 
b/Å 10.5900(3) 
c/Å 16.6901(6) 
α/° 90 
β/° 90 
γ/° 90 
V/Å3 2321.38(14) 
Z 8 
calc. density/g cm−3 1.84362(11) 
Co1
N4
O5
O6
N3
C5
C6
N1
C4
C1
C2
N2
C3
O2
O1
C8
O4
O3
C7
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µ/mm−1 1.511 
absorption correction none 
refls. measured 13451 
Rint 0.0608 
mean σ(I)/I 0.0327 
θ range 3.47–25.36 
observed refls. 1688 
x, y (weighting scheme) 0.0399, 1.2695 
hydrogen refinement constr 
refls in refinement 2120 
parameters 172 
restraints 0 
R(Fobs) 0.0310 
Rw(F2) 0.0803 
S 1.054 
shift/errormax 0.001 
max electron density/e Å−3 0.441 
min electron density/e Å−3 −0.328 
 
 
 
Solution of the structures of compound III.6 requires further refinement, which is carried out 
by Dr. Peter Mayer in the analytics department in the Ludwig-Maximilians-Universität 
München. The illustration of III.6 shown in Chapter III, Section 3.2.1, Figure III.12 is based 
on preliminary data, as also mentioned under the respective Figure. 
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Appendix 7: Computational Details 
All calculations were performed by Dr. Elena Herrero-Gómez with Gaussian03.[170] The 
method was B3LYP.[171] The inner electrons of Cr were described by an effective core 
potential (SDD),[172] and the associated double-ζ basis set was used for the outer electrons. 
The 6-31G(d) basis set was used for H, C, N.[173] The starting complex structure was taken 
from available X-ray structures.[153] Optimizations of the ligands and anionic complexes were 
performed. The nature of the stationary points as local minima was confirmed through 
frequency calculations. No solvation effects were considered in these calculations 
(Scheme App.7a). 
 
 
Scheme App.7a: SCF Energies and Free Energies (in brackets) in kcal·mol-1 
 
Cartesian Coordinates (in Å) and Absolute Energies (in a.u.) 
Cartesian coordinates of C3_AcCN (E =  -825.334125110 a.u.) 
--------------------------------------------------------------------------------------------------------- 
 Center Atomic Atomic  Coordinates (Angstroms) 
 Number Number Type  X  Y  Z 
 --------------------------------------------------------------------------------------------------------- 
    1  6   0  0.973218 1.179828 1.612754 
    2  7  0  -0.626547 1.526326 -0.659442 
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    3  8  0  1.577687 1.925306 2.275265 
    4  6  0  0.603614 -1.422540 1.600513 
    5  7  0   -1.025677 -1.288275 -0.674301 
    6  8  0  0.974544 -2.313460 2.255268 
    7  6  0  -0.999036 2.420559 -1.298818 
    8  7  0  1.612743 -0.226540 -0.721779 
    9  8  0  -2.397481 0.324268 2.347612 
   10  6  0  -1.643085 -2.024921 -1.324939 
   11  6  0  2.548030 -0.356256 -1.396748 
   12  6   0   -1.466010 0.196950 1.657492 
   13          24              0          0.013826    -0.006264     0.559311 
   14           6              0         -1.475245     3.568985    -2.062026 
   15           1              0         -1.703272     3.280446    -3.093604 
   16           1              0         -2.383789     3.975995    -1.605012 
   17           1              0         -0.713703     4.356092    -2.080144 
   18           6              0          3.750784    -0.523893    -2.205101 
   19           1              0          3.491658    -0.667299    -3.259469 
   20           1              0          4.391948     0.360170    -2.120356 
   21           1              0          4.317116    -1.397109    -1.863505 
   22           6              0         -2.425639    -2.978606    -2.103539 
   23           1              0         -3.468573    -2.976042    -1.768604 
   24           1              0         -2.400771    -2.722037    -3.167945 
   25           1              0         -2.023862    -3.990001    -1.978871 
----------------------------------------------------------------------------------------------------------------- 
Cartesian coordinates of AcCN (E =  −132.754924908 a.u.) 
----------------------------------------------------------------------------------------------------------------- 
 Center  Atomic      Atomic              Coordinates (Angstroms) 
 Number      Number       Type               X            Y           Z 
----------------------------------------------------------------------------------------------------------------- 
    1           7              0         −1.440859     0.000842    −0.001490 
    2           6              0         −0.280454    −0.001984     0.003541 
    3           6              0          1.180943     0.000412    −0.000725 
    4           1              0          1.565401    −0.226419     0.998722 
    5           1              0          1.559875   −0.751922    −0.699710 
    6           1              0         1.557805    0.981881   −0.305480 
 ---------------------------------------------------------------------------------------------------------------- 
Cartesian coordinates of C5_unit(E =  −654.845730687 a.u.) 
----------------------------------------------------------------------------------------------------------------- 
 Center      Atomic      Atomic              Coordinates (Angstroms) 
 Number      Number       Type               X            Y            Z 
 ---------------------------------------------------------------------------------------------------------------- 
    1           6              0         0.083319     1.204672    −0.000293 
    2           7              0          0.260492     3.781214     0.006349 
    3           6              0         −1.119728     0.451172    −0.000804 
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    4           7             0         −3.515658     1.415579    −0.005051 
    5           6              0         −0.774958    −0.925943    −0.000179 
    6           7              0        −2.435103    −2.904336     0.005002 
    7           6              0          0.641165    −1.023472     0.000272 
    8           7              0          2.012325    −3.212128    −0.001864 
    9           6              0          1.171510     0.293064    −0.000041 
   10           7              0          3.676975     0.920090    −0.003303 
   11           6              0          0.180480     2.618173    −0.000311 
   12           6              0         −2.434234     0.980211    −0.001723 
   13           6              0         −1.685788    −2.011258    −0.000613 
   14           6              0          1.393296    −2.224268     0.001941 
   15           6              0          2.546068     0.637159     0.000430 
 ---------------------------------------------------------------------------------------------------------------- 
Cartesian coordinates of Crplex 1(E =  −1347.42339992 a.u.) 
----------------------------------------------------------------------------------------------------------------- 
 Center      Atomic      Atomic              Coordinates (Angstroms) 
 Number      Number       Type               X            Y            Z 
 ---------------------------------------------------------------------------------------------------------------- 
    1           6              0          2.776791    −0.363932    −2.136672 
    2           7              0          2.259895     1.715359    −0.306276 
    3           8              0          2.893931    −0.387614    −3.297722 
    4           6              0          2.847925    −2.163217    −0.226063 
    5           7              0          2.359738    −0.235655     1.749955 
    6           8              0          3.016740    −3.317340    −0.183891 
    7           6              0          1.978049     2.839440    −0.345097 
    8           8              0          5.603331     0.067097    −0.037176 
    9           6              0          2.168344    −0.210593     2.894109 
   10           6              0          4.447092    −0.083173    −0.133777 
   11          24              0          2.621809    −0.326617    −0.289762 
   12           6              0          1.585668     4.242293    −0.414801 
   13           1              0          2.071303     4.816426     0.381760 
   14           1              0          1.877574     4.667810    −1.381130 
   15           1              0          0.497180     4.312714    −0.303257 
   16           6              0          1.939360    −0.198765     4.334335 
   17           1              0          2.831496    0.156636     4.861577 
   18           1              0          1.100671     0.460644     4.582410 
   19           1              0          1.703299    −1.207940     4.689356 
   20           6              0         −2.001984    −0.263818    −0.218526 
   21           7              0          0.563714    −0.449311    −0.347524 
   22           6              0         −2.700261     0.973875    −0.124787 
   23           7              0         −1.598503     3.306491    −0.074374 
   24           6              0         −4.088660     0.691517    −0.047469 
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   25           7              0         −5.973268     2.445672     0.154863 
   26           6              0         −4.250949    −0.717546    −0.092146 
   27           7              0         −6.500746    −1.981686     0.014951 
   28           6              0         −2.963997    −1.308288    −0.196782 
   29           7              0         −2.470520    −3.841211    −0.295523 
   30           6              0         −0.599955    −0.397743    −0.297621 
   31           6              0         −2.103259     2.255447    −0.100162 
   32           6              0         −5.125648     1.650940     0.062053 
   33           6              0         −5.484840    −1.412775    −0.034911 
   34           6              0         −2.690198    −2.697367    −0.254791 
 ---------------------------------------------------------------------------------------------------------------- 
Cartesian coordinates of Crplex2 (E =  −1869.45832005  a.u.) 
----------------------------------------------------------------------------------------------------------------- 
 Center      Atomic      Atomic              Coordinates (Angstroms) 
 Number      Number       Type               X            Y            Z 
 ---------------------------------------------------------------------------------------------------------------- 
    1           6              0         −1.289829     3.798115     0.597631 
    2           7              0         −0.001548     1.685174     2.023517 
    3           8              0         −2.088997     4.600495     0.891947 
    4           6              0          0.004089     3.191821    −1.607381 
    5           8              0          0.006294     3.621569    −2.692649 
    6           6              0         −0.003124     1.084838     3.014551 
    7           8              0          2.105874     4.586520     0.889864 
    8           6              0          1.301251     3.789040     0.597075 
    9          24              0          0.001304     2.559282     0.132407 
   10           6              0         −0.005368     0.289974     4.236635 
   11           1              0          0.887412    −0.345540     4.249817 
   12           1              0          0.000273     0.943317     5.116096 
   13           1              0         −0.905342    −0.335148     4.253296 
   14           6              0         −3.405738    −0.532165    −0.360335 
   15           7              0         −1.455622     1.149375    −0.251923 
   16           6              0         −3.871777    −1.277183     0.760242 
   17           7              0         −2.906652    −1.190413     3.152552 
   18           6              0         −4.973255    −2.067402     0.338656 
   19           7              0         −6.352304    −3.671430     1.820445 
   20           6              0         −5.191125    −1.812572    −1.040465 
   21           7              0         −7.039510    −2.881868    −2.493478 
   22           6              0         −4.224625    −0.865373    −1.472881 
   23           7              0         −4.051536     0.073753    −3.872256 
   24           6              0         −2.331832     0.384400    −0.335876 
   25           6              0         −3.339195    −1.229922     2.070331 
   26           6              0         −5.728070    −2.948362     1.151553 
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   27           6              0         −6.202943    −2.398414    −1.840701 
   28           6              0         −4.118173    −0.344773    −2.786354 
   29           6             0          3.402221    −0.538796    −0.355842 
   30           7              0         1.449303     1.139717    −0.250669 
   31           6              0          3.861711    −1.291006     0.762610 
   32           7              0          2.879603    −1.220973     3.148559 
   33           6             0          4.967437    −2.076397     0.343147 
   34           7              0          6.339187    −3.688270     1.823189 
   35           6              0          5.194121    −1.811776    −1.032709 
   36           7              0          7.054108    −2.867957    −2.480513 
   37           6              0          4.229194    −0.862970    −1.465109 
   38           7              0          4.071119     0.092601    −3.859015 
   39           6              0          2.326762     0.375896    −0.332214 
   40           6              0          3.319918    −1.253409     2.069242 
   41           6              0          5.718210    −2.961668     1.155091 
  42           6              0          6.212298    −2.390443    −1.830109 
   43           6              0          4.130838    −0.333459    −2.775643 
 ---------------------------------------------------------------------------------------------------------------- 
Cartesian coordinates of Crplex3 (E = −2391.42383805  a.u.) 
----------------------------------------------------------------------------------------------------------------- 
 Center      Atomic      Atomic              Coordinates (Angstroms) 
 Number      Number       Type               X            Y            Z 
 ---------------------------------------------------------------------------------------------------------------- 
    1           6              0          1.168200     0.938403     3.258396 
    2           8              0          1.896348     1.505535     3.975086 
    3           6              0          0.248087    −1.492788     3.251474 
    4           8              0          0.376728    −2.410796     3.963016 
    5           8              0         −2.247520     0.862539     3.986726 
    6           6              0         −1.394730     0.520190     3.264810 
    7          24              0          0.004231    −0.007630     2.174424 
    8           6              0          3.790648    −1.190643    −0.231479 
    9           7              0          1.591979    −0.552683     0.957236 
   10           6              0          4.345319    −0.592078    −1.396649 
   11           7              0          3.353209     1.330880    −2.805990 
   12           6              0          5.588978    −1.221146    −1.667816 
   13           7              0          7.208009    −0.675820    −3.604986 
   14           6              0          5.807562    −2.209638    −0.671640 
   15           7              0          7.878695    −3.744011    −0.505658 
   16           6              0          4.698929    −2.191661     0.215461 
   17          7              0          4.484565    −3.731318     2.277486 
   18           6              0          2.572339    −0.839668     0.394624 
   19           6              0          3.783907     0.460877    −2.160829 
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   20           6              0          6.470243    −0.917696    −2.734222 
   21           6              0          6.940213    −3.054527    −0.578319 
   22           6              0          4.559208    −3.028855     1.349831 
   23           6              0         −2.946357    −2.684998    −0.202790 
   24           7              0         −1.273827    −1.106353     0.965507 
   25           6              0         −4.310898    −2.853284     0.166286 
   26           7              0         −5.614529    −1.647924     2.041416 
   27           6              0        −4.876677   −3.846890    −0.675770 
   28           7              0         −7.305980    −4.720987    −0.599244 
   29           6              0         −3.865438    −4.295518   −1.566485 
   30           7              0         −4.170304    −6.118179    −3.370984 
   31           6              0         −2.674540    −3.579499    −1.275038 
   32           7              0         −0.430752    −3.932791    −2.503378 
   33           6              0         −2.022788    −1.808881     0.412759 
   34           6              0         −5.007893    −2.177124     1.197945 
   35           6              0         −6.210394    −4.320970    −0.631943 
   36           6              0         −4.025383    −5.292224    −2.559904 
   37           6              0         −1.436379    −3.757193    −1.940739 
   38           6              0         −0.847783     3.877978    −0.215416 
   39           7              0         −0.315998     1.648106     0.967486 
   40           6              0         −0.372649     5.155375     0.196000 
   41           7              0          1.189590     5.712229     2.175334 
   42           6              0         −0.924665     6.132800    −0.673658 
   43           7              0         −0.543462     8.684454    −0.550633 
   44           6              0         −1.741723     5.464040    −1.623622 
   45           7              0         −3.083914     6.615517    −3.506154 
   46           6             0         −1.694853     4.073354    −1.341415 
   47           7             0         −2.988140     2.277581    −2.672201 
   48           6              0         −0.551376     2.643975     0.408191 
   49           6              0          0.488126     5.437995     1.285202 
   50           6              0         −0.710942     7.530977    −0.604138 
   51           6              0         −2.478655     6.087569    −2.660020 
   52           6              0         −2.394295     3.074084    −2.062666 
 ---------------------------------------------------------------------------------------------------------------- 
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Appendix 8: Screening Tables 
 
 
Figure App.8a: Chemical structure of pccp salts and of disodium croconate 
 
 
Entry Pccp salt Additive Solvent Temperature Time Observation 
1 Et4N, III.3 - MeCN reflux 16 h starting material 
2 Et4N, III.3 -  MeCN r.t. 6 d starting material[a] 
3 Et4N, III.3 - MeCN reflux 6 d complex mixture 
4 Et4N, III.3 -  toluene reflux 48 h starting material 
5 Et4N, III.3 - THF reflux 48 h complex mixture 
6 Et4N, III.3 - DMSO 100 °C 48 h complex mixture 
7 Et4N, III.3 - DME reflux 48 h complex mixture 
8 Et4N, III.3 - diglyme reflux 48 h complex mixture 
9 Et4N, III.3 - acetone reflux 48 h complex mixture 
10 Et4N, III.3 C60 (III.6) o-C6H4Cl2 reflux 96 h starting material[b] 
11 Et4N, III.3 C60 (III.6) acetone reflux 48 h complex mixture 
12 HNEt3, III.13 - MeCN reflux 16 h starting material 
13 HNEt3, III.13 - MeCN reflux 6 d complex mixture 
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14 Ag, III.15 - MeCN[c] reflux 16 h complex mixture 
15 Ag, III.15 - MeCN[c] reflux 6 d complex mixture 
16 Ag, III.15 -  MeCN[c] r.t. 6 d starting material 
17 Ag, III.15 - DMSO[c] 120 °C 48 h complex mixture 
18 Ag, III.15 C60 (III.6) o-C6H4Cl2 reflux 72 h complex mixture 
19 Na, III.14 - MeCN reflux 16 h starting material 
20 Na, III.14 - MeCN reflux 6 d complex mixture 
21 Na, III.14 -  MeCN r.t. 6 d starting material 
22 Na, III.14 -  toluene reflux 48 h starting material 
23 Na, III.14 - THF reflux 48 h complex mixture 
24 Na, III.14 - DME reflux 48 h complex mixture 
25 Na, III.14 - diglyme reflux 48 h complex mixture 
26 Na, III.14 C60 (III.6) o-C6H4Cl2 reflux 72 h starting material 
27 cp2Fe, III.16 - MeCN reflux 16 h complex mixture[d] 
28 cp2Fe, III.16 -  MeCN r.t. 6 d complex mixture[d] 
29 cp2Fe, III.16 -  THF 50 °C 16 h complex mixture[d] 
30 cp2Fe, III.16 -  DMF r.t. 16 h complex mixture[d] 
31 cp2Fe, III.16 C60 (III.6) o-C6H4Cl2 80 °C 16 h complex mixture[d] 
32 cp*2Fe, III.17 - MeCN reflux 16 h complex mixture[e] 
33 cp*2Fe, III.17 -  MeCN r.t. 6 d complex mixture[e] 
34 cp*2Fe, III.17 -  acetone reflux 24 h complex mixture[e,f] 
35 cp*2Fe, III.17 C60 (III.6) o-C6H4Cl2 r.t. 16 h complex mixture[e] 
36 cp*2Fe, III.17 C60 (III.6) benzene reflux 16 h complex mixture[e] 
[a] Upon recrystallization, crystalline material of III.3 was obtained (Cc-cell, Chapter III, Section 3.2.1, 
Figure III.13) [b] crystal structure of C60∙o-C6H4Cl2 was obtained upon recrystallization (Chapter III, Section 3.2.1, 
Figure III.12); [c] reaction was performed as a suspension due to low solubility of III.15; [d] ferrocene (III.33) was 
formed during the reaction, which could be separated by filtration and was the only reaction product that could be 
characterized; [e] decamethylferrocene (III.35) was formed during the reaction, which could be separated by 
filtration and was the only reaction product that could be characterized; [f] crystal structure of 
decamethylmetallocenium (Fe0.67Cr0.33) pccp (III.18) was obtained upon recrystallization (Chapter III, 
Section 3.2.1, Figure III.17) 
Table App.8a: Conditions and observations for self-assembly of III.4 with pccp salts. 
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Entry Pccp salt Additive Solvent Temperature Time Observation 
1 Et4N, III.3 - MeCN reflux 96 h complex mixture 
2 Et4N, III.3 - DME reflux 24 h complex mixture 
3 Et4N, III.3 - diglyme reflux 48 h complex mixture 
4 Et4N, III.3 C60 (III.6) o-C6H4Cl2 reflux 96 h starting material 
5 Ag, III.15 - MeCN[a] reflux 16 h complex mixture 
6 Na, III.14 - MeCN reflux 72 h starting material 
7 Na, III.14 - MeCN reflux 6 d complex mixture 
8 Na, III.14 -  MeCN r.t. 6 d starting material 
9 Na, III.14 - DME reflux 48 h complex mixture 
10 cp*2Fe, III.17 - MeCN reflux 16 h complex mixture 
[a] Reaction was performed as a suspension due to low solubility of III.15. 
Table App.8b: Conditions and observations for self-assembly of III.7 with pccp salts. 
 
 
Entry Pccp salt Additive Solvent Temperature Time Observation 
1 Et4N, III.3 - MeCN reflux 6 d complex mixture 
2 Et4N, III.3 - DME reflux 96 h complex mixture 
3 Et4N, III.3 - MeCN microwave, 80 °C 2 h complex mixture[a] 
4 Et4N, III.3 C60 (III.6) o-C6H4Cl2 reflux 96 h starting material 
5 Ag, III.15 - MeCN[b] reflux 16 h complex mixture 
6 Na, III.14 - MeCN reflux 16 h complex mixture 
7 Na, III.14 - MeCN reflux 6 d complex mixture 
8 Na, III.14 -  DME r.t. 6 d complex mixture 
9 Na, III.14 - diglyme reflux 48 h complex mixture 
10 Na, III.14 - dioxane reflux 24 h complex mixture 
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11 cp*2Fe, III.17 - MeCN reflux 16 h complex mixture 
[a] Upon recrystallization crystalline material of III.3 was obtained (Cc-cell, Chapter III, Section 3.2.1, 
Figure III.13); [b] reaction was performed as a suspension due to low solubility of III.15. 
Table App.8c: Conditions and observations for self-assembly of III.10 with pccp salts. 
 
 
Entry Pccp salt Additive Solvent Temperature Time Observation 
1 Et4N, III.3 - MeCN reflux 6 d complex mixture 
2 Et4N, III.3 - DME reflux 24 h complex mixture 
3 Et4N, III.3 C60 (III.6) o-C6H4Cl2 reflux 72 h starting material[a] 
4 Na, III.14 - MeCN reflux 16 h complex mixture 
5 Na, III.14 -  DME r.t. 6 d complex mixture 
6 Na, III.14 - DMSO 80 °C 24 h complex mixture 
7 cp*2Fe, III.17 - MeCN reflux 16 h complex mixture 
[a] Upon recrystallization crystalline material of III.3 was obtained (Cc-cell, Chapter III, Section 3.2.1, 
Figure III.13). 
Table App.8d: Conditions and observations for self-assembly of III.12 with pccp salts. 
 
 
Entry Pccp salt Additive Solvent Temperature Time Observation 
1 Et4N, III.3 - CD3CN r.t. 18 h starting material 
2 Et4N, III.3 - CD2Cl2[a] r.t. 18 h complex mixture 
3 Et4N, III.3 - d6-acetone r.t. 18 h starting material 
4 Et4N, III.3 - H2O/EtOH reflux 1 h complex mixture 
5 Et4N, III.3 -  THF reflux 1 h complex mixture 
6 Et4N, III.3 C60 (III.6) o-C6H4Cl2 80 °C 24 h complex mixture 
7 Na, III.14 - MeCN reflux 16 h complex mixture 
[a] Reaction was performed as a suspension due to low solubility of III.3. 
Table App.8e: Conditions and observations for self-assembly of III.26 with pccp salts. 
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Entry Pccp salt Additive Solvent Non-solvent Time Observation 
1 Et4N, III.3 - H2O, THF Et2O 2 d starting material 
2 Et4N, III.3 - H2O, acetone EtOAc 20 d starting material 
3 Et4N, III.3 - diglyme Et2O 4 d starting material 
4 Et4N, III.3 - diglyme CHCl3 11 d starting material 
5 Et4N, III.3 - ionic liquid III.37 MeNO2, Et2O 18 d complex mixture 
6 Et4N, III.3 - ionic liquid III.37 THF 14 d complex mixture 
7 Et4N, III.3 - ionic liquid III.37 CHCl3 12 d complex mixture 
8 Et4N, III.3 - DMSO Et2O[a] 12 d starting material[b] 
9 Et4N, III.3 C60 (III.6) o-C6H4Cl2[c] -[d] 52 d starting material 
10 HNEt3, III.13 - H2O, acetone Et2O 3 d starting material 
11 Na, III.15 - H2O, acetone[e] Et2O 3 d complex mixture 
12 Na, III.15 - H2O, acetone[e] CHCl3 5 d complex mixture 
13 Na, III.15 - MeCN Et2O 2 d complex mixture 
14 Na, III.15 - MeCN CHCl3 4 d complex mixture 
15 Na, III.15 - MeCN -[d] 5 d complex mixture 
16 Na, III.15 - DMSO Et2O 4 d complex mixture 
17 Na, III.15 - DMSO EtOAc 18 d complex mixture 
18 Na, III.15 - DMSO MTBE 4 d complex mixture 
19 Na, III.15 - DMSO CH2Cl2 4 d complex mixture 
20 Na, III.15 - DMSO CHCl3 4 d complex mixture 
21 Na, III.15 - DMSO H2O 14 d complex mixture 
22 Na, III.15 - DMSO EtOH 21 d complex mixture 
23 Na, III.15 - dioxane, H2O acetone 21 d formation of III.27[f] 
24 Na, III.15 - DMF Et2O 5 d complex mixture 
25 Na, III.15 - DMF EtOAc 5 d complex mixture 
26 Na, III.15 - DMF MTBE 5 d complex mixture 
27 Na, III.15 - DMF CH2Cl2 16 d complex mixture 
N
N
PF6
III.37
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28 Na, III.15 - DMF CHCl3 8 d complex mixture 
29 Na, III.15 - DMF benzene 8 d complex mixture 
30 Na, III.15 - DMF H2O 20 d formation of III.27[g] 
31 Na, III.15 - DMF EtOH 8 d complex mixture 
32 Na, III.15 - MeNO2 Et2O 3 d complex mixture 
33 Na, III.15 - MeNO2 CH2Cl2 3 d complex mixture 
34 Na, III.15 - MeNO2 -[d] 25 d complex mixture 
35 Ag, III.14 - H2O[h] - - starting material 
36 Ag, III.14 - DMSO[h] - - starting material 
37 Ag, III.14 - DMF[h] - - starting material 
38 cp2Fe, III.16 - acetone -[d] 6 d starting material 
39 cp2Fe, III.16 C60 (III.6) acetone -[d] 8 d starting material 
40 cp2Fe, III.16 - MeCN -[d] 5 d complex mixture 
41 cp2Fe, III.16 - DMF Et2O 5 d complex mixture 
42 cp*2Fe, III.17 - MeCN -[d] 10 d complex mixture 
43 cp*2Fe, III.17 - acetone -[d] 10 d complex mixture 
44 cp*2Fe, III.17 C60 (III.6) acetone -[d] 10 d complex mixture 
45 cp*2Fe, III.17 - DMF Et2O 3 d complex mixture 
46 cp*2Fe, III.17 - DMSO Et2O 3 d complex mixture 
47 cp*2Fe, III.17 - MeNO2 Et2O 3 d complex mixture 
48 III.28 - H2O -[d] 24 d complex mixture 
49 III.28 - H2O acetone 12 d complex mixture 
[a] Initially, a biphasic system of Et2O over DMSO was obtained; solvens diffusion was then triggered by addition 
of 2 drops of THF to the ether layer [b] crystalline material of III.3 was obtained (Cc-cell, Chapter III, Section 3.2.1, 
Figure III.13); [c] Reaction was performed as a suspension due to low solubility of III.14; [d] sample was filtered 
and solvent was allowed to evaporate; [e] mixture was heated to 60 °C until a homogenous solution was obtained 
(30 min); [f] III.27∙dioxane∙acetone was obtained as a crystalline solid (for crystal structure see Chapter III, 
Section 3.2.1, Figure III.19); [g] III.27∙DMF∙3H2O was obtained as a crystalline solid (for crystal structure see 
Chapter III, Section 3.2.1, Figure III.18); [h] Reaction was performed as a suspension due to low solubility of 
III.14. 
Table App.8f: Conditions and observations for self-assembly of III.24 with pccp salts and III.28. 
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Entry Pccp salt Additive Solvent Temperature Time Observation 
1 Et4N, III.3 - MeCN reflux 48 h starting material 
2 Et4N, III.3 - acetone reflux 48 h starting material[a] 
3 Et4N, III.3 - DMSO 100 °C 48 h starting material 
4 Et4N, III.3 NaPF6 MeCN reflux 48 h starting material 
5 Na, III.15 -  MeCN reflux 48 h formation of III.3[b] 
6 Na, III.15 - acetone reflux 48 h formation of III.3 [b] 
7 Na, III.15 - DMSO 100 °C 48 h formation of III.3 
8 Na, III.15 NaPF6 MeCN reflux 48 h formation of III.3 
9 Ag, III.14 - H2O[c] reflux 48 h complex mixture 
10 Ag, III.14 - DMSO[c] 100 °C 48 h complex mixture 
11 Ag, III.14 - DMF[c] 100 °C 48 h complex mixture 
12 cp2Fe, III.16 - MeCN reflux 48 h formation of III.3 
13 cp2Fe, III.16 - acetone reflux 48 h formation of III.3 
14 cp2Fe, III.16 - DMSO 100 °C 48 h complex mixture 
15 cp*2Fe, III.17 - MeCN reflux 48 h formation of III.3 
16 cp*2Fe, III.17 - acetone reflux 48 h formation of III.3 [b] 
17 cp*2Fe, III.17 - DMSO 100 °C 48 h complex mixture 
[a] crystalline material of III.3 was obtained (Pc-cell, Chapter III, Section 3.2.1, Figure III.14); [b] crystalline 
material of III.3 was obtained (Cc-cell, Chapter III, Section 3.2.1, Figure III.13); [c] Reaction was performed as a 
suspension due to low solubility of III.14. 
Table App.8g: Conditions and observations for self-assembly of III.25 with pccp salts. 
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Entry Pccp salt Additive Solvent Temperature Time Observation 
1 Et4N, III.3 - DMSO 100 °C 72 h complex mixture 
2 Et4N, III.3 - H2O, acetone reflux 72 h complex mixture 
3 Ag, III.14 - DMSO 100 °C 72 h complex mixture 
4 Na, III.15 - DMSO 100 °C 72 h complex mixture 
5 cp*2Fe, III.17 - DMSO 100 °C 72 h complex mixture 
6 III.28 - H2O reflux 72 h formation of III.29[a] 
[a] upon slow evaporation of solvent on air, crystalline material of III.29 was obtained after 14 days (for crystal 
structure see Chapter III, Section 3.2.1, Figure III.20). 
Table App.8h: Conditions and observations for self-assembly of III.21 with pccp salts and III.28. 
 
 
Entry Pccp salt Additive Solvent Temperature Time Observation 
1 Et4N, III.3 - DMSO[a] 100 °C 72 h complex mixture 
2 Et4N, III.3 - H2O, acetone[a] reflux 72 h complex mixture 
3 Ag, III.14 - DMSO[a] 100 °C 72 h complex mixture 
4 Na, III.15 - DMSO[a] 100 °C 72 h complex mixture 
5 cp*2Fe, III.17 - DMSO[a] 100 °C 72 h complex mixture 
6 III.28 - H2O[a] reflux 72 h complex mixture 
[a] Reaction was performed as a suspension due to low solubility of III.22. 
Table App.8i: Conditions and observations for self-assembly of III.22 with pccp salts and III.28. 
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